Document:

ex_434224.htm

Exhibit 10.1

 

SECURITIES PURCHASE AGREEMENT

 

This Securities Purchase Agreement (this “Agreement”) is dated as of October 18, 2022, between RiceBran Technologies, a California corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

 

WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to (i) an effective registration statement under the Securities Act (as defined below) as to the Shares, the Pre-Funded Warrants and Pre-Funded Warrant Shares (each as defined below) and (ii) an exemption from the registration requirements of Section 5 of the Securities Act contained in Section 4(a)(2) thereof as to the Common Warrants and the Common Warrant Shares (each as defined below), the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement.

 

NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows:

 

ARTICLE I.

DEFINITIONS

 

1.1          Definitions. In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms have the meanings set forth in this Section 1.1:

 

“Acquiring Person” shall have the meaning ascribed to such term in Section 4.5.

 

“Action” shall have the meaning ascribed to such term in Section 3.1(j).

 

“Affiliate” means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control with a Person as such terms are used in and construed under Rule 405 under the Securities Act.

 

“Board of Directors” means the board of directors of the Company.

 

“Business Day” means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized or required by law to remain closed; provided, however, for clarification, commercial banks shall not be deemed to be authorized or required by law to remain closed due to “stay at home”, “shelter-in-place”, “non-essential employee”  or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York generally are open for use by customers on such day.

 

“Closing” means the closing of the purchase and sale of the Securities pursuant to Section 2.1.

 

 

 

 

 

“Closing Date” means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties thereto, and all conditions precedent to (i) the Purchasers’ obligations to pay the Subscription Amount and (ii) the Company’s obligations to deliver the Securities, in each case, have been satisfied or waived, but in no event later than the second (2nd) Trading Day following the date hereof.

 

“Commission” means the United States Securities and Exchange Commission.

 

“Common Stock” means the common stock of the Company, no par value per share, and any other class of securities into which such securities may hereafter be reclassified or changed.

 

“Common Stock Equivalents” means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.

 

“Common Warrants” means, collectively, the Common Stock purchase warrants delivered to the Purchasers at the Closing in accordance with Section 2.2(a) hereof, which Common Warrants shall be exercisable six months after issuance and have a term of exercise equal to two and one-half (2.5) years after the initial exercise date, in the form of Exhibit A-1 attached hereto.

 

“Common Warrant Shares” means the Common Stock issuable upon exercise of the Common Warrants

 

“Company Counsel” means Vinson & Elkins L.L.P., with offices located at 845 Texas Ave Suite 4700, Houston, Texas 77002.

 

“Disclosure Schedules” means the Disclosure Schedules of the Company delivered concurrently herewith.

 

“Disclosure Time” means, (i) if this Agreement is signed on a day that is not a Trading Day or after 9:00 a.m. (New York City time) and before midnight (New York City time) on any Trading Day, 9:01 a.m. (New York City time) on the Trading Day immediately following the date hereof, unless otherwise instructed as to an earlier time by the Placement Agent, and (ii) if this Agreement is signed between midnight (New York City time) and 9:00 a.m. (New York City time) on any Trading Day, no later than 9:01 a.m. (New York City time) on the date hereof, unless otherwise instructed as to an earlier time by the Placement Agent.

 

“EGS” means Ellenoff Grossman & Schole LLP, with offices located at 1345 Avenue of the Americas, New York, New York 10105-0302.

 

“Evaluation Date” shall have the meaning ascribed to such term in Section 3.1(s).

 

2

 

 

“Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

 

“Exempt Issuance” means the issuance of (a) securities to employees, officers or directors of the Company pursuant to any equity plan duly adopted for such purpose, by a majority of the non-employee members of the Board of Directors or a majority of the members of a committee of non-employee directors established for such purpose for services rendered to the Company, (b) securities upon the exercise or exchange of or conversion of any Securities issued hereunder, warrants to the Placement Agent in connection with the transactions pursuant to this Agreement and any securities upon exercise of warrants to the Placement Agent and/or other securities exercisable or exchangeable for or convertible into shares of Common Stock issued and outstanding on the date of this Agreement, provided that such securities have not been amended since the date of this Agreement to increase the number of such securities or to decrease the exercise price, exchange price or conversion price of such securities (other than pursuant to the terms of such securities) or to extend the term of such securities, (c) securities issued pursuant to acquisitions or strategic transactions approved by a majority of the disinterested directors of the Company, provided that such securities are issued as “restricted securities” (as defined in Rule 144) and carry no registration rights that require or permit the filing of any registration statement in connection therewith during the prohibition period in Section 4.11(a) herein, and provided that any such issuance shall only be to a Person (or to the equityholders of a Person) which is, itself or through its subsidiaries, an operating company or an owner of an asset in a business synergistic with the business of the Company and shall provide to the Company additional benefits in addition to the investment of funds, but shall not include a transaction in which the Company is issuing securities primarily for the purpose of raising capital or to an entity whose primary business is investing in securities and (d) securities to an individual or entity providing services to the Company or its Subsidiaries in connection with such services, provided that such securities are issued as “restricted securities” (as defined in Rule 144) and carry no registration rights that require or permit the filing of any registration statement in connection therewith during the prohibition period in Section 4.11(a) herein.

 

“FCPA” means the Foreign Corrupt Practices Act of 1977, as amended.

 

“GAAP” shall have the meaning ascribed to such term in Section 3.1(h).

 

“Indebtedness” shall have the meaning ascribed to such term in Section 3.1(aa).

 

“Intellectual Property Rights” shall have the meaning ascribed to such term in Section 3.1(p).

 

“Legend Removal Date” shall have the meaning ascribed to such term in Section 4.1(c).

 

“Liens” means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.

 

3

 

 

“Lock-Up Agreement” means the Lock-Up Agreement, dated as of the date hereof, by and among the Company and the directors and officers of the Company, in the form of Exhibit B attached hereto.

 

“Material Adverse Effect” shall have the meaning assigned to such term in Section 3.1(b).

 

“Material Permits” shall have the meaning ascribed to such term in Section 3.1(n).

 

“Per Share Purchase Price” equals $1.50, subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the date of this Agreement, provided that the purchase price per Pre-Funded Warrant shall be the Per Share Purchase Price minus $0.0001.

 

“Person” means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.

 

“Placement Agent” means H.C. Wainwright & Co., LLC.

 

“Pre-Funded Warrants” means, collectively, the pre-funded Common Stock purchase warrants delivered to the Purchasers at the Closing in accordance with Section 2.2(a) hereof, which Pre-Funded Warrants shall be exercisable immediately and will expire when exercised in full, substantially in the form of Exhibit A-2 attached hereto.

 

“Pre-Funded Warrant Shares” means the Common Stock issuable upon exercise of the Pre-Funded Warrants.

 

“Proceeding” means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding, such as a deposition), whether commenced or threatened.

 

“Prospectus” means the final prospectus filed for the Registration Statement.

 

“Prospectus Supplement” means the supplement to the Prospectus complying with Rule 424(b) of the Securities Act that is filed with the Commission and delivered by the Company to each Purchaser at the Closing.

 

“Purchaser Party” shall have the meaning ascribed to such term in Section 4.8.

 

“Registration Statement” means the effective registration statement with Commission file No. 333-266194 which registers the sale of the Shares, the Pre-Funded Warrants and the Pre-Funded Warrant Shares to the Purchasers.

 

“Required Approvals” shall have the meaning ascribed to such term in Section 3.1(e).

 

4

 

 

“Rule 144” means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.

 

“Rule 424” means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.

 

“SEC Reports” shall have the meaning ascribed to such term in Section 3.1(h).

 

“Securities” means the Shares, the Warrants and the Warrant Shares.

 

“Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

 

“Shares” means the shares of Common Stock issued or issuable to each Purchaser pursuant to this Agreement, but excluding the Warrant Shares.

 

“Short Sales” means all “short sales” as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall not be deemed to include locating and/or borrowing shares of Common Stock). 

 

“Subscription Amount” means, as to each Purchaser, the aggregate amount to be paid for Shares and Warrants purchased hereunder as specified below such Purchaser’s name on the signature page of this Agreement and next to the heading “Subscription Amount,” in United States dollars and in immediately available funds (minus, if applicable, a Purchaser’s aggregate exercise price of the Pre-Funded Warrants, which amounts shall be paid as and when such Pre-Funded Warrants are exercised for cash).

 

“Subsidiary” means any subsidiary of the Company as set forth on Schedule 3.1(a).

 

“Trading Day” means a day on which the principal Trading Market is open for trading.

 

“Trading Market” means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, or the New York Stock Exchange (or any successors to any of the foregoing).

 

“Transaction Documents” means this Agreement, the Warrants, the Lock-Up Agreements, all exhibits and schedules thereto and hereto and any other documents or agreements executed in connection with the transactions contemplated hereunder.

 

5

 

 

“Transfer Agent” means American Stock Transfer & Trust Company, the current transfer agent of the Company, with a mailing address of 6201 15th Avenue, Brooklyn, New York 11219, and any successor transfer agent of the Company.

 

“Variable Rate Transaction” shall have the meaning ascribed to such term in Section 4.11(b).

 

“VWAP” means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b)  if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.

 

“Warrants” means, collectively, the Common Warrants and the Pre-Funded Warrants.

 

“Warrant Shares” means, collectively, the Common Warrant Shares and the Pre-Funded Warrant Shares.

 

6

 

 

ARTICLE II.

PURCHASE AND SALE

 

2.1          Closing. On the Closing Date, upon the terms and subject to the conditions set forth herein, substantially concurrent with the execution and delivery of this Agreement by the parties hereto, the Company agrees to sell, and the Purchasers, severally and not jointly, agree to purchase, up to an aggregate of $1,500,000 of Shares and Common Warrants; provided, however, that to the extent that a Purchaser determines, in its sole discretion, that such Purchaser (together with such Purchaser’s Affiliates, and any Person acting as a group together with such Purchaser or any of such Purchaser’s Affiliates) would beneficially own in excess of the Beneficial Ownership Limitation, or as such Purchaser may otherwise choose, in lieu of purchasing Shares, such Purchaser may elect to purchase Pre-Funded Warrants in such manner to result in the same aggregate purchase price being paid by such Purchaser to the Company. The “Beneficial Ownership Limitation” shall be 4.99% (or, with respect to each Purchaser, at the election of such Purchaser at Closing, 9.99%) of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of the Securities on the Closing Date. Each Purchaser’s Subscription Amount as set forth on the signature page hereto executed by such Purchaser shall be made available for “Delivery Versus Payment” settlement with the Company or its designee. The Company shall deliver to each Purchaser its respective Shares and Warrants as determined pursuant to Section 2.2(a), and the Company and each Purchaser shall deliver the other items set forth in Section 2.2 deliverable at the Closing. Upon satisfaction of the covenants and conditions set forth in Sections 2.2 and 2.3, the Closing shall take place remotely by electronic transfer of the Closing documentation. Notwithstanding anything herein to the contrary, if at any time on or after the time of execution of this Agreement by the Company and an applicable Purchaser, through and including the time immediately prior to the Closing (the “Pre-Settlement Period”), such Purchaser sells to any Person all, or any portion, of the Shares to be issued hereunder to such Purchaser at the Closing (collectively, the “Pre-Settlement Shares”), such Purchaser shall, automatically hereunder (without any additional required actions by such Purchaser or the Company), be deemed to be unconditionally bound to purchase, such Pre-Settlement Shares to such Purchaser at the Closing; provided, that the Company shall not be required to deliver any Pre-Settlement Shares to such Purchaser prior to the Company’s receipt of the purchase price of such Pre-Settlement Shares hereunder; and provided, further, that the Company hereby acknowledges and agrees that the forgoing shall not constitute a representation or covenant by such Purchaser as to whether or not during the Pre-Settlement Period such Purchaser shall sell any shares of Common Stock to any Person and that any such decision to sell any shares of Common Stock by such Purchaser shall solely be made at the time such Purchaser elects to effect any such sale, if any. Unless otherwise directed by the Placement Agent, settlement of the Shares shall occur via “Delivery Versus Payment” (i.e., on the Closing Date, the Company shall issue the Shares registered in the Purchasers’ names and addresses and released by the Transfer Agent directly to the account(s) at the Placement Agent identified by each Purchaser; upon receipt of such Shares, the Placement Agent shall promptly electronically deliver such Shares to the applicable Purchaser, and payment therefor shall be made by the Placement Agent (or its clearing firm) by wire transfer to the Company).

 

2.2          Deliveries.

 

(a)          On or prior to the Closing Date (except as indicated below), the Company shall deliver or cause to be delivered to each Purchaser the following:

 

(i)    this Agreement duly executed by the Company;

 

(ii)    a legal opinion of Company Counsel, in form and substance reasonably satisfactory to the Placement Agent;

 

(iii)    subject to Section 2.1, the Company shall have provided each Purchaser with the Company’s wire instructions, on Company letterhead and executed by the Chief Executive Officer or Chief Financial Officer;

 

(iv)    subject to Section 2.1, a copy of the irrevocable instructions to the Transfer Agent instructing the Transfer Agent to deliver on an expedited basis via The Depository Trust Company Deposit or Withdrawal at Custodian system Shares equal to such Purchaser’s Subscription Amount divided by the Per Share Purchase Price (minus the number of shares of Common Stock issuable upon exercise of such Purchaser’s Pre-Funded Warrant, if applicable), registered in the name of such Purchaser;

 

7

 

 

(v)    for each Purchaser of Pre-Funded Warrants pursuant to Section 2.1, a Pre-Funded Warrant registered in the name of such Purchaser to purchase up to a number of shares of Common Stock equal to the portion of such Purchaser’s Subscription Amount applicable to Pre-Funded Warrant divided by the Per Share Purchase Price minus $0.0001, with an exercise price equal to $0.0001, subject to adjustment therein;

 

(vi)    a Common Warrant registered in the name of such Purchaser to purchase up to a number of shares of Common Stock equal to 200% of the sum of such Purchaser’s Shares and Pre-Funded Warrant Shares initially issuable upon exercise of the Pre-Funded Warrants, if applicable, with an exercise price equal to $1.60, subject to adjustment therein;

 

(vii)    the duly executed Lock-Up Agreements; and

 

(viii)    the Prospectus and Prospectus Supplement (which may be delivered in accordance with Rule 172 under the Securities Act).

 

(b)         On or prior to the Closing Date, each Purchaser shall deliver or cause to be delivered to the Company the following:

 

(i)    this Agreement duly executed by such Purchaser; and

 

(ii)    such Purchaser’s Subscription Amount, which shall be made available for “Delivery Versus Payment” settlement with the Company or its designee.

 

2.3          Closing Conditions. 

 

(a)          The obligations of the Company hereunder in connection with the Closing are subject to the following conditions being met:

 

(i)    the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect, in all respects) on the Closing Date of the representations and warranties of the Purchasers contained herein (unless as of a specific date therein in which case they shall be accurate in all material respects (or to the extent representations or warranties are qualified by materiality or Material Adverse Effect, in all respects) as of such date);

 

(ii)    all obligations, covenants and agreements of each Purchaser required to be performed at or prior to the Closing Date shall have been performed; and

 

8

 

 

(iii)    the delivery by each Purchaser of the items set forth in Section 2.2(b) of this Agreement.

 

(b)          The respective obligations of the Purchasers hereunder in connection with the Closing are subject to the following conditions being met:

 

(i)    the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect, in all respects) when made and on the Closing Date of the representations and warranties of the Company contained herein (unless as of a specific date therein in which case they shall be accurate in all respects (or to the extent representations or warranties are qualified by materiality or Material Adverse Effect, in all respects) as of such date);

 

(ii)    all obligations, covenants and agreements of the Company required to be performed at or prior to the Closing Date shall have been performed;

 

(iii)    the delivery by the Company of the items set forth in Section 2.2(a) of this Agreement;

 

(iv)    there shall have been no Material Adverse Effect with respect to the Company since the date hereof; and

 

(v)    from the date hereof to the Closing Date, trading in the Common Stock shall not have been suspended by the Commission or the Company’s principal Trading Market, and, at any time prior to the Closing Date, trading in securities generally as reported by Bloomberg L.P. shall not have been suspended or limited, or minimum prices shall not have been established on securities whose trades are reported by such service, or on any Trading Market, nor shall a banking moratorium have been declared either by the United States or New York State authorities nor shall there have occurred any material outbreak or escalation of hostilities or other national or international calamity of such magnitude in its effect on, or any material adverse change in, any financial market which, in each case, in the reasonable judgment of such Purchaser, makes it impracticable or inadvisable to purchase the Securities at the Closing.

 

ARTICLE III.

REPRESENTATIONS AND WARRANTIES

 

3.1          Representations and Warranties of the Company. Except as set forth in the Disclosure Schedules, which Disclosure Schedules shall be deemed a part hereof and shall qualify any representation or otherwise made herein to the extent of the disclosure contained in the corresponding section of the Disclosure Schedules, the Company hereby makes the following representations and warranties to each Purchaser:

 

(a)        Subsidiaries. All of the direct and indirect subsidiaries of the Company are set forth on Schedule 3.1(a). The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.

 

9

 

 

(b)        Organization and Qualification. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized, validly existing and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite power and authority to own and use its properties and assets and to carry on its business as currently conducted. Neither the Company nor any Subsidiary is in violation nor default of any of the provisions of its respective certificate or articles of incorporation, bylaws or other organizational or charter documents. Each of the Company and the Subsidiaries is duly qualified to conduct business and is in good standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, could not have or reasonably be expected to result in: (i) a material adverse effect on the legality, validity or enforceability of any Transaction Document, (ii) a material adverse effect on the results of operations, assets, business, prospects or condition (financial or otherwise) of the Company and the Subsidiaries, taken as a whole, or (iii) a material adverse effect on the Company’s ability to perform in any material respect on a timely basis its obligations under any Transaction Document (any of (i), (ii) or (iii), a “Material Adverse Effect”) and no Proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail such power and authority or qualification.

 

(c)         Authorization; Enforcement. The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the consummation by it of the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company and no further action is required by the Company, the Board of Directors or the Company’s stockholders in connection herewith or therewith other than in connection with the Required Approvals. This Agreement and each other Transaction Document to which it is a party has been (or upon delivery will have been) duly executed by the Company and, when delivered in accordance with the terms hereof and thereof, will constitute the valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors’ rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.

 

10

 

 

(d)          No Conflicts. The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to which it is a party, the issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby and thereby do not and will not (i) conflict with or violate any provision of the Company’s or any Subsidiary’s certificate or articles of incorporation, bylaws or other organizational or charter documents, or (ii) conflict with, or constitute a default (or an event that with notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties or assets of the Company or any Subsidiary, or give to others any rights of termination, amendment, anti-dilution or similar adjustments, acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument (evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by which any property or asset of the Company or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority to which the Company or a Subsidiary is subject (including federal and state securities laws and regulations), or by which any property or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and (iii), such as could not have or reasonably be expected to result in a Material Adverse Effect.

 

(e)         Filings, Consents and Approvals. The Company is not required to obtain any consent, waiver, authorization or order of, give any notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority or other Person in connection with the execution, delivery and performance by the Company of the Transaction Documents, other than: (i) the filings required pursuant to Section 4.4 of this Agreement, (ii) the filing with the Commission of the Prospectus Supplement, (iii) application(s) to each applicable Trading Market for the listing of the Shares and Warrant Shares for trading thereon in the time and manner required thereby, and (iv) such filings as are required to be made under applicable state securities laws (collectively, the “Required Approvals”).

 

(f)         Issuance of the Securities; Registration. The Securities are duly authorized and, when issued and paid for in accordance with the applicable Transaction Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company. The Warrant Shares, when issued in accordance with the terms of the Warrants, will be validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company. The Company has reserved from its duly authorized capital stock the maximum number of shares of Common Stock issuable pursuant to this Agreement and the Warrants. The Company has prepared and filed the Registration Statement in conformity with the requirements of the Securities Act, which became effective on July 27, 2022, including the Prospectus, and such amendments and supplements thereto as may have been required to the date of this Agreement. The Registration Statement is effective under the Securities Act and no stop order preventing or suspending the effectiveness of the Registration Statement or suspending or preventing the use of the Prospectus has been issued by the Commission and no proceedings for that purpose have been instituted or, to the knowledge of the Company, are threatened by the Commission. The Company, if required by the rules and regulations of the Commission, shall file the Prospectus with the Commission pursuant to Rule 424(b). At the time the Registration Statement and any amendments thereto became effective, at the date of this Agreement and at the Closing Date, the Registration Statement and any amendments thereto conformed and will conform in all material respects to the requirements of the Securities Act and did not and will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein not misleading; and the Prospectus and any amendments or supplements thereto, at the time the Prospectus or any amendment or supplement thereto was issued and at the Closing Date, conformed and will conform in all material respects to the requirements of the Securities Act and did not and will not contain an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. The Company was at the time of the filing of the Registration Statement eligible to use Form S-3. The Company is eligible to use Form S-3 under the Securities Act and it meets the transaction requirements with respect to the aggregate market value of securities being sold pursuant to this offering and during the twelve (12) months prior to this offering, as set forth in General Instruction I.B.6 of Form S-3.

 

11

 

 

(g)        Capitalization. The capitalization of the Company as of the date hereof is as set forth on Schedule 3.1(g), which Schedule 3.1(g) shall also include the number of shares of Common Stock owned beneficially, and of record, by Affiliates of the Company as of the date hereof. The Company has not issued any capital stock since its most recently filed periodic report under the Exchange Act, other than pursuant to the exercise of employee stock options under the Company’s stock option plans, the issuance of shares of Common Stock to employees pursuant to the Company’s employee stock purchase plans and pursuant to the conversion and/or exercise of Common Stock Equivalents outstanding as of the date of the most recently filed periodic report under the Exchange Act. Except as set forth on Schedule 3.1(g), no Person has any right of first refusal, preemptive right, right of participation, or any similar right to participate in the transactions contemplated by the Transaction Documents. Except as a result of the purchase and sale of the Securities or as set forth on Schedule 3.1(g), there are no outstanding options, warrants, scrip rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities, rights or obligations convertible into or exercisable or exchangeable for, or giving any Person any right to subscribe for or acquire, any shares of Common Stock or the capital stock of any Subsidiary, or contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to issue additional shares of Common Stock or Common Stock Equivalents or capital stock of any Subsidiary. Except as set forth on Schedule 3.1(g), including exhibits thereto and documents incorporated by reference therein, the issuance and sale of the Securities will not obligate the Company or any Subsidiary to issue shares of Common Stock or other securities to any Person (other than the Purchasers), and there are no outstanding securities or instruments of the Company or any Subsidiary with any provision that adjusts the exercise, conversion, exchange or reset price of such security or instrument upon an issuance of securities by the Company or any Subsidiary. There are no outstanding securities or instruments of the Company or any Subsidiary that contain any redemption or similar provisions, and there are no contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to redeem a security of the Company or such Subsidiary. The Company does not have any stock appreciation rights or “phantom stock” plans or agreements or any similar plan or agreement. All of the outstanding shares of capital stock of the Company are duly authorized, validly issued, fully paid and nonassessable, have been issued in compliance with all federal and state securities laws, and none of such outstanding shares was issued in violation of any preemptive rights or similar rights to subscribe for or purchase securities. No further approval or authorization of any stockholder, the Board of Directors or others is required for the issuance and sale of the Securities. Except as set forth on Schedule 3.1(g), including exhibits thereto and documents incorporated by reference therein, there are no stockholders agreements, voting agreements or other similar agreements with respect to the Company’s capital stock to which the Company is a party or, to the knowledge of the Company, between or among any of the Company’s stockholders.

 

12

 

 

(h)         SEC Reports; Financial Statements. The Company has filed all reports, schedules, forms, statements and other documents required to be filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the two years preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such material) (the foregoing materials, including the exhibits thereto and documents incorporated by reference therein, together with the Prospectus and the Prospectus Supplement, being collectively referred to herein as the “SEC Reports”) on a timely basis or has received a valid extension of such time of filing and has filed any such SEC Reports prior to the expiration of any such extension. As of their respective dates, the SEC Reports complied in all material respects with the requirements of the Securities Act and the Exchange Act, as applicable, and none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. The financial statements of the Company included in the SEC Reports comply in all material respects with applicable accounting requirements and the rules and regulations of the Commission with respect thereto as in effect at the time of filing. Such financial statements have been prepared in accordance with United States generally accepted accounting principles applied on a consistent basis during the periods involved (“GAAP”), except as may be otherwise specified in such financial statements or the notes thereto and except that unaudited financial statements may not contain all footnotes required by GAAP, and fairly present in all material respects the financial position of the Company and its consolidated Subsidiaries as of and for the dates thereof and the results of operations and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments.

 

13

 

 

(i)         Material Changes; Undisclosed Events, Liabilities or Developments. Since the date of the latest audited financial statements included within the SEC Reports, (i) there has been no event, occurrence or development that has had or that could reasonably be expected to result in a Material Adverse Effect, (ii) the Company has not incurred any liabilities (contingent or otherwise) other than (A) trade payables and accrued expenses incurred in the ordinary course of business consistent with past practice, (B) liabilities not required to be reflected in the Company’s financial statements pursuant to GAAP or disclosed in filings made with the Commission, (C) liabilities set forth on Schedule 3.1(i) and (D) liabilities incurred to finance the acquisition of equipment, (iii) the Company has not altered its method of accounting, (iv) the Company has not declared or made any dividend or distribution of cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase or redeem any shares of its capital stock and (v) the Company has not issued any equity securities to any officer, director or Affiliate, except pursuant to existing Company equity plans. The Company does not have pending before the Commission any request for confidential treatment of information. Except for the issuance of the Securities contemplated by this Agreement or as set forth on Schedule 3.1(i), no material event, liability, fact, circumstance, occurrence or development has occurred or exists or is reasonably expected to occur or exist with respect to the Company or its Subsidiaries or their respective businesses, prospects, properties, operations, assets or financial condition that would be required to be disclosed by the Company under applicable securities laws at the time this representation is made or deemed made that has not been publicly disclosed at least one (1) Trading Day prior to the date that this representation is made.

 

(j)          Litigation. There is no action, suit, inquiry, notice of violation, proceeding or investigation pending or, to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their respective properties before or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county, local or foreign) (collectively, an “Action”) which (i) adversely affects or challenges the legality, validity or enforceability of any of the Transaction Documents or the Securities or (ii) could, if there were an unfavorable decision, have or reasonably be expected to result in a Material Adverse Effect. Neither the Company nor any Subsidiary, nor any director or officer thereof (in his or her capacity as such), is or has been the subject of any Action involving a claim of violation of or liability under federal or state securities laws or a claim of breach of fiduciary duty. There has not been, and to the knowledge of the Company, there is not pending or contemplated, any investigation by the Commission involving the Company or any current or former director or officer of the Company (in his or her capacity as such). The Commission has not issued any stop order or other order suspending the effectiveness of any registration statement filed by the Company or any Subsidiary under the Exchange Act or the Securities Act.

 

(k)        Labor Relations. No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees of the Company, which could reasonably be expected to result in a Material Adverse Effect. None of the Company’s or its Subsidiaries’ employees is a member of a union that relates to such employee’s relationship with the Company or such Subsidiary, and neither the Company nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe that their relationships with their employees are good. To the knowledge of the Company, no executive officer of the Company or any Subsidiary, is, or is now expected to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary information agreement or non-competition agreement, or any other contract or agreement or any restrictive covenant in favor of any third party, and the continued employment of each such executive officer does not subject the Company or any of its Subsidiaries to any liability with respect to any of the foregoing matters. The Company and its Subsidiaries are in compliance with all U.S. federal, state, local and foreign laws and regulations relating to employment and employment practices, terms and conditions of employment and wages and hours, except where the failure to be in compliance could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.

 

14

 

 

(l)          Compliance. Neither the Company nor any Subsidiary: (i) is in default under or in violation of (and no event has occurred that has not been waived that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under), nor has the Company or any Subsidiary received notice of a claim that it is in default under or that it is in violation of, any indenture, loan or credit agreement or any other agreement or instrument to which it is a party or by which it or any of its properties is bound (whether or not such default or violation has been waived), (ii) is in violation of any judgment, decree or order of any court, arbitrator or other governmental authority or (iii) is or has been in violation of any statute, rule, ordinance or regulation of any governmental authority, including without limitation all foreign, federal, state and local laws relating to taxes, environmental protection, occupational health and safety, product quality and safety and employment and labor matters, except in each case as could not have or reasonably be expected to result in a Material Adverse Effect.

 

(m)        Environmental Laws.The Company and its Subsidiaries (i) are in compliance with all federal, state, local and foreign laws relating to pollution or protection of human health or the environment (including ambient air, surface water, groundwater, land surface or subsurface strata), including laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants, or toxic or hazardous substances or wastes (collectively, “Hazardous Materials”) into the environment, or otherwise relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials, as well as all authorizations, codes, decrees, demands, or demand letters, injunctions, judgments, licenses, notices or notice letters, orders, permits, plans or regulations, issued, entered, promulgated or approved thereunder (“Environmental Laws”); (ii) have received all permits licenses or other approvals required of them under applicable Environmental Laws to conduct their respective businesses; and (iii) are in compliance with all terms and conditions of any such permit, license or approval where in each clause (i), (ii) and (iii), the failure to so comply could be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect.

 

(n)        Regulatory Permits. The Company and the Subsidiaries possess all certificates, authorizations and permits issued by the appropriate federal, state, local or foreign regulatory authorities necessary to conduct their respective businesses as described in the SEC Reports, except where the failure to possess such permits could not reasonably be expected to result in a Material Adverse Effect (“Material Permits”), and neither the Company nor any Subsidiary has received any notice of proceedings relating to the revocation or modification of any Material Permit.

 

15

 

 

(o)          Title to Assets. The Company and the Subsidiaries have good and marketable title in fee simple to all real property owned by them and good and marketable title in all personal property owned by them that is material to the business of the Company and the Subsidiaries, in each case free and clear of all Liens, except for (i) Liens as do not materially affect the value of such property and do not materially interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries, (ii) Liens for the payment of federal, state or other taxes, for which appropriate reserves have been made therefor in accordance with GAAP and, the payment of which is neither delinquent nor subject to penalties and (iii) Liens set forth on Schedule 3.1(o). Any real property and facilities held under lease by the Company and the Subsidiaries are held by them under valid, subsisting and enforceable leases with which the Company and the Subsidiaries are in compliance in all material respects.

 

(p)          Intellectual Property. To the knowledge of the Company, the Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks, trademark applications, service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights and similar rights necessary or required for use in connection with their respective businesses as described in the SEC Reports and which the failure to so have could have a Material Adverse Effect (collectively, the “Intellectual Property Rights”). Neither the Company nor any Subsidiary has received written notice that any of the Intellectual Property Rights that are material to the Company have expired, terminated or been abandoned, or is expected to expire or terminate or be abandoned, within two (2) years from the date of this Agreement, other than in accordance with the terms of the Intellectual Property Rights. Neither the Company nor any Subsidiary has received, since the date of the latest audited financial statements included within the SEC Reports, a written notice of a claim or otherwise has any knowledge that the Intellectual Property Rights violate or infringe upon the rights of any Person, except as could not reasonably be expected to have a Material Adverse Effect. To the knowledge of the Company, all such Intellectual Property Rights are enforceable and there is no existing infringement by another Person of any of the Intellectual Property Rights. The Company and its Subsidiaries have taken reasonable security measures to protect the secrecy, confidentiality and value of all of their intellectual properties, except where failure to do so could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.

 

(q)        Insurance. The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and in such amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged, including, but not limited to, directors and officers insurance coverage at least equal to the aggregate Subscription Amount. Neither the Company nor any Subsidiary has any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business without a significant increase in cost.

 

16

 

 

(r)           Transactions With Affiliates and Employees. Except as set forth on Schedule 3.1(r), none of the officers or directors of the Company or any Subsidiary and, to the knowledge of the Company, none of the employees of the Company or any Subsidiary is presently a party to any transaction with the Company or any Subsidiary (other than for services as employees, officers and directors), including any contract, agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal property to or from, providing for the borrowing of money from or lending of money to or otherwise requiring payments to or from any officer, director or such employee or, to the knowledge of the Company, any entity in which any officer, director, or any such employee has a substantial interest or is an officer, director, trustee, stockholder, member or partner, in each case in excess of $120,000 other than for (i) payment of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other employee benefits, including award agreements under any equity plan of the Company.

 

(s)          Sarbanes-Oxley; Internal Accounting Controls. The Company and the Subsidiaries are in compliance in all material respects with any and all applicable requirements of the Sarbanes-Oxley Act of 2002, as amended, that are effective as of the date hereof, and any and all applicable rules and regulations promulgated by the Commission thereunder that are effective as of the date hereof and as of the Closing Date. The Company and the Subsidiaries maintain a system of internal accounting controls sufficient to provide reasonable assurance that: (i) transactions are executed in accordance with management’s general or specific authorizations, (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability, (iii) access to assets is permitted only in accordance with management’s general or specific authorization, and (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences. The Company and the Subsidiaries have established disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company and the Subsidiaries and designed such disclosure controls and procedures to ensure that information required to be disclosed by the Company in the reports it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Commission’s rules and forms. The Company’s certifying officers have evaluated the effectiveness of the disclosure controls and procedures of the Company and the Subsidiaries as of the end of the period covered by the most recently filed periodic report under the Exchange Act (such date, the “Evaluation Date”). The Company presented in its most recently filed periodic report under the Exchange Act the conclusions of the certifying officers about the effectiveness of the disclosure controls and procedures based on their evaluations as of the Evaluation Date. Since the Evaluation Date, there have been no changes in the internal control over financial reporting (as such term is defined in the Exchange Act) of the Company and its Subsidiaries that have materially affected, or is reasonably likely to materially affect, the internal control over financial reporting of the Company and its Subsidiaries.

 

(t)        Certain Fees. Except for fees payable by the Company to the Placement Agent or as set forth in the Prospectus Supplement, no brokerage or finder’s fees or commissions are or will be payable by the Company or any Subsidiary to any broker, financial advisor or consultant, finder, placement agent, investment banker, bank or other Person with respect to the transactions contemplated by the Transaction Documents. The Purchasers shall have no obligation with respect to any fees or with respect to any claims made by or on behalf of other Persons for fees of a type contemplated in this Section 3.1(t) that may be due in connection with the transactions contemplated by the Transaction Documents.

 

17

 

 

(u)          Investment Company. The Company is not, and immediately after receipt of payment for the Securities, will not be, an “investment company” within the meaning of the Investment Company Act of 1940, as amended. The Company shall conduct its business in a manner so that it will not become an “investment company” subject to registration under the Investment Company Act of 1940, as amended.

 

(v)          Registration Rights. No Person has any right to cause the Company or any Subsidiary to effect the registration under the Securities Act of any securities of the Company or any Subsidiary.

 

(w)         Listing and Maintenance Requirements. The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange Act, and the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating such registration. Except as set forth in the SEC Reports, the Company has not, in the 12 months preceding the date hereof, received notice from any Trading Market on which the Common Stock is or has been listed or quoted to the effect that the Company is not in compliance with the listing or maintenance requirements of such Trading Market. The Company is, and has no reason to believe that it will not in the foreseeable future continue to be, in compliance with all such listing and maintenance requirements. The Common Stock is currently eligible for electronic transfer through the Depository Trust Company or another established clearing corporation and the Company is current in payment of the fees to the Depository Trust Company (or such other established clearing corporation) in connection with such electronic transfer.

 

(x)          Application of Takeover Protections. The Company and the Board of Directors have taken all necessary action, if any, in order to render inapplicable any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or other similar anti‐takeover provision under the Company’s certificate of incorporation (or similar charter documents) or the laws of its state of incorporation that is or could become applicable to the Purchasers as a result of the Purchasers and the Company fulfilling their obligations or exercising their rights under the Transaction Documents, including without limitation as a result of the Company’s issuance of the Securities and the Purchasers’ ownership of the Securities.

 

18

 

 

(y)        Disclosure. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents, the Company confirms that neither it nor any other Person acting on its behalf has provided any of the Purchasers or their agents or counsel with any information that it believes constitutes or might constitute material, non-public information which is not otherwise disclosed in the Prospectus Supplement. The Company understands and confirms that the Purchasers will rely on the foregoing representation in effecting transactions in securities of the Company. All of the disclosure furnished by or on behalf of the Company to the Purchasers regarding the Company and its Subsidiaries, their respective businesses and the transactions contemplated hereby, including the Disclosure Schedules to this Agreement, is true and correct in all material respects and does not contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements made therein, in the light of the circumstances under which they were made, not misleading. The press releases disseminated by the Company during the twelve months preceding the date of this Agreement taken as a whole do not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made and when made, not misleading. The Company acknowledges and agrees that no Purchaser makes or has made any representations or warranties with respect to the transactions contemplated hereby other than those specifically set forth in Section 3.2 hereof.

 

(z)          No Integrated Offering. Assuming the accuracy of the Purchasers’ representations and warranties set forth in Section 3.2, neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers or sales of any security or solicited any offers to buy any security, under circumstances that would cause this offering of the Securities to be integrated with prior offerings by the Company for purposes of (i) the Securities Act which would require the registration of the Common Warrants or Common Warrant Shares under the Securities Act, or (ii) any applicable stockholder approval provisions of any Trading Market on which any of the securities of the Company are listed or designated.

 

(aa)       Solvency. Based on the consolidated financial condition of the Company as of the Closing Date, after giving effect to the receipt by the Company of the proceeds from the sale of the Securities hereunder, (i) the fair saleable value of the Company’s assets exceeds the amount that will be required to be paid on or in respect of the Company’s existing debts and other liabilities (including known contingent liabilities) as they mature, (ii) the Company’s assets do not constitute unreasonably small capital to carry on its business as now conducted and as proposed to be conducted including its capital needs taking into account the particular capital requirements of the business conducted by the Company, consolidated and projected capital requirements and capital availability thereof, and (iii) the current cash flow of the Company, together with the proceeds the Company would receive, were it to liquidate all of its assets, after taking into account all anticipated uses of the cash, would be sufficient to pay all amounts on or in respect of its liabilities when such amounts are required to be paid. The Company does not intend to incur debts beyond its ability to pay such debts as they mature (taking into account the timing and amounts of cash to be payable on or in respect of its debt). The Company has no knowledge of any facts or circumstances which lead it to believe that it will file for reorganization or liquidation under the bankruptcy or reorganization laws of any jurisdiction within one year from the Closing Date. Schedule 3.1(aa) sets forth as of the date hereof all outstanding secured and unsecured Indebtedness of the Company or any Subsidiary, or for which the Company or any Subsidiary has commitments. For the purposes of this Agreement, “Indebtedness” means (x) any liabilities for borrowed money or amounts owed in excess of $50,000 (other than trade accounts payable incurred in the ordinary course of business), (y) all guaranties, endorsements and other contingent obligations in respect of indebtedness of others, whether or not the same are or should be reflected in the Company’s consolidated balance sheet (or the notes thereto), except guaranties by endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary course of business; and (z) the present value of any lease payments in excess of $50,000 due under leases required to be capitalized in accordance with GAAP. Neither the Company nor any Subsidiary is in default with respect to any Indebtedness.

 

19

 

 

(bb)       Tax Status. Except for matters that would not, individually or in the aggregate, reasonably be expected to result in a Material Adverse Effect, the Company and its Subsidiaries each (i) has made or filed all United States federal, state and local income and all foreign income and franchise tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii) has paid all taxes and other governmental assessments and charges that are material in amount, shown or determined to be due on such returns, reports and declarations and (iii) has set aside on its books provision reasonably adequate for the payment of all material taxes for periods subsequent to the periods to which such returns, reports or declarations apply. There are no unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company or of any Subsidiary know of no basis for any such claim.

 

(cc)      Foreign Corrupt Practices. Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary, any agent or other person acting on behalf of the Company or any Subsidiary, has (i) directly or indirectly, used any funds for unlawful contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful payment to foreign or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate funds, (iii) failed to disclose fully any contribution made by the Company or any Subsidiary (or made by any person acting on its behalf of which the Company is aware) which is in violation of law, or (iv) violated in any material respect any provision of FCPA.

 

(dd)       Accountants. The Company’s accounting firm is RSM US LLP. To the knowledge and belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements to be included in the Company’s Annual Report on Form 10-K for the fiscal year ending December 31, 2022.

 

(ee)        Acknowledgment Regarding Purchasers’ Purchase of Securities. The Company acknowledges and agrees that each of the Purchasers is acting solely in the capacity of an arm’s length purchaser with respect to the Transaction Documents and the transactions contemplated thereby. The Company further acknowledges that no Purchaser is acting as a financial advisor or fiduciary of the Company (or in any similar capacity) with respect to the Transaction Documents and the transactions contemplated thereby and any advice given by any Purchaser or any of their respective representatives or agents in connection with the Transaction Documents and the transactions contemplated thereby is merely incidental to the Purchasers’ purchase of the Securities. The Company further represents to each Purchaser that the Company’s decision to enter into this Agreement and the other Transaction Documents has been based solely on the independent evaluation of the transactions contemplated hereby by the Company and its representatives.

 

20

 

 

(ff)         Acknowledgment Regarding Purchaser’s Trading Activity. Anything in this Agreement or elsewhere herein to the contrary notwithstanding (except for Sections 3.2(f) and 4.13 hereof), it is understood and acknowledged by the Company that: (i) none of the Purchasers has been asked by the Company to agree, nor has any Purchaser agreed, to desist from purchasing or selling, long and/or short, securities of the Company, or “derivative” securities based on securities issued by the Company or to hold the Securities for any specified term; (ii) past or future open market or other transactions by any Purchaser, specifically including, without limitation, Short Sales or “derivative” transactions, before or after the closing of this or future transactions, may negatively impact the market price of the Company’s publicly-traded securities; (iii) any Purchaser, and counter-parties in “derivative” transactions to which any such Purchaser is a party, directly or indirectly, presently may have a “short” position in the Common Stock, and (iv) each Purchaser shall not be deemed to have any affiliation with or control over any arm’s length counter-party in any “derivative” transaction. The Company further understands and acknowledges that (y) one or more Purchasers may engage in hedging activities at various times during the period that the Securities are outstanding, including, without limitation, during the periods that the value of the Warrant Shares deliverable with respect to Securities are being determined, and (z) such hedging activities (if any) could reduce the value of the existing stockholders’ equity interests in the Company at and after the time that the hedging activities are being conducted.  The Company acknowledges that such aforementioned hedging activities do not constitute a breach of any of the Transaction Documents.

 

(gg)        Regulation M Compliance.  The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly or indirectly, any action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of any of the Securities, (ii) sold, bid for, purchased, or, paid any compensation for soliciting purchases of, any of the Securities, or (iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities of the Company, other than, in the case of clauses (ii) and (iii), compensation paid to the Placement Agent in connection with the placement of the Securities.

 

(hh)       Equity Plans. Each award granted by the Company under the Company’s equity plans was granted (i) in accordance with the terms of the Company’s equity plans and (ii) with an exercise price at least equal to the fair market value of the Common Stock on the date such award would be considered granted under GAAP and applicable law. No award granted under the Company’s equity plan has been backdated. The Company has not knowingly granted, and there is no and has been no Company policy or practice to knowingly grant, awards prior to, or otherwise knowingly coordinate the grant of awards with, the release or other public announcement of material information regarding the Company or its Subsidiaries or their financial results or prospects.

 

21

 

 

(ii)        Cybersecurity.  Except as set forth in the SEC Reports, to the knowledge of the Company, (i)(x) there has been no material security breach or other compromise of or relating to any of the Company’s or any Subsidiary’s information technology and computer systems, networks, hardware, software, equipment or technology (collectively, “IT Systems”) and (y) the Company and the Subsidiaries have not been notified of any material security breach or other material compromise to its IT Systems; (ii) the Company and the Subsidiaries are presently in compliance in all material respects with all applicable laws or statutes and all applicable judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory authority, internal policies and contractual obligations relating to the privacy and security of IT Systems and to the protection of such IT Systems from unauthorized use, access, misappropriation or modification, except as would not, individually or in the aggregate, have a Material Adverse Effect; (iii) the Company and the Subsidiaries have implemented and maintained commercially reasonable safeguards designed to maintain and protect its material confidential information and the integrity, continuous operation, redundancy and security of all IT Systems; and (iv) the Company and the Subsidiaries have implemented backup and disaster recovery technology consistent with industry standards and practices.

 

(jj)         FDA.  As to each product subject to the jurisdiction of the U.S. Food and Drug Administration (“FDA”) under the Federal Food, Drug and Cosmetic Act, as amended, and the regulations thereunder (“FDCA”) that is manufactured, packaged, labeled, tested, distributed, sold, and/or marketed by the Company or any of its Subsidiaries (each such product, a “Product”), such Product is being manufactured, packaged, labeled, tested, distributed, sold and/or marketed by the Company in compliance with all applicable requirements under FDCA and similar laws, rules and regulations relating to registration, investigational use, premarket clearance, licensure, or application approval, good manufacturing practices, good laboratory practices, good clinical practices, product listing, quotas, labeling, advertising, record keeping and filing of reports, except where the failure to be in compliance would not have a Material Adverse Effect.  There is no pending, completed or, to the Company’s knowledge, threatened, action (including any lawsuit, arbitration, or legal or administrative or regulatory proceeding, charge, complaint, or investigation) against the Company or any of its Subsidiaries, and none of the Company or any of its Subsidiaries has received any notice, warning letter or other communication from the FDA or any other governmental entity, which (i) contests the premarket clearance, licensure, registration, or approval of, the uses of, the distribution of, the manufacturing or packaging of, the testing of, the sale of, or the labeling and promotion of any Product, (ii) withdraws its approval of, requests the recall, suspension, or seizure of, or withdraws or orders the withdrawal of advertising or sales promotional materials relating to, any Product, (iii) imposes a clinical hold on any clinical investigation by the Company or any of its Subsidiaries, (iv) enjoins production at any facility of the Company or any of its Subsidiaries, (v) enters or proposes to enter into a consent decree of permanent injunction with the Company or any of its Subsidiaries, or (vi) otherwise alleges any violation of any laws, rules or regulations by the Company or any of its Subsidiaries, and which, either individually or in the aggregate, would have a Material Adverse Effect.  The properties, business and operations of the Company have been and are being conducted in all material respects in accordance with all applicable laws, rules and regulations of the FDA.  The Company has not been informed by the FDA that the FDA will prohibit the marketing, sale, license or use in the United States of any product proposed to be developed, produced or marketed by the Company nor has the FDA expressed any concern as to approving or clearing for marketing any product being developed or proposed to be developed by the Company.

 

22

 

 

(kk)       Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s knowledge, any director, officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).

 

(ll)          U.S. Real Property Holding Corporation. The Company is not and has never been a U.S. real property holding corporation within the meaning of Section 897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon Purchaser’s request.

 

(mm)     Bank Holding Company Act. Neither the Company nor any of its Subsidiaries, nor, to the Company’s knowledge, any of its Affiliates is subject to the Bank Holding Company Act of 1956, as amended (the “BHCA”) and to regulation by the Board of Governors of the Federal Reserve System (the “Federal Reserve”). Neither the Company nor any of its Subsidiaries, nor, to the Company’s knowledge, any of its Affiliates owns or controls, directly or indirectly, five percent (5%) or more of the outstanding shares of any class of voting securities or twenty-five percent (25%) or more of the total equity of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Subsidiaries nor, to the Company’s knowledge, any of its Affiliates exercises a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve.

 

(nn)       Money Laundering. The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with applicable financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, applicable money laundering statutes and applicable rules and regulations thereunder (collectively, the “Money Laundering Laws”), and no Action or Proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge of the Company or any Subsidiary, threatened.

 

(oo)        Private Placement. Assuming the accuracy of the Purchasers’ representations and warranties set forth in Section 3.2, no registration under the Securities Act is required for the offer and sale of the Common Warrants or the Common Warrant Shares by the Company to the Purchasers as contemplated hereby.

 

(pp)       No General Solicitation. Neither the Company nor any Person acting on behalf of the Company has offered or sold any of the Common Warrant or Common Warrant Shares by any form of general solicitation or general advertising. The Company has offered the Common Warrants and Common Warrant Shares for sale only to the Purchasers and certain other “accredited investors” within the meaning of Rule 501 under the Securities Act.

 

23

 

 

(qq)       Other Covered Persons. Other than the Placement Agent, the Company is not aware of any person (other than any Issuer Covered Person) that has been or will be paid (directly or indirectly) remuneration for solicitation of purchasers in connection with the sale of any Securities.

 

(rr)        Notice of Disqualification Events. The Company will notify the Purchasers in writing, prior to the Closing Date of (i) any Disqualification Event relating to any Issuer Covered Person and (ii) any event that would, with the passage of time, reasonably be expected to become a Disqualification Event relating to any Issuer Covered Person, in each case of which it is aware.

 

3.2          Representations and Warranties of the Purchasers. Each Purchaser, for itself and for no other Purchaser, hereby represents and warrants as of the date hereof and as of the Closing Date to the Company as follows (unless as of a specific date therein, in which case they shall be accurate as of such date):

 

(a)        Organization; Authority. Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing and in good standing under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership, limited liability company or similar power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and performance by such Purchaser of the transactions contemplated by the Transaction Documents have been duly authorized by all necessary corporate, partnership, limited liability company or similar action, as applicable, on the part of such Purchaser. Each Transaction Document to which it is a party has been duly executed by such Purchaser, and when delivered by such Purchaser in accordance with the terms hereof, will constitute the valid and legally binding obligation of such Purchaser, enforceable against it in accordance with its terms, except: (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors’ rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.

 

(b)        Understandings or Arrangements. Such Purchaser is acquiring the Securities as principal for its own account and has no direct or indirect arrangement or understandings with any other persons to distribute or regarding the distribution of such Securities (this representation and warranty not limiting such Purchaser’s right to sell the Securities pursuant to the Registration Statement or otherwise in compliance with applicable federal and state securities laws). Such Purchaser is acquiring the Securities hereunder in the ordinary course of its business. Such Purchaser understands that the Common Warrants and the Common Warrant Shares are “restricted securities” and have not been registered under the Securities Act or any applicable state securities law and is acquiring such Securities as principal for his, her or its own account and not with a view to or for distributing or reselling such Securities or any part thereof in violation of the Securities Act or any applicable state securities law, has no present intention of distributing any of such Securities in violation of the Securities Act or any applicable state securities law and has no direct or indirect arrangement or understandings with any other persons to distribute or regarding the distribution of such Securities in violation of the Securities Act or any applicable state securities law (this representation and warranty not limiting such Purchaser’s right to sell such Securities pursuant to a registration statement or otherwise in compliance with applicable federal and state securities laws).

 

24

 

 

(c)          Purchaser Status. At the time such Purchaser was offered the Securities, it was, and as of the date hereof it is, and on each date on which it exercises any Warrants, it will be either: (i) an “accredited investor” as defined in Rule 501(a)(1), (a)(2), (a)(3), (a)(7), (a)(8), (a)(9), (a)(12) or (a)(13) under the Securities Act or (ii) a “qualified institutional buyer” as defined in Rule 144A(a) under the Securities Act.

 

(d)         Experience of Such Purchaser. Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication and experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment in the Securities, and has so evaluated the merits and risks of such investment. Such Purchaser is able to bear the economic risk of an investment in the Securities and, at the present time, is able to afford a complete loss of such investment.

 

(e)          Access to Information. Such Purchaser acknowledges that it has had the opportunity to review the Transaction Documents (including all exhibits and schedules thereto) and the SEC Reports and has been afforded, (i) the opportunity to ask such questions as it has deemed necessary of, and to receive answers from, representatives of the Company concerning the terms and conditions of the offering of the Securities and the merits and risks of investing in the Securities; (ii) access to information about the Company and its financial condition, results of operations, business, properties, management and prospects sufficient to enable it to evaluate its investment; and (iii) the opportunity to obtain such additional information that the Company possesses or can acquire without unreasonable effort or expense that is necessary to make an informed investment decision with respect to the investment.  Such Purchaser acknowledges and agrees that neither the Placement Agent nor any Affiliate of the Placement Agent has provided such Purchaser with any information or advice with respect to the Securities nor is such information or advice necessary or desired.  Neither the Placement Agent nor any Affiliate has made or makes any representation as to the Company or the quality of the Securities and the Placement Agent and any Affiliate may have acquired non-public information with respect to the Company which such Purchaser agrees need not be provided to it.  In connection with the issuance of the Securities to such Purchaser, neither the Placement Agent nor any of its Affiliates has acted as a financial advisor or fiduciary to such Purchaser.

 

25

 

 

(f)        Certain Transactions and Confidentiality. Other than consummating the transactions contemplated hereunder, such Purchaser has not, nor has any Person acting on behalf of or pursuant to any understanding with such Purchaser, directly or indirectly executed any purchases or sales, including Short Sales, of the securities of the Company during the period commencing as of the time that such Purchaser first received a term sheet (written or oral) from the Company or any other Person representing the Company setting forth the material terms of the transactions contemplated hereunder and ending immediately prior to the execution hereof. Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser’s assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other portions of such Purchaser’s assets, the representation set forth above shall only apply with respect to the portion of assets managed by the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement. Other than to other Persons party to this Agreement or to such Purchaser’s representatives, including, without limitation, its officers, directors, partners, legal and other advisors, employees, agents and Affiliates, such Purchaser has maintained the confidentiality of all disclosures made to it in connection with this transaction (including the existence and terms of this transaction). Notwithstanding the foregoing, for the avoidance of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any actions, with respect to locating or borrowing shares in order to effect short sales or similar transactions in the future.

 

(g)          General Solicitation. Such Purchaser is not purchasing the Securities as a result of any advertisement, article, notice or other communication regarding the Securities published in any newspaper, magazine or similar media or broadcast over television or radio or presented at any seminar or, to the knowledge of such Purchaser, any other general solicitation or general advertisement.

 

The Company acknowledges and agrees that the representations contained in this Section 3.2 shall not modify, amend or affect such Purchaser’s right to rely on the Company’s representations and warranties contained in this Agreement or any representations and warranties contained in any other Transaction Document or any other document or instrument executed and/or delivered in connection with this Agreement or the consummation of the transactions contemplated hereby. Notwithstanding the foregoing, for the avoidance of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any actions, with respect to locating or borrowing shares in order to effect Short Sales or similar transactions in the future.

 

26

 

 

ARTICLE IV.

OTHER AGREEMENTS OF THE PARTIES

 

4.1         Removal of Legends.

 

(a)       The Common Warrants and Common Warrant Shares may only be disposed of in compliance with state and federal securities laws. In connection with any transfer of Common Warrants or Common Warrant Shares other than pursuant to an effective registration statement or Rule 144, to the Company or to an Affiliate of a Purchaser or in connection with a pledge as contemplated in Section 4.1(b), the Company may require the transferor thereof to provide to the Company an opinion of counsel selected by the transferor and reasonably acceptable to the Company, the form and substance of which opinion shall be reasonably satisfactory to the Company, to the effect that such transfer does not require registration of such transferred Common Warrant under the Securities Act.

 

(b)       The Purchasers agree to the imprinting, so long as is required by this Section 4.1, of a legend on any of the Common Warrants or Common Warrant Shares in the following form:

 

NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE HAS BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL INSTITUTION THAT IS AN “ACCREDITED INVESTOR” AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT OR OTHER LOAN SECURED BY SUCH SECURITIES.

 

The Company acknowledges and agrees that a Purchaser may from time to time pledge pursuant to a bona fide margin agreement with a registered broker-dealer or grant a security interest in some or all of the Common Warrants or Common Warrant Shares to a financial institution that is an “accredited investor” as defined in Rule 501(a) under the Securities Act and, if required under the terms of such arrangement, such Purchaser may transfer pledged or secured Common Warrants or Common Warrant Shares to the pledgees or secured parties. Such a pledge or transfer would not be subject to approval of the Company and no legal opinion of legal counsel of the pledgee, secured party or pledgor shall be required in connection therewith. Further, no notice shall be required of such pledge. At the appropriate Purchaser’s expense, the Company will execute and deliver such reasonable documentation as a pledgee or secured party of Common Warrants and Common Warrant Shares may reasonably request in connection with a pledge or transfer of the Common Warrants or Common Warrant Shares.

 

27

 

 

(c)         Certificates evidencing the Common Warrant Shares shall not contain any legend (including the legend set forth in Section 4.1(b) hereof): (i) while a registration statement covering the resale of such security is effective under the Securities Act, or (ii) following any sale of such Common Warrant Shares pursuant to Rule 144 (assuming cashless exercise of the Common Warrants), or (iii) if such Common Warrant Shares are eligible for sale under Rule 144 (assuming cashless exercise of the Common Warrants and the holder of such Common Warrant Shares is not an Affiliate of the Company) without the need for current public information, or (iv) if such legend is not required under applicable requirements of the Securities Act (including judicial interpretations and pronouncements issued by the staff of the Commission). The Company shall cause its counsel to issue a legal opinion to the Transfer Agent or the Purchaser promptly if required by the Transfer Agent to effect the removal of the legend hereunder, or if requested by a Purchaser, respectively, provided that, upon request of the Company (which request shall also include a form of customary representation letter), the Purchaser has delivered in advance to the Company a customary representation letter that is reasonably satisfactory to the Company and its counsel. If all or any portion of a Common Warrant is exercised at a time when there is an effective registration statement to cover the resale of the Common Warrant Shares, or if such Common Warrant Shares may be sold under Rule 144 (assuming cashless exercise of the Common Warrants and the holder of such Common Warrant Shares is not an Affiliate of the Company) without the need for current public information or if such legend is not otherwise required under applicable requirements of the Securities Act (including judicial interpretations and pronouncements issued by the staff of the Commission) then such Common Warrant Shares shall be issued free of all legends, provided that, upon request of the Company (which request shall also include a form of customary representation letter), the Purchaser has delivered in advance to the Company a customary representation letter that is reasonably satisfactory to the Company and its counsel. The Company agrees that following such time as such legend is no longer required under this Section 4.1(c), the Company will, no later than the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined below) following the delivery by a Purchaser to the Company or the Transfer Agent (with simultaneous notice to the Company) of a certificate representing Common Warrant Shares, as applicable, issued with a restrictive legend (such date, the “Legend Removal Date”), deliver or cause to be delivered to such Purchaser a certificate representing such shares that is free from all restrictive and other legends, provided that, upon request of the Company (which request shall also include a form of customary representation letter), the Purchaser has delivered in advance to the Company a customary representation letter that is reasonably satisfactory to the Company and its counsel. The Company may not make any notation on its records or give instructions to the Transfer Agent that enlarge the restrictions on transfer set forth in this Article IV. Common Warrant Shares subject to legend removal hereunder shall be transmitted by the Transfer Agent to the Purchaser by crediting the account of the Purchaser’s prime broker with the Depository Trust Company System as directed by such Purchaser. As used herein, “Standard Settlement Period” means the standard settlement period, expressed in a number of Trading Days, on the Company’s primary Trading Market with respect to the Common Stock as in effect on the date of delivery of a certificate representing Common Warrant Shares issued with a restrictive legend.

 

28

 

 

(d)        In addition to such Purchaser’s other available remedies, the Company shall pay to a Purchaser, in cash, (i) as partial liquidated damages and not as a penalty, for each $1,000 of Common Warrant Shares (based on the VWAP of the Common Stock on the date such Securities are submitted to the Transfer Agent) delivered for removal of the restrictive legend and subject to Section 4.1(c), $10 per Trading Day (increasing to $20 per Trading Day five (5) Trading Days after such damages have begun to accrue) for each Trading Day after the Legend Removal Date until such certificate is delivered without a legend and (ii) if the Company fails to (a) issue and deliver (or cause to be delivered) to a Purchaser by the Legend Removal Date a certificate representing the Securities so delivered to the Company by such Purchaser that is free from all restrictive and other legends and (b) if after the Legend Removal Date such Purchaser purchases (in an open market transaction or otherwise) shares of Common Stock to deliver in satisfaction of a sale by such Purchaser of all or any portion of the number of shares of Common Stock that such Purchaser anticipated receiving from the Company without any restrictive legend, then an amount equal to the excess of such Purchaser’s total purchase price (including brokerage commissions and other out-of-pocket expenses, if any) for the shares of Common Stock so purchased (including brokerage commissions and other out-of-pocket expenses, if any) over the product of (A) such number of Common Warrant Shares that the Company was required to deliver to such Purchaser by the Legend Removal Date and for which the Purchaser actually purchased shares of Common Stock to timely satisfy delivery requirements, multiplied by (B) the lowest closing sale price of the Common Stock on any Trading Day during the period commencing on the date of the delivery by such Purchaser to the Company of the applicable Warrant Shares (as the case may be) and ending on the date of such delivery and payment under this Section 4.1(d).

 

(e)          The Shares shall be issued free of legends. If all or any portion of a Pre-Funded Warrant is exercised at a time when there is an effective registration statement to cover the issuance or resale of the Pre-Funded Warrant Shares or if the Pre-Funded Warrant is exercised via cashless exercise, the Pre-Funded Warrant Shares issued pursuant to any such exercise shall be issued free of all legends. If at any time following the date hereof the Registration Statement (or any subsequent registration statement registering the sale or resale of the Pre-Funded Warrant Shares) is not effective or is not otherwise available for the sale or resale of the Pre-Funded Warrant Shares, the Company shall immediately notify the holders of the Pre-Funded Warrants in writing that such registration statement is not then effective and thereafter shall promptly notify such holders when the registration statement is effective again and available for the sale or resale of the Pre-Funded Warrant Shares (it being understood and agreed that the foregoing shall not limit the ability of the Company to issue, or any Purchaser to sell, any of the Pre-Funded Warrant Shares in compliance with applicable federal and state securities laws). The Company shall use best efforts to keep a registration statement (including the Registration Statement) registering the issuance or resale of the Pre-Funded Warrant Shares effective during the term of the Pre-Funded Warrants.

 

29

 

 

4.2          Furnishing of Information.

 

(a)         Until the earlier of the time that (i) no Purchaser owns Securities or (ii) the Warrants have expired, the Company covenants to timely file (or obtain extensions in respect thereof and file within the applicable grace period) all reports required to be filed by the Company after the date hereof pursuant to the Exchange Act.

 

(b)          At any time during the period commencing from the six (6) month anniversary of the date hereof and ending at such time that all of the Common Warrant Shares (assuming cashless exercise) may be sold without the requirement for the Company to be in compliance with Rule 144(c)(1) and otherwise without restriction or limitation pursuant to Rule 144, if the Company (i) shall fail for any reason to satisfy the current public information requirement under Rule 144(c) or (ii) has ever been an issuer described in Rule 144(i)(1)(i) or becomes an issuer in the future, and the Company shall fail to satisfy any condition set forth in Rule 144(i)(2) (a “Public Information Failure”) then, in addition to such Purchaser’s other available remedies, the Company shall pay to a Purchaser, in cash, as partial liquidated damages and not as a penalty, by reason of any such delay in or reduction of its ability to sell the Common Warrant Shares, an amount in cash equal to two percent (2.0%) of the aggregate exercise price of such Purchaser’s Common Warrants on the day of a Public Information Failure and on every thirtieth (30th) day (pro-rated for periods totaling less than thirty days) thereafter until the earlier of (a) the date such Public Information Failure is cured and (b) such time that such public information is no longer required for the Purchasers to transfer the Common Warrant Shares pursuant to Rule 144.  The payments to which a Purchaser shall be entitled pursuant to this Section 4.2(b) are referred to herein as “Public Information Failure Payments.”  Public Information Failure Payments shall be paid on the earlier of (i) the last day of the calendar month during which such Public Information Failure Payments are incurred and (ii) the third (3rd) Business Day after the event or failure giving rise to the Public Information Failure Payments is cured.  In the event the Company fails to make Public Information Failure Payments in a timely manner, such Public Information Failure Payments shall bear interest at the rate of 1.5% per month (prorated for partial months) until paid in full. Nothing herein shall limit such Purchaser’s right to pursue actual damages for the Public Information Failure, and such Purchaser shall have the right to pursue all remedies available to it at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief.

 

4.3          Integration. The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in Section 2 of the Securities Act) that would be integrated with the offer or sale of the Securities in a manner that would require the registration under the Securities Act of the sale of the Common Warrants or Common Warrant Shares or that would be integrated with the offer or sale of the Securities for purposes of the rules and regulations of any Trading Market such that it would require stockholder approval prior to the closing of such other transaction unless stockholder approval is obtained before the closing of such subsequent transaction.

 

30

 

 

4.4          Securities Laws Disclosure; Publicity. The Company shall (a) by the Disclosure Time, issue a press release disclosing the material terms of the transactions contemplated hereby, and (b) file a Current Report on Form 8-K, including the Transaction Documents as exhibits thereto, with the Commission within the time required by the Exchange Act. From and after the issuance of such press release, the Company represents to the Purchasers that it shall have publicly disclosed all material, non-public information delivered to any of the Purchasers by the Company or any of its Subsidiaries, or any of their respective officers, directors, employees, or agents, including, without limitation, the Placement Agent, in connection with the transactions contemplated by the Transaction Documents. In addition, effective upon the issuance of such press release, the Company acknowledges and agrees that any and all confidentiality or similar obligations under any agreement, whether written or oral, between the Company, any of its Subsidiaries or any of their respective officers, directors, employees, Affiliates or agents, including, without limitation, the Placement Agent, on the one hand, and any of the Purchasers or any of their Affiliates on the other hand, shall terminate and be no further force or effect. The Company understands that each Purchaser may be relying on the foregoing covenant in effecting transactions in securities of the Company. The Company and each Purchaser shall consult with each other in issuing any other press releases with respect to the transactions contemplated hereby, and neither the Company nor any Purchaser shall issue any such press release nor otherwise make any such public statement without the prior consent of the Company, with respect to any press release of any Purchaser, or without the prior consent of each Purchaser, with respect to any press release of the Company, which consent shall not unreasonably be withheld or delayed, except if such disclosure is required by law, in which case the disclosing party shall promptly provide the other party with prior notice of such public statement or communication. Notwithstanding the foregoing, the Company shall not publicly disclose the name of any Purchaser, or include the name of any Purchaser in any filing with the Commission or any regulatory agency or Trading Market, without the prior written consent of such Purchaser, except (a) as required by federal securities law in connection with the filing of final Transaction Documents with the Commission and (b) to the extent such disclosure is required by law or Trading Market regulations, in which case the Company shall provide the Purchasers with prior notice of such disclosure permitted under this clause (b).

 

4.5          Stockholder Rights Plan. No claim will be made or enforced by the Company or, with the consent of the Company, any other Person, that any Purchaser is an “Acquiring Person” under any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter adopted by the Company, or that any Purchaser could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving Securities under the Transaction Documents or under any other agreement between the Company and the Purchasers.

 

4.6          Non-Public Information. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents, which shall be disclosed pursuant to Section 4.4, the Company covenants and agrees that neither it, nor any other Person acting on its behalf will provide any Purchaser or its agents or counsel with any information that constitutes, or the Company reasonably believes constitutes, material non-public information, unless prior thereto such Purchaser shall have consented to the receipt of such information and agreed with the Company to keep such information confidential. The Company understands that each Purchaser may be relying on the foregoing covenant in effecting transactions in securities of the Company. To the extent that the Company, any of its Subsidiaries, or any of their respective officers, directors, agents, employees or Affiliates delivers any material, non-public information to a Purchaser without such Purchaser’s consent, the Company hereby covenants and agrees that such Purchaser shall not have any duty of confidentiality to the Company, any of its Subsidiaries, or any of their respective officers, directors, employees, Affiliates or agents, including, without limitation, the Placement Agent, or a duty to the Company, any of its Subsidiaries or any of their respective officers, directors, employees, Affiliates or agents, including, without limitation, the Placement Agent, not to trade on the basis of, such material, non-public information, provided that the Purchaser shall remain subject to applicable law. To the extent that any notice provided pursuant to any Transaction Document constitutes, or contains, material, non-public information regarding the Company or any Subsidiaries, the Company shall simultaneously with the delivery of such notice file such notice with the Commission pursuant to a Current Report on Form 8-K. The Company understands that each Purchaser may be relying on the foregoing covenant in effecting transactions in securities of the Company.

 

31

 

 

4.7          Use of Proceeds. The Company shall use the net proceeds from the sale of the Securities hereunder as set forth in the Prospectus Supplement and shall not use such proceeds: (a) for the satisfaction of any portion of the Company’s debt (other than payment of trade payables in the ordinary course of the Company’s business and prior practices), (b) for the redemption of any Common Stock or Common Stock Equivalents, (c) for the settlement of any outstanding litigation or (d) in violation of FCPA or OFAC regulations.

 

4.8          Indemnification of Purchasers. Subject to the provisions of this Section 4.8, the Company will indemnify and hold each Purchaser and its directors, officers, shareholders, members, partners, employees and agents (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack of such title or any other title), each Person who controls such Purchaser (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, shareholders, agents, members, partners or employees (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack of such title or any other title) of such controlling persons (each, a “Purchaser Party”) harmless from any and all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts paid in settlements, court costs and reasonable attorneys’ fees and costs of investigation that any such Purchaser Party may suffer or incur as a result of or relating to (a) any breach of any of the representations, warranties, covenants or agreements made by the Company in this Agreement or in the other Transaction Documents, (b) any action instituted against the Purchaser Parties in any capacity, or any of them or their respective Affiliates, by any stockholder of the Company who is not an Affiliate of such Purchaser Party, to any of the transactions contemplated by the Transaction Documents (unless such action is solely based upon a material breach of such Purchaser Party’s representations, warranties or covenants under the Transaction Documents or any agreements or understandings such Purchaser Party may have with any such stockholder or any violations by such Purchaser Party of state or federal securities laws or any conduct by such Purchaser Party which is finally judicially determined to constitute fraud, gross negligence or willful misconduct), or (c) in connection with any registration statement of the Company providing for the resale by the Purchasers of the Warrant Shares issued and issuable upon exercise of the Warrants, the Company will indemnify each Purchaser Party, to the fullest extent permitted by applicable law, from and against any and all losses, claims, damages, liabilities, costs (including, without limitation, reasonable attorneys’ fees) and expenses, as incurred, arising out of or relating to (i) any untrue or alleged untrue statement of a material fact contained in such registration statement, any prospectus or any form of prospectus or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating to any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein (in the case of any prospectus or supplement thereto, in the light of the circumstances under which they were made) not misleading, except to the extent, but only to the extent, that such untrue statements or omissions are based solely upon information regarding such Purchaser Party furnished in writing to the Company by such Purchaser Party expressly for use therein, or (ii) any violation or alleged violation by the Company of the Securities Act, the Exchange Act or any state securities law, or any rule or regulation thereunder in connection therewith. If any action shall be brought against any Purchaser Party in respect of which indemnity may be sought pursuant to this Agreement, such Purchaser Party shall promptly notify the Company in writing, and the Company shall have the right to assume the defense thereof with counsel of its own choosing reasonably acceptable to the Purchaser Party. Any Purchaser Party shall have the right to employ separate counsel in any such action and participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense of such Purchaser Party except to the extent that (x) the employment thereof has been specifically authorized by the Company in writing, (y) the Company has failed after a reasonable period of time to assume such defense and to employ counsel or (z) in such action there is, in the reasonable opinion of counsel, a material conflict on any material issue between the position of the Company and the position of such Purchaser Party, in which case the Company shall be responsible for the reasonable fees and expenses of no more than one such separate counsel. The Company will not be liable to any Purchaser Party under this Agreement (1) for any settlement by a Purchaser Party effected without the Company’s prior written consent, which shall not be unreasonably withheld or delayed or (2) to the extent, but only to the extent, that a loss, claim, damage or liability is attributable to any Purchaser Party’s breach of any of the representations, warranties, covenants or agreements made by such Purchaser Party in this Agreement or in the other Transaction Documents. The indemnification required by this Section 4.8 shall be made by periodic payments of the amount thereof during the course of the investigation or defense, as and when bills are received or are incurred. The indemnity agreements contained herein shall be in addition to any cause of action or similar right of any Purchaser Party against the Company or others and any liabilities the Company may be subject to pursuant to law.

 

32

 

 

4.9          Reservation of Common Stock. As of the date hereof, the Company has reserved and the Company shall continue to reserve and keep available at all times, free of preemptive rights, a sufficient number of shares of Common Stock for the purpose of enabling the Company to issue Shares pursuant to this Agreement and Warrant Shares pursuant to any exercise of the Warrants. 

 

4.10        Listing of Common Stock. The Company hereby agrees to use reasonable efforts to maintain the listing or quotation of the Common Stock on the Trading Market on which it is currently listed, and concurrently with the Closing, the Company shall apply to list or quote all of the Shares and Warrant Shares on such Trading Market and use commercially reasonably efforts to secure the listing of all of the Shares and Warrant Shares on such Trading Market. The Company further agrees, if the Company applies to have the Common Stock traded on any other Trading Market, it will then include in such application all of the Shares and Warrant Shares, and will take such other action as is necessary to cause all of the Shares and Warrant Shares to be listed or quoted on such other Trading Market as promptly as possible. The Company will then take all action reasonably necessary to continue the listing and trading of its Common Stock on a Trading Market and will comply in all respects with the Company’s reporting, filing and other obligations under the bylaws or rules of the Trading Market. The Company agrees to maintain the eligibility of the Common Stock for electronic transfer through the Depository Trust Company or another established clearing corporation, including, without limitation, by timely payment of fees to the Depository Trust Company or such other established clearing corporation in connection with such electronic transfer.

 

33

 

 

4.11        Subsequent Equity Sales.

 

(a)       From the date hereof until seven (7) months following the Closing Date, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii) file any registration statement or amendment or supplement thereto, other than the Prospectus Supplement or filing a registration statement pursuant to this Agreement or on Form S-8 in connection with any employee benefit plan.

 

(b)          From the date hereof until twelve (12) months following the Closing Date, the Company shall be prohibited from effecting or entering into an agreement to effect any issuance by the Company or any of its Subsidiaries of Common Stock or Common Stock Equivalents (or a combination of units thereof) involving a Variable Rate Transaction. “Variable Rate Transaction” means a transaction in which the Company (i) issues or sells any debt or equity securities that are convertible into, exchangeable or exercisable for, or include the right to receive additional shares of Common Stock either (A) at a conversion price, exercise price or exchange rate or other price that is based upon and/or varies with the trading prices of or quotations for the shares of Common Stock at any time after the initial issuance of such debt or equity securities, or (B) with a conversion, exercise or exchange price that is subject to being reset at some future date after the initial issuance of such debt or equity security or upon the occurrence of specified or contingent events directly or indirectly related to the business of the Company or the market for the Common Stock or (ii) enters into, or effects a transaction under, any agreement, including, but not limited to, an equity line of credit or an “at-the-market offering”, whereby the Company may issue securities at a future determined price regardless of whether shares pursuant to such agreement have actually been issued and regardless of whether such agreement is subsequently canceled. Any Purchaser shall be entitled to obtain injunctive relief against the Company to preclude any such issuance, which remedy shall be in addition to any right to collect damages.

 

(c)         Notwithstanding the foregoing, this Section 4.11 shall not apply in respect of an Exempt Issuance, except that no Variable Rate Transaction (for purposes of clarity, other than pursuant to a security issued and outstanding on the date of this Agreement pursuant to clause (b) of the definition of Exempt Issuance) shall be an Exempt Issuance.

 

4.12        Equal Treatment of Purchasers. No consideration (including any modification of any Transaction Document) shall be offered or paid to any Person to amend or consent to a waiver or modification of any provision of the Transaction Documents unless the same consideration is also offered to all of the parties to the Transaction Documents. For clarification purposes, this provision constitutes a separate right granted to each Purchaser by the Company and negotiated separately by each Purchaser, and is intended for the Company to treat the Purchasers as a class and shall not in any way be construed as the Purchasers acting in concert or as a group with respect to the purchase, disposition or voting of Securities or otherwise.

 

34

 

 

4.13        Certain Transactions and Confidentiality. Each Purchaser, severally and not jointly with the other Purchasers, covenants that neither it nor any Affiliate acting on its behalf or pursuant to any understanding with it will execute any purchases or sales, including Short Sales of any of the Company’s securities during the period commencing with the execution of this Agreement and ending at such time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release as described in Section 4.4.  Each Purchaser, severally and not jointly with the other Purchasers, covenants that until such time as the transactions contemplated by this Agreement are publicly disclosed by the Company pursuant to the initial press release as described in Section 4.4, such Purchaser will maintain the confidentiality of the existence and terms of this transaction and the information included in the Disclosure Schedules (other than as disclosed to its legal and other representatives).  Notwithstanding the foregoing and notwithstanding anything contained in this Agreement to the contrary, the Company expressly acknowledges and agrees that (i) no Purchaser makes any representation, warranty or covenant hereby that it will not engage in effecting transactions in any securities of the Company after the time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release as described in Section 4.4, (ii) no Purchaser shall be restricted or prohibited from effecting any transactions in any securities of the Company in accordance with applicable securities laws from and after the time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release as described in Section 4.4 and (iii) no Purchaser shall have any duty of confidentiality or duty not to trade in the securities of the Company to the Company, any of its Subsidiaries, or any of their respective officers, directors, employees, Affiliates or agent, including, without limitation, the Placement Agent, after the issuance of the initial press release as described in Section 4.4.  Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser’s assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other portions of such Purchaser’s assets, the covenant set forth above shall only apply with respect to the portion of assets managed by the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement.

 

4.14        Exercise Procedures. The form of Notice of Exercise included in the Warrants set forth the totality of the procedures required of the Purchasers in order to exercise the Warrants. No additional legal opinion, other information or instructions shall be required of the Purchasers to exercise their Warrants. Without limiting the preceding sentences, no ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise form be required in order to exercise the Warrants. The Company shall honor exercises of the Warrants and shall deliver Warrant Shares in accordance with the terms, conditions and time periods set forth in the Transaction Documents.

 

4.15        Blue Sky Filings. The Company shall take such action as the Company shall reasonably determine is necessary in order to obtain an exemption for, or to qualify the Common Warrant and Common Warrant Shares for, sale to the Purchasers at the Closing under applicable securities or “Blue Sky” laws of the states of the United States, and shall provide evidence of such actions promptly upon request of any Purchaser.

 

35

 

 

4.16        Registration Statement. As soon as practicable (and in any event within 90 calendar days of the date of this Agreement), the Company shall file a registration statement on Form S-1 (or other appropriate form) providing for the resale by the Purchasers of the Common Warrant Shares issued and issuable upon exercise of the Common Warrants.  The Company shall use commercially reasonable efforts to cause such registration statement to become effective within 180 days following the Closing Date and to keep such registration statement effective at all times until no Purchaser owns any Common Warrants or Common Warrant Shares issuable upon exercise thereof.

 

4.17        Lock-Up Agreements. The Company shall not amend, modify, waive or terminate any provision of any of the Lock-Up Agreements except to extend the term of the lock-up period and shall enforce the provisions of each Lock-Up Agreement in accordance with its terms. If any party to a Lock-Up Agreement breaches any provision of a Lock-Up Agreement, the Company shall promptly use its best efforts to seek specific performance of the terms of such Lock-Up Agreement.

 

ARTICLE V.

MISCELLANEOUS

 

5.1          Termination.  This Agreement may be terminated by any Purchaser, as to such Purchaser’s obligations hereunder only and without any effect whatsoever on the obligations between the Company and the other Purchasers, by written notice to the other parties, if the Closing has not been consummated on or before the fifth (5th) Trading Day following the date hereof; provided, however, that no such termination will affect the right of any party to sue for any breach by any other party (or parties).

 

5.2          Fees and Expenses. Except as expressly set forth in the Transaction Documents to the contrary, each party shall pay the fees and expenses of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the negotiation, preparation, execution, delivery and performance of this Agreement. The Company shall pay all Transfer Agent fees (including, without limitation, any fees required for same-day processing of any instruction letter delivered by the Company and any exercise notice delivered by a Purchaser), and any stamp taxes and other taxes and duties levied in connection with the delivery of any Securities to the Purchasers.

 

5.3          Entire Agreement. The Transaction Documents, together with the exhibits and schedules thereto, the Prospectus and the Prospectus Supplement, contain the entire understanding of the parties with respect to the subject matter hereof and thereof and supersede all prior agreements and understandings, oral or written, with respect to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.

 

36

 

 

5.4          Notices. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall be deemed given and effective on the earliest of: (a) the time of transmission, if such notice or communication is delivered via email attachment at the email address as set forth on the signature pages attached hereto at or prior to 5:30 p.m. (New York City time) on a Trading Day, (b) the next Trading Day after the time of transmission, if such notice or communication is delivered via email attachment at the email address as set forth on the signature pages attached hereto on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (c) the second (2nd) Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service or (d) upon actual receipt by the party to whom such notice is required to be given. The address for such notices and communications shall be as set forth on the signature pages attached hereto.

 

5.5          Amendments; Waivers. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument signed, in the case of an amendment, by the Company and Purchasers which purchased at least 50.1% in interest of the Shares and Pre-Funded Warrants based on the initial Subscription Amounts hereunder (or, prior to the Closing, the Company and each Purchaser) or, in the case of a waiver, by the party against whom enforcement of any such waived provision is sought, provided that if any amendment, modification or waiver disproportionately and adversely impacts a Purchaser (or group of Purchasers), the consent of such disproportionately impacted Purchaser (or group of Purchasers) shall also be required. No waiver of any default with respect to any provision, condition or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement hereof, nor shall any delay or omission of any party to exercise any right hereunder in any manner impair the exercise of any such right. Any proposed amendment or waiver that disproportionately, materially and adversely affects the rights and obligations of any Purchaser relative to the comparable rights and obligations of the other Purchasers shall require the prior written consent of such adversely affected Purchaser. Any amendment effected in accordance with this Section 5.5 shall be binding upon each Purchaser and holder of Securities and the Company.

 

5.6          Headings. The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect any of the provisions hereof.

 

5.7          Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns. The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent of each Purchaser (other than by merger). Any Purchaser may assign any or all of its rights under this Agreement to any Person to whom such Purchaser assigns or transfers any Securities, provided that such transferee agrees in writing to be bound, with respect to the transferred Securities, by the provisions of the Transaction Documents that apply to the “Purchasers.”

 

5.8          No Third-Party Beneficiaries. The Placement Agent shall be the third party beneficiary of the representations and warranties of the Company in Section 3.1 and the representations and warranties of the Purchasers in Section 3.2. This Agreement is intended for the benefit of the parties hereto and their respective successors and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person, except as otherwise set forth in Section 4.8 and this Section 5.8.

 

37

 

 

5.9          Governing Law. All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of law thereof. Each party agrees that all legal Proceedings concerning the interpretations, enforcement and defense of the transactions contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto or its respective affiliates, directors, officers, stockholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of any of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any Action or Proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such Action or Proceeding is improper or is an inconvenient venue for such Proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any such Action or Proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law. If any party shall commence an Action or Proceeding to enforce any provisions of the Transaction Documents, then, in addition to the obligations of the Company under Section 4.8, the prevailing party in such Action or Proceeding shall be reimbursed by the non-prevailing party for its reasonable attorneys’ fees and other costs and expenses incurred with the investigation, preparation and prosecution of such Action or Proceeding.

 

5.10        Survival. The representations and warranties contained herein shall survive the Closing and the delivery of the Securities.

 

5.11        Execution. This Agreement may be executed by DocuSign or in two or more counterparts, all of which when taken together shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to each other party, it being understood that the parties need not sign the same counterpart. In the event that any signature is delivered by e-mail delivery of a “.pdf” format data file or other electronic medium recognized as an electronic signature under applicable law, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such “.pdf” signature page or other electronic signature were an original thereof.

 

5.12        Severability. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or unenforceable.

 

38

 

 

5.13       Rescission and Withdrawal Right. Notwithstanding anything to the contrary contained in (and without limiting any similar provisions of) any of the other Transaction Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction Document and the Company does not timely perform its related obligations within the periods therein provided, then such Purchaser may rescind or withdraw, in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand or election in whole or in part without prejudice to its future actions and rights; provided, however, that in the case of a rescission of an exercise of a Warrant, the applicable Purchaser shall be required to return any shares of Common Stock subject to any such rescinded exercise notice concurrently with the return to such Purchaser of the aggregate exercise price paid to the Company for such shares and the restoration of such Purchaser’s right to acquire such shares pursuant to such Purchaser’s Warrant (including, issuance of a replacement warrant certificate evidencing such restored right).

 

5.14        Replacement of Securities. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed, the Company shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation), or in lieu of and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to the Company of such loss, theft or destruction. The applicant for a new certificate or instrument under such circumstances shall also pay any reasonable third-party costs (including customary indemnity) associated with the issuance of such replacement Securities.

 

5.15        Remedies. In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, each of the Purchasers and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction Documents and hereby agree to waive and not to assert in any Action for specific performance of any such obligation the defense that a remedy at law would be adequate.

 

5.16        Payment Set Aside. To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction Document or a Purchaser enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise or any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by or are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other Person under any law (including, without limitation, any bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent of any such restoration the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect as if such payment had not been made or such enforcement or setoff had not occurred.

 

39

 

 

5.17        Independent Nature of Purchasers’ Obligations and Rights. The obligations of each Purchaser under any Transaction Document are several and not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance or non-performance of the obligations of any other Purchaser under any Transaction Document. Nothing contained herein or in any other Transaction Document, and no action taken by any Purchaser pursuant hereto or thereto, shall be deemed to constitute the Purchasers as a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any way acting in concert or as a group with respect to such obligations or the transactions contemplated by the Transaction Documents. Each Purchaser shall be entitled to independently protect and enforce its rights including, without limitation, the rights arising out of this Agreement or out of the other Transaction Documents, and it shall not be necessary for any other Purchaser to be joined as an additional party in any Proceeding for such purpose. Each Purchaser has been represented by its own separate legal counsel in its review and negotiation of the Transaction Documents. For reasons of administrative convenience only, each Purchaser and its respective counsel have chosen to communicate with the Company through EGS. EGS does not represent any of the Purchasers and only represents the Placement Agent. The Company has elected to provide all Purchasers with the same terms and Transaction Documents for the convenience of the Company and not because it was required or requested to do so by any of the Purchasers. It is expressly understood and agreed that each provision contained in this Agreement and in each other Transaction Document is between the Company and a Purchaser, solely, and not between the Company and the Purchasers collectively and not between and among the Purchasers.

 

5.18        Liquidated Damages. The Company’s obligations to pay any partial liquidated damages or other amounts owing under the Transaction Documents is a continuing obligation of the Company and shall not terminate until all unpaid partial liquidated damages and other amounts have been paid notwithstanding the fact that the instrument or security pursuant to which such partial liquidated damages or other amounts are due and payable shall have been canceled.

 

5.19        Saturdays, Sundays, Holidays, etc.If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.

 

5.20        Construction. The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise the Transaction Documents and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party shall not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each and every reference to share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the date of this Agreement.

 

5.21       WAIVER OF JURY TRIAL. IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY. 

 

 

(Signature Pages Follow)

 

40

 

 

 

IN WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.

 

 

	
			RICEBRAN TECHNOLOGIES

				
			Address for Notice:

			
	 	 
	 	 
	
			By:__________________________________________

			Name:

			Title:

				
			E-Mail:

			
	 	 
	
			With a copy to (which shall not constitute notice):

			Vinson & Elkins L.L.P.

			Attn: Scott Rubinsky, Esq.

				 

 

 

 

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK

SIGNATURE PAGE FOR PURCHASER FOLLOWS]

 

41

 

 

[PURCHASER SIGNATURE PAGES TO SECURITIES PURCHASE AGREEMENT]

 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.

 

	Name of Purchaser: 	 

	Signature of Authorized Signatory of Purchaser: 	 

	Name of Authorized Signatory: 	 

	Title of Authorized Signatory: 	 

	Email Address of Authorized Signatory: 	 

Address for Notice to Purchaser:

 

 

Address for Delivery of Warrants to Purchaser (if not same as address for notice):

 

 

 

 

Subscription Amount: $_________________

 

Shares: _________________

 

Pre-Funded Warrant Shares: __________________ Beneficial Ownership Blocker ☐ 4.99% or ☐ 9.99%

 

Common Warrant Shares: __________________ Beneficial Ownership Blocker ☐ 4.99% or ☐ 9.99%

 

EIN Number: _______________________

 

☐ Notwithstanding anything contained in this Agreement to the contrary, by checking this box (i) the obligations of the above-signed to purchase the securities set forth in this Agreement to be purchased from the Company by the above-signed, and the obligations of the Company to sell such securities to the above-signed, shall be unconditional and all conditions to Closing shall be disregarded, (ii) the Closing shall occur on the second (2nd) Trading Day following the date of this Agreement and (iii) any condition to Closing contemplated by this Agreement (but prior to being disregarded by clause (i) above) that required delivery by the Company or the above-signed of any agreement, instrument, certificate or the like or purchase price (as applicable) shall no longer be a condition and shall instead be an unconditional obligation of the Company or the above-signed (as applicable) to deliver such agreement, instrument, certificate or the like or purchase price (as applicable) to such other party on the Closing Date.

 

 

[SIGNATURE PAGES CONTINUE]

 

42EX-10.1

 Exhibit 10.1 

TRANSACTION SUPPORT AGREEMENT 

This Transaction Support Agreement (together with the exhibits and attachments hereto, including the Term Sheet (as defined
below) as each may be amended, restated, supplemented, or otherwise modified from time to time in accordance with the terms hereof, this “Agreement”), dated as of October 20, 2022 (the “Execution Date”), is
entered into by and among: 
  

	 	(a)	 Diebold Nixdorf, Incorporated, an Ohio corporation (the “Company”) and the other guarantors
under the Existing Documents (as defined herein) as set forth in the signature page to this Agreement (each such party listed in this clause (a), a “Company Party” and, such parties collectively, the “Company
Parties”); and 

  

	 	(b)	 the Consenting Parties1 (as defined below).

 This Agreement collectively refers to the Company Parties and the Consenting Parties signatory hereto
as the “Parties” and each individually as a “Party.” 
 RECITALS 

WHEREAS, the Parties have, in good faith and at arm’s length, negotiated or been apprised of the terms of the
transactions contemplated in the term sheet attached as Exhibit A hereto (together with the exhibits and attachments hereto, as each may be amended, restated, supplemented, or otherwise modified from time to time in accordance with the terms
hereof, the “Term Sheet”) and have agreed to support and pursue the Transactions (as defined herein) in accordance with and subject to the terms and conditions set forth herein; and 

WHEREAS, this Agreement sets forth the agreement among the Parties concerning their respective commitments, subject to the
terms and conditions hereof, to support and implement the Transactions. 
  

	1 	 For the avoidance of doubt, any Affiliates (as defined herein) or related parties of any such Consenting
Party shall not be deemed to be Consenting Parties themselves. The Parties acknowledge and agree that all representations, warranties, covenants, and other agreements made by any Consenting Party that is a separately managed account of or advised by
an investment manager are being made only with respect to the Claims held by such separately managed or advised account (in the amount identified on the signature pages hereto), and shall not apply to (or be deemed to be made in relation to) any
Claims that may be beneficially owned by other accounts that are managed or advised by such investment manager. The Parties further acknowledge and agree that all representations, warranties, covenants, and other agreements made by any
Consenting Party that is an investment advisor, sub-advisor, or manager of managed accounts are being made solely in such Consenting Party’s capacity as an investment advisor, sub-advisor, or manager to the beneficial owners of the Existing Debt specified on the applicable signature pages hereto (in the amount identified on such signature pages), and shall not apply to (or be deemed to be
made in relation to) such investment advisor, sub-advisor, or manager in any other capacity, including, without limitation, in its capacity as an investment advisor,
sub-advisor, or manager of other managed accounts. Solely to the extent that and so long as applicable fund policies of a Consenting Party prohibit such Consenting Party from accepting the 2024 Consent
Solicitation and Exchange Offer with respect to certain 2024 Notes of such Consenting Party (the “Exempt Notes”) and such Exempt Notes are specifically identified as such on its signature page to this Agreement, such Consenting Party shall
not be required to accept the 2024 Consent Solicitation and Exchange Offer solely with respect to such Exempt Notes and Section 5(k) and Section 8 of this Agreement shall not apply with respect to the Exempt Notes. 

 NOW, THEREFORE, in consideration of the promises, mutual covenants,
and agreements set forth herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, each of the Parties, intending to be legally bound, hereby agrees as follows: 

AGREEMENT 

1. Definitions. Capitalized terms used but not otherwise defined herein shall have the meanings given to them in the
Term Sheet or as otherwise expressly set forth herein. The following terms used in this Agreement are defined as: 

“2024 Consent Solicitation and Exchange Offer” shall have the meaning set forth in the Term Sheet. 

“2024 Notes” shall have the meaning set forth in the Term Sheet. 

“2024 Offering Memorandum” means that certain Exchange Offering Memorandum and Solicitation of Consents
related to the 2024 Consent Solicitation and Exchange Offer. 
 “2025 Consent Solicitation” shall have the
meaning set forth in the Term Sheet. 
 “2025 Euro Notes” means the notes issued under the Existing Euro
2025 Indenture. 
 “2025 Notes” means, collectively, the 2025 Euro Notes and the 2025 U.S. Notes. 

“2025 Supplemental Indentures” shall have the meaning set forth in the Term Sheet. 

“2025 U.S. Notes” means the notes issued under the Existing U.S. 2025 Indenture. 

“Ad Hoc Group” means the ad hoc group of holders of Existing Debt represented by the Ad Hoc Group Advisors.

 “Ad Hoc Group Advisors” means, collectively, Davis Polk, Houlihan Lokey Capital, Inc., Ashurst LLP, and
counsel to be selected by the Majority Consenting Parties in each Specified Jurisdiction (as defined in the Term Sheet); provided that, so long as an actual conflict of interest exists, the Term Loan Group and Ad Hoc Group may engage separate
counsel in each Specified Jurisdiction where such conflict of interest exists. 
 “Ad Hoc Group Steering
Committee” means those certain members of the ad hoc group of holders of Existing Debt represented by the Ad Hoc Group Advisors set forth on Exhibit D hereto. 

“Ad Hoc Group Termination Event” has the meaning given to such term in Section 7(a) hereof. 

“Additional Consenting Parties” has the meaning set forth in Section 27 hereof. 

  
 -2- 

 “Advisors” means, collectively, the Ad Hoc Group Advisors
and the Term Loan Group Advisors. 
 “Affiliate” means, with respect to any Person, any other Person
directly or indirectly controlling, controlled by or under common control with, such Person. For the avoidance of doubt, Parties with investments managed by separate Persons shall be deemed to be Affiliates of one another if the Persons who manage
their investments are themselves under common control. 
 “Agreement” has the meaning set forth in the
preamble hereof. 
 “Agreement Effective Date” has the meaning set forth in Section 3 hereof. 

“Alternative Transaction” means any dissolution, winding up, liquidation, receivership, assignment for the
benefit of creditors, restructuring, reorganization, workout, material amendment, exchange, extension, sale, disposition, merger, amalgamation, acquisition, consolidation, partnership, plan of arrangement, plan of reorganization, plan of
liquidation, investment, debt investment, equity investment, tender offer, refinancing, recapitalization, share exchange, business combination, joint venture or similar transaction involving all or a material portion of the assets, debt or equity of
the Company Parties and their respective subsidiaries (taken as a whole), that is not consistent with, or an alternative to, the Transactions. 

“Amendments” shall have the meaning set forth in the Term Sheet. 

“Automatic Termination Event” has the meaning set forth in Section 7(e) hereof. 

“Bankruptcy Code” means title 11 of the United States Code, 11 U.S.C. §§ 101,
et seq., as amended from time to time. 
 “Business Day” means any day other than
a Saturday, Sunday, or any other day on which banks in New York, New York are authorized or required by law to close. 

“Claim” means (a) a right to payment, whether or not such right is reduced to judgment, liquidated,
unliquidated, fixed, contingent, matured, unmatured, disputed, undisputed, legal, equitable, secured, or unsecured, or (b) a right to an equitable remedy for breach of performance if such breach gives rise to a right to payment, whether or not
such right to an equitable remedy is reduced to judgment, fixed, contingent, matured, unmatured, disputed undisputed, secured, or unsecured, each as set forth in section 101(5) of the Bankruptcy Code. 

“Closing Date” shall mean the date of the satisfaction (or waiver, if applicable) of the closing conditions
set forth in the Definitive Documents and the consummation of the Transactions, including the funding of the Superpriority Facility. 

“Commencement Date” means the date that is twenty (20) Business Days after the Execution Date or such
later date acceptable to the Company and the Majority Consenting Parties. 
 “Commitment Notice” has the
meaning set forth in Section 6(c) hereof. 

  
 -3- 

 “Commitment Parties” means the Consenting Parties set forth
on Exhibit B hereto (as updated and replaced in accordance with Section 6(c)). 
 “Company” has
the meaning set forth in the preamble hereof. 
 “Company Parties” has the meaning set forth in the
preamble hereof. 
 “Company Released Claims” has the meaning set forth in Section 10(a). 

“Company Released Party” means each of: (a) the Company Parties and each of their Affiliates;
(b) the predecessors, successors, and assigns of each of the foregoing; and (c) the current and former officers, directors, members, managers, partners, employees, shareholders, advisors, agents, professionals, attorneys, financial
advisors, and other representatives of each of the foregoing, in each case in their capacity as such. 
 “Company
Termination Event” has the meaning given to such term in Section 7(c) hereof. 
 “Consenting
Parties” means, subject to footnote 1 hereof, collectively, (a) the undersigned holders of Existing Debt and (b) in their capacity as such, the undersigned investment advisors, sub-advisors,
or managers (together with their respective successors and permitted assigns) of discretionary accounts or other beneficial owners that hold Existing Debt, which such accounts or beneficial owners such investment advisors, sub-advisors, or managers have authority to bind, and by executing this Agreement do thereby bind, to the terms of this Agreement (including, for the avoidance of doubt, the Additional Consenting Parties). 

“Consenting Party Released Claims” has the meaning given to such term in Section 10(b) hereof. 

“Control” (including the terms “controlling,” “controlled by” and
“under common control with”), with respect to the relationship between or among two or more Persons, means the possession, directly or indirectly, of the power to direct or cause the direction of the affairs or management of a
Person, whether through the ownership of voting securities, as trustee or executor, by contract or otherwise. 

“Davis Polk” means Davis Polk & Wardwell LLP. 

“Diebold Industry” means the industries in which the Company Parties and their subsidiaries operate. 

“Definitive Documents” means (a) the credit agreement for the Superpriority Facility (or indenture if
structured in the form of notes), (b) the credit agreement for the ABL Facility (as defined in the Term Sheet), (c) the credit agreement for the New Term Loans (as defined in the Term Sheet), (d) the indenture for the New 2L Notes (as defined in the
Term Sheet), (e) the Amendments, (f) any security or collateral documents entered into in connection with the Transactions, (g) the Intercreditor Agreements, (h) securities offering or exchange offer documents in connection with the
Transactions, (i) consent solicitation statements or other solicitation 

  
 -4- 

 
materials, including related notices, ballots, or other election forms used in connection with the Transactions, (j) the Warrant Agreement (as defined in the Term Sheet) and (k) all
other ancillary and related documents, schedules, exhibits, addenda and instruments entered into in connection with the Transactions. 

“Exchange Act” means the Securities Exchange Act of 1934, as amended. 

“Execution Date” has the meaning set forth in the preamble hereof. 

“Existing 2024 Indenture” shall have the meaning set forth in the Term Sheet. 

“Existing 2025 Indentures” shall have the meaning set forth in the Term Sheet. 

“Existing Agent” means the administrative agent under the Existing Credit Agreement. 

“Existing Credit Agreement” shall have the meaning set forth in the Term Sheet. 

“Existing Debt” means the Existing Revolver Exposure, the Existing Term Loans, the 2025 Notes and the 2024
Notes. 
 “Existing Documents” means, collectively, the Existing Credit Agreement, the Existing 2025
Indentures, the Existing 2024 Indenture and all documents and agreements (including amendments and/or supplemental indentures) related thereto. 

“Existing Euro 2025 Indenture” shall have the meaning set forth in the Term Sheet. 

“Existing Revolver Exposure” shall have the meaning set forth in the Term Sheet. 

“Existing Term Loans” shall have the meaning set forth in the Term Sheet. 

“Existing Trustees” means the trustees under the Existing 2025 Indentures and the Existing 2024 Indenture, or
any successor to any such Existing Trustee that has replaced it in accordance with the applicable provisions of the applicable indenture. 

“Existing U.S. 2025 Indenture” shall have the meaning set forth in the Term Sheet. 

“Gibson Dunn” means Gibson, Dunn & Crutcher LLP. 

“Indemnification Obligations” has the meaning set forth in Section 11(a) hereof. 

“Indemnified Party” has the meaning set forth in Section 11(a) hereof. 

“Initial Eligible Consenting Parties” has the meaning set forth in Section 6(a) hereof. 

“Intercreditor Agreements” has the meaning set forth in the Term Sheet. 

“Losses” has the meaning set forth in Section 11(a) hereof. 

  
 -5- 

 “Majority Ad Hoc Parties” means the members of the Ad Hoc
Group holding a majority, in the aggregate, of the aggregate principal amount of the Specified Debt held by the Ad Hoc Group at the applicable time. 

“Majority Consenting Parties” means the Initial Eligible Consenting Parties holding a majority of the
principal amount of each tranche of (i) the Existing Term Loans, (ii) the 2025 Notes and (iii) the 2024 Notes, in each case held by the Initial Eligible Consenting Parties at the applicable time. For the avoidance of doubt, the test for Majority
Consenting Parties is only satisfied if each of subsections (i)-(iii) of the immediately preceding sentence, tested separately for each tranche, is satisfied. 

“Majority Term Loan Parties” means the members of the Term Loan Group holding a majority, in the aggregate,
of the aggregate principal amount of the Specified Debt held by the Term Loan Group at the applicable time. 

“Market Capitalization” shall mean an amount equal to (a) the total number of shares of issued and
outstanding common stock of the Company at the close of trading on the trading day prior to the Closing Date multiplied by (b) the arithmetic mean of the per share volume weighted average price as displayed under the heading “Bloomberg
VWAP” (or its equivalent successor if such page is not available) in respect of the period from the scheduled open of trading until the scheduled close of trading of the primary trading session on each such trading day as reported during the
thirty (30) consecutive trading day-period ending on the trading day immediately preceding the Closing Date.2 

“Material Adverse Effect” means (i) an effect, event, change, occurrence or circumstance that is
materially adverse to the business, results of operations or financial condition of the Company and its subsidiaries taken as a whole or (ii) a material and adverse effect on the ability of the Company to consummate the Transactions;
provided, however, that no effect, event, change, occurrence or circumstance arising or resulting from any of the following, either alone or in combination, shall constitute a Material Adverse Effect: (a) operating, business,
regulatory, political or other conditions in the Diebold Industry in the United States, Germany or elsewhere in the world; (b) general economic conditions, including changes in the credit, debt, financial or capital markets (including changes
in interest or exchange rates), in each case, in the United States, Germany or anywhere else in the world; (c) earthquakes, floods, hurricanes, tornadoes, natural disasters or other acts of nature, acts of war (whether or not declared), civil
disobedience, sabotage, terrorism, military actions, hostilities or the escalation of any of the foregoing, whether perpetrated or encouraged by a state or non-state actor or actors, including cyberattacks,
any outbreak of illness or other public health event, whether or not caused by any Person (other than the Company Parties or their subsidiaries); (d) the negotiation, execution, announcement or performance of this 

 

	2 	 Market Capitalization shall be calculated with appropriate adjustments as needed to account for any stock
splits or reverse stock splits during the thirty (30) consecutive trading day-period ending on the trading day immediately preceding the Closing Date. 

  
 -6- 

 
Agreement or the consummation of the Transactions contemplated hereby, including the impact thereof on relationships, contractual or otherwise, with, or actual or potential loss or impairment of,
clients, customers, suppliers, distributors, partners, financing sources, employees and/or independent contractors and/or on revenue, profitability and/or cash flows; (e) any change in laws or GAAP or other applicable accounting rules, or the
interpretation thereof; and (f) any actions taken or not taken by the Company Parties or any of their subsidiaries pursuant to this Agreement or permitted under this Agreement or with consent pursuant to the terms of this Agreement;
provided, however, that in the case of the foregoing clauses (a), (b), (c) and (e), only to the extent such effects, events, changes, occurrences or circumstances do not materially disproportionately impact the Company and its
subsidiaries, taken as a whole, as compared to other Persons operating in the Diebold Industry. 
 “Mutual
Termination Event” has the meaning set forth in Section 7(d) hereof. 
 “Open Trade” means a
transaction, agreement, or other arrangement, whether done through an oral or written confirmation, under which a Party to this Agreement is entitled or obligated to Transfer or receive a Transfer of any 2024 Notes, 2025 Notes, Existing Term Loans,
and/or 2023 Revolving Credit Loans, with a trade date on or prior to the applicable date of determination. 
 “Other
Eligible Consenting Parties” has the meaning set forth in Section 6(b) hereof. 
 “Other Released
Party” means each of: (a) the Consenting Parties and each of their Affiliates; (b) the predecessors, successors, and assigns of each of the foregoing, and (c) the current and former officers, directors, members, managers,
partners, employees, shareholders, advisors, agents, professionals, attorneys, financial advisors, and other representatives of each of the foregoing, in each case in their capacity as such. 

“Party” or “Parties” has the meaning set forth in the preamble hereof. 

“Permitted Transferee” has the meaning set forth in Section 8(a) hereof. 

“Person” means an individual, partnership, joint venture, limited liability company, corporation, trust,
unincorporated organization, group, or any other legal entity or association. 
 “Public Disclosure” has
the meaning set forth in Section 24 hereof. 
 “Record Date” has the meaning set forth in
Section 6(b) hereof. 
 “Revolver Exchange” shall have the meaning set forth in the Term Sheet. 

“SEC” means the U.S. Securities and Exchange Commission. 

“Securities Act” means the Securities Act of 1933, as amended. 

“Specified Debt” shall mean, collectively, Existing Term Loans, 2025 Notes and 2024 Notes. 

  
 -7- 

 “Strategic Transaction” means any sale, disposition,
merger, amalgamation, acquisition, consolidation, partnership, business combination, joint venture or similar transaction involving all or a material portion of the assets, debt or equity of the Company Parties and their respective subsidiaries
(taken as a whole) that, in each case, provides for the payment at par in full in cash of the Existing Debt. 

“Structuring Premium” has the meaning set forth in Section 6(g) hereof. 

“Structuring Parties” means those certain Consenting Parties set forth on Exhibit C hereto. 

“Structuring Premium Amount” has the meaning set forth in Section 6(g) hereof. 

“Sullivan & Cromwell” means Sullivan & Cromwell LLP. 

“Superpriority Commitment” means the commitments of the Commitment Parties set forth on Exhibit B
hereto (as updated and replaced in accordance with Section 6(c)) to fund the Superpriority Facility and Superpriority Loans on the Closing Date, subject to the terms and conditions of this Agreement. 

“Superpriority Facility” has the meaning set forth in the Term Sheet. 

“Superpriority Loans” has the meaning set forth in the Term Sheet. 

“Term Loan Exchange” shall have the meaning set forth in the Term Sheet. 

“Term Loan Group” means the ad hoc group of holders of Existing Debt represented by the Term Loan Group
Advisors. 
 “Term Loan Group Advisors” means, collectively, Gibson Dunn, PJT Partners Inc., and counsel to
be selected by the Majority Consenting Parties in each Specified Jurisdiction (as defined in the Term Sheet); provided that, so long as an actual conflict of interest exists, the Term Loan Group and Ad Hoc Group may engage separate counsel in
each Specified Jurisdiction where such conflict of interest exists. 
 “Term Loan Group Termination Event”
has the meaning set forth in Section 7(b) hereof. 
 “Term Sheet” has the meaning set forth in the
recitals hereof. 
 “Termination Date” has the meaning set forth in Section 7(f) hereof. 

“Termination Event” means any of an Ad Hoc Group Termination Event, a Term Loan Group Termination Event, a
Company Termination Event, a Mutual Termination Event, or an Automatic Termination Event. 
 “Transactions”
means the transactions as described in this Agreement including, without limitation, the Revolver Exchange, the Term Loan Exchange, the 2025 Consent Solicitation, the 

  
 -8- 

 
2024 Consent Solicitation and Exchange Offer, entry into the Amendments, and all other transactions contemplated by the foregoing documents. 

“Transfer” or “Transferred” has the meaning set forth in Section 8(a) hereof. 

“Transferor” has the meaning set forth in Section 8(a) hereof. 

2. Definitive Documents; Incorporation by Reference. 

(a) The Definitive Documents remain subject to negotiation and completion. Except as otherwise set forth in this Agreement,
the Definitive Documents shall be consistent in all respects with the terms set forth in this Agreement and shall otherwise be reasonably acceptable in form and substance to (1) the Company and (2) the Majority Consenting Parties;
provided that from and after the Closing Date, the Indemnification Obligations in favor of any Consenting Party that becomes a “Lender” under the Superpriority Facility shall constitute “Obligations” as such term is used
in the Superpriority Facility. Upon negotiation and completion of the Definitive Documents, the Definitive Documents and every other document, deed, agreement, indenture, filing, notification, letter or instrument related to the Transactions shall
contain terms, conditions, representations, warranties and covenants consistent with the terms of this Agreement. 
 (b) The
exhibits hereto are fully incorporated by reference herein and are made a part of this Agreement as if fully set forth herein, and all references to this Agreement shall include and incorporate all exhibits hereto; provided, however,
that (i) to the extent that there is a conflict between this Agreement (excluding the Term Sheet), on the one hand, and the Term Sheet, on the other hand, the terms and provisions of the Term Sheet shall govern and, (ii) to the extent that
there is a conflict between the Term Sheet, on the one hand, and any of the Definitive Documents, on the other hand, the terms and provisions of any such Definitive Document shall govern. Neither this Agreement nor any provision hereof may be
modified, waived, amended, or supplemented, except in accordance with Section 16 hereof. 
 3. Agreement Effective
Date. This Agreement shall become effective upon the occurrence of each of the following events (the date on which such events occur, the “Agreement Effective Date”): 

 

	 	(a)	 the execution and delivery of this Agreement by each of the Company Parties; 

 

	 	(b)	 the execution and delivery of this Agreement by the Consenting Parties beneficially owning a majority in
principal amount of the 2025 U.S. Notes outstanding under the Existing U.S. 2025 Indenture; 

  

	 	(c)	 the execution and delivery of this Agreement by the Consenting Parties beneficially owning a majority in
principal amount of the 2025 Euro Notes outstanding under the Existing Euro 2025 Indenture; 

  
 -9- 

	 	(d)	 the execution and delivery of this Agreement by the Consenting Parties beneficially owning a majority in
principal amount of the 2024 Notes outstanding under the Existing 2024 Indenture; and 

  

	 	(e)	 the execution and delivery of this Agreement by the Consenting Parties beneficially owning a majority in
principal amount of the Existing Term Loans. 

 4. Commitments of the Company Parties. Subject to
the terms and conditions of this Agreement, each Company Party agrees that it shall (and shall cause each of its direct and indirect subsidiaries to), so long as no Termination Event has occurred: 

(a) support and take all commercially reasonable actions necessary to facilitate the implementation and consummation of the
Transactions, including, without limitation, (i) taking all actions to support and complete the Transactions and all other actions contemplated in connection therewith and under the Definitive Documents, (ii) obtaining any and all required
governmental, regulatory and/or third-party approvals or consents for the implementation and consummation of the Transactions, (iii) refraining from taking any actions inconsistent with, and not failing or omitting to take an action that is
required by, this Agreement or the Definitive Documents, and (iv) seeking additional support for the Transactions to the extent reasonably prudent; 

(b) (i) not directly or indirectly negotiate, enter into, issue, incur, arrange, participate in or consent to any credit
facility, bond issuance or other financing, rights offering or issuance of debt or equity securities or (ii) undertake or otherwise support or participate in any reorganization, merger, consolidation, business combination or other
recapitalization or debt restructuring (whether through a judicial process or otherwise) other than in the ordinary course of business or in connection with the Transactions; 

(c) on the Closing Date, effectuate the Revolver Exchange in accordance with the provisions of this Agreement; 

(d) on the Closing Date, effectuate the Term Loan Exchange in accordance with the provisions of this Agreement, and enter into
the Existing Credit Agreement Amendment; 
 (e) on or prior to the Commencement Date, distribute the documents for the 2025
Consent Solicitation to the holders of the 2025 Notes in accordance with the provisions of the related consent solicitation statements, this Agreement and applicable requirements of the Securities Act, the Exchange Act, and the rules and regulations
of the SEC thereunder and, on the Closing Date, enter into the 2025 Supplemental Indentures; 
 (f) on or prior to the
Commencement Date, distribute the documents for the 2024 Consent Solicitation and Exchange Offer to the holders of the 2024 Notes and, on the Closing Date, (i) issue, in exchange for the tendered 2024 Notes, the New 2L Notes and the Warrants
(as defined in the Term Sheet), and to cancel such tendered 2024 Notes, and (ii) enter into the 2024 Supplemental Indenture, in each case in accordance with the provisions of this Agreement, the

  
 -10- 

 
2024 Offering Memorandum and applicable requirements of the Securities Act, the Exchange Act, and the rules and regulations of the SEC thereunder; 

(g) not purchase or exchange, or offer to purchase or exchange, any Existing Debt, or solicit consents to any material
amendments, modifications or supplements to the Existing Documents (other than an amendment to, or waiver of, a financial or reporting covenant included in the Existing Credit Agreement, unless such amendment or waiver requires the Company to
provide value in exchange for such amendment or waiver that is not acceptable to the Majority Consenting Parties) or any related guarantees, security documents, intercreditor agreements or ancillary documents (other than, in each case, as
contemplated by this Agreement); 
 (h) negotiate in good faith the Definitive Documents with the respective Parties thereto
and execute and deliver each Definitive Document to which it is to be a party and consummate the Transactions, in each case as promptly as reasonably practicable; 

(i) promptly provide a Consenting Party with any documentation or information that is reasonably requested by such Consenting
Party or is reasonably necessary to consummate the Transactions, including “know your customer” and like materials, which documentation and information shall be subject to any confidentiality restrictions to which the Consenting Party may
be subject; 
 (j) (i) no later than five (5) Business Days following the date hereof, the Company Parties shall pay
all invoiced unpaid fees, costs, and out-of-pocket expenses of the Advisors; and (ii) promptly pay when due all the reasonable and documented and invoiced fees,
costs, and out-of-pocket expenses of the Advisors in accordance with their respective engagement letters and/or fee letters entered into with the Company (if any);3 
 (k) to the extent any legal or structural impediment arises that would
prevent, hinder, or delay the consummation of the Transactions, support and take all steps reasonably necessary or desirable to address any such impediment, including notifying the Advisors of any material governmental or third-party complaints,
litigations, investigations or hearings related to the Transactions; 
 (l) conduct its business in the ordinary course
substantially consistent with past practice and in light of then-current market conditions, and use its commercially reasonable efforts to (i) preserve intact its present business organization, (ii) maintain in effect all of its material
foreign, federal, state and local licenses, permits, consents, franchises, approvals and authorizations required to operate its business, (iii) preserve relationships with its customers, suppliers and others having material business
relationships with it, and (iv) maintain its good standing under the laws of the state or other jurisdictions in which they are incorporated or organized. Without limiting the generality of the foregoing, except as expressly contemplated
by 
  

	3 	 Including, for the avoidance of doubt, payment of reasonable and documented and invoiced fees, costs, and
out of pocket expenses of local counsel submitted in connection with the fee letters with respect to Davis Polk or Gibson Dunn. 

  
 -11- 

 
this Agreement, each Company Party shall not (and shall cause each of its direct and indirect subsidiaries not to): 

(i) amend its articles of incorporation, bylaws or other similar organizational documents (whether by merger, consolidation or
otherwise); 
 (ii) split, combine or reclassify any shares of capital stock of any Company Party or declare, set aside or
pay any dividend or other distribution (whether in cash, stock or property or any combination thereof) in respect of the capital stock of any Company Party, or redeem, repurchase or otherwise acquire or offer to redeem, repurchase, or otherwise
acquire any Company Party securities (other than pursuant to an agreement in effect as of the date hereof pursuant to the Company Parties’ executive compensation plans); 

(iii) issue, deliver or sell, or authorize the issuance, delivery or sale of, any Company Party securities or amend any term
of any Company Party security (in each case, whether by merger, consolidation or otherwise); 
 (iv) acquire (by merger,
consolidation, acquisition of stock or assets or otherwise), directly or indirectly, any assets, securities, properties, interests or businesses, other than in the ordinary course of business substantially consistent with past practice and permitted
under the Existing Documents; 
 (v) sell, lease or otherwise transfer, or create or incur any lien on, any of the
Company’s assets, securities, properties, interests or businesses, other than in the ordinary course of business, consistent with past practice and permitted under the Existing Documents; 

(vi) make any loans, advances or capital contributions to, or investments in, any other Person, other than in the ordinary
course of business substantially consistent with past practice; 
 (vii) make any payment in satisfaction of any existing
funded indebtedness other than regularly scheduled payments of interest and principal; 
 (viii) create, incur, assume,
suffer to exist or otherwise be liable with respect to any indebtedness for borrowed money or guarantees thereof (other than with respect to the Existing Debt), other than in the ordinary course of business substantially consistent with past
practice and permitted under the Existing Documents; 
 (ix) seek, solicit, support, formulate, entertain, encourage, engage
in any inquiries or discussions concerning, or enter into any agreements relating to, any Alternative Transaction, and if the Company receives an unsolicited bona fide proposal or expression of interest in undertaking an Alternative Transaction, the
Company will, within 24 hours of the receipt of such proposal or expression of interests, notify the Advisors of the receipt thereof, with such notice to include the material terms thereof, including the identity of the Person or group of Persons
involved in making such proposal; 

  
 -12- 

 (x) enter into any agreement or arrangement that limits or otherwise
restricts in any material respect it or any of its Affiliates or any successor thereto or that could, after the Closing Date, limit or restrict in any material respect it or any of its Affiliates, from engaging or competing in any line of business,
in any location or with any Person; or 
 (xi) enter into any agreement or arrangement that waives, releases or assigns, or
modifies in any material respect, any of its material rights, claims or benefits, other than in the ordinary course of business substantially consistent with past practice; 

(m) notify the Advisors as promptly as reasonably possible (but in no event later than two (2) Business Days after the
applicable occurrence) as to: (i) any material change in the business or financial (including liquidity) performance of the Company Parties (taken as a whole); (ii) the status and progress of the Transactions, including any material
changes thereto; (iii) the receipt or rejection of any material authorizations (including any consents) from any competent judicial body, governmental authority, banking, taxation, supervisory or regulatory body or any stock exchange that are
required for the implementation and consummation of the Transactions; (iv) any material governmental or third-party complaints, litigations, investigations or hearings; (v) any notice of any commencement of any involuntary insolvency
proceedings of the Company or any of its Affiliates, or material legal suit for payment of debt or securement of security from or by any Person in respect of the Company; (vi) any material representation or statement made or deemed to be made
by them under this Agreement which is or proves to have been incorrect or misleading in any material respect when made or deemed to be made; and (vii) any breach of any of its obligations or covenants set forth in this Agreement; 

(n) not (i) form, designate, acquire or otherwise create an “Unrestricted Subsidiary” (as defined in the
Existing Documents) or (ii) enter into any transaction with (including by selling or transferring property or assets to, or purchasing or acquiring property or assets from) any “Unrestricted Subsidiary”; 

(o) promptly provide the Advisors, upon reasonable advance notice to the Company, timely responses to all reasonable diligence
requests and any documentation or information that is reasonably requested by the Advisors for purposes of negotiating, documenting and effectuating the Transactions, subject to any confidentiality restrictions to which the Advisors may be subject;
provided that the foregoing shall not require the disclosure of any legally privileged document or information of any Company Party; and 

(p) to the extent any legal or structural impediments arise that would prevent, hinder, or delay the consummation of the
Transactions, negotiate, subject to applicable laws and regulations, in good faith appropriate additional or alternative provisions to address any such impediments; provided that such alternative does not alter, in any material respect, the
substance and economics of the Transactions. 
 Notwithstanding the foregoing or anything in this Agreement to the contrary,
(i) nothing in this Agreement shall limit the rights, power or ability of the Company Parties to seek, solicit, support, formulate, entertain, encourage, engage, negotiate, participate in any inquiries or discussions concerning, or enter into
any agreements relating to, any Strategic Transaction, excluding, for the 

  
 -13- 

 
avoidance of doubt, consummating or entering into a binding agreement to consummate a Strategic Transaction, and (ii) no such action shall constitute a breach of this Agreement. 

5. Commitments of the Consenting Parties. Subject to the terms and conditions of this Agreement, each Consenting Party
(severally and not jointly) agrees that it shall, so long as no Termination Event has occurred: 
 (a) support and take all
commercially reasonable actions necessary or reasonably requested by the Company to facilitate the implementation and consummation of the Transactions, including, without limitation, (i) taking all actions to support and complete the
Transactions and all other actions contemplated in connection therewith and in this Agreement and under the Definitive Documents, (ii) refraining from taking any actions inconsistent with, and not failing or omitting to take an action that is
required by, this Agreement or the Definitive Documents; (iii) directing the Existing Agent and the Existing Trustees; and (iv) if requested by the Company and subject to the consent of the Majority Consenting Parties, facilitating the
replacement of the Existing Agent or Existing Trustees, as applicable, in connection with the consummation of the Amendments; 

(b) on a timely basis, negotiate in good faith the Definitive Documents with the Company and execute and deliver each
Definitive Document to which it is to be a party; 
 (c) provide all consents required for the consummation of the
Transactions; 
 (d) not directly or indirectly (i) object to, delay or impede the Transactions or the implementation
thereof or initiate any legal proceedings that are inconsistent with, or that would delay, prevent, frustrate, or impede the approval, solicitation, or consummation of, the Transactions, the Definitive Documents, or any other transactions outlined
therein or in this Agreement, or take any other action that is barred by this Agreement; (ii) vote for, consent to, support or participate in the formulation of any other restructuring, exchange or settlement of any Existing Debt or other
transaction that is inconsistent with this Agreement or the Transactions; or (iii) solicit, encourage, or direct any Person to undertake any action set forth in clauses (i) through (ii) of this subsection (d); 

(e) to the extent any legal or structural impediments arise that would prevent, hinder, or delay the consummation of the
Transactions, negotiate, subject to applicable laws and regulations, in good faith appropriate additional or alternative provisions to address any such impediments; provided that such alternative does not alter, in any material respect, the
substance and economics of the Transactions; 
 (f) notify the Company and the Advisors as promptly as reasonably possible
(but in no event later than two (2) Business Days after the applicable occurrence) as to: (i) any event or circumstance that such Consenting Party has actual knowledge of that has occurred, or that is reasonably likely to occur (and if it
did so occur), that would permit any Party to terminate, or could reasonably be expected to result in the termination of, this Agreement; (ii) any matter or circumstance that such Consenting Party has actual knowledge of that constitutes or
could reasonably be expected to constitute a material impediment to the implementation or 

  
 -14- 

 
consummation of the Transactions; (iii) any material representation or statement made or deemed to be made by them under this Agreement which is or proves to have been incorrect or
misleading in any material respect when made or deemed to be made, to the extent actually known by such Consenting Party and (iv) any breach of any of its obligations or covenants set forth in this Agreement. 

(g) not instruct the Existing Agent or the Existing Trustees to take any action, or to refrain from taking any action, that
would be inconsistent with this Agreement or the Transactions; 
 (h) timely exchange and assign (or cause to be assigned)
to the Company for cancellation or termination all of its Existing Revolver Exposure as part of the Revolver Exchange, including with respect to any Existing Revolver Exposure for which the Consenting Party serves (now or hereafter) as nominee,
investment manager, or advisor for beneficial holders thereof and not withdraw or revoke its assignment or consent with respect to such Existing Revolver Exposure; 

(i) timely exchange and assign (or cause to be assigned) to the Company for cancellation all of its Existing Term Loans as
part of the Term Loan Exchange, including with respect to any Existing Term Loans for which the Consenting Party serves (now or hereafter) as nominee, investment manager, or advisor for beneficial holders thereof and not withdraw or revoke its
assignment or consent with respect to such Existing Term Loans; 
 (j) timely participate in, and provide consents under,
the 2025 Consent Solicitation, in accordance with the applicable procedures set forth in the related consent solicitation statement and any other documents related thereto (e.g., notices, ballots, or other election forms), including with respect to
any 2025 Notes for which the Consenting Party serves (now or hereafter) as nominee, investment manager, or advisor for beneficial holders thereof and not withdraw or revoke its consent with respect to such 2025 Notes; and 

(k) (i) timely exchange and tender (or cause to be tendered) all if its 2024 Notes in accordance with the applicable
procedures set forth in the 2024 Offering Memorandum, including with respect to any 2024 Notes for which the Consenting Party serves (now or hereafter) as nominee, investment manager, or advisor for beneficial holders thereof and (ii) not
withdraw or revoke its tender or consent with respect to such 2024 Notes. 
 6. Superpriority Commitment. 

(a) Each Structuring Party and other Consenting Party that was an initial party to the Transaction Support Agreement on the
Execution Date with their signatures attached hereto (the “Initial Eligible Consenting Parties”) shall have the right to elect, on such date, by way of written notice (email being sufficient) to Houlihan Lokey Capital, Inc., PJT
Partners, Inc. and Evercore Group LLC, to (or cause to) provide (or for any of its Affiliates to (or cause to) provide) a percentage of the aggregate principal amount of the Superpriority Loans on the Closing Date calculated on a pro rata basis
based on such Initial Eligible Consenting Party’s pro rata share of all outstanding Specified Debt (reflecting any Open Trade as of such time) as of 11:59 pm EST on the Execution Date. The commitment amounts allocated to each Initial Eligible
Consenting Party (including oversubscription amounts) as of the Execution 

  
 -15- 

 
Date are set forth on Exhibit B hereto; provided that the aggregate amount of the Superpriority Commitments (including oversubscription amounts) as of the Execution Date shall be in
an amount equal to the aggregate principal amount of the Superpriority Loans. If the Term Loan Group terminates this Agreement in accordance with Section 7(b) hereto, then: (i) the Initial Eligible Consenting Parties that are members of
the Ad Hoc Group shall have the right to elect, within five (5) Business Days of the occurrence of such termination, by way of written notice (email being sufficient) to Houlihan Lokey Capital, Inc. and Evercore Group LLC, to (or cause to)
provide (or for any of its Affiliates to (or cause to) provide) an additional percentage of the aggregate principal amount of the Superpriority Loans corresponding to up to the Superpriority Commitments allocated to the Term Loan Group as set out in
Exhibit B hereto; (ii) to the extent that such Initial Eligible Consenting Parties oversubscribe any available amount, then any oversubscribed amount shall be reduced such that the oversubscriptions are provided on a pro rata basis in
accordance with the holdings of the oversubscribing Initial Eligible Consenting Parties of the Specified Debt (reflecting any Open Trade as of the relevant time); and (iii) to the extent that such Initial Eligible Consenting Parties do not
fully subscribe for the Superpriority Commitments allocated to the Term Loan Group, then the Company shall be free to solicit commitments from any Person. If the Ad Hoc Group terminates this Agreement in accordance with Section 7(a) hereto,
then: (i) the Initial Eligible Consenting Parties that are members of the Term Loan Group shall have the right to elect, within five (5) Business Days of the occurrence of such termination, by way of written notice (email being sufficient)
to PJT Partners, Inc. and Evercore Group LLC, to (or cause to) provide (or for any of its Affiliates to (or cause to) provide) an additional percentage of the aggregate principal amount of the Superpriority Loans corresponding to up to the
Superpriority Commitments allocated to the Ad Hoc Group as set out in Exhibit B hereto; (ii) to the extent that such Initial Eligible Consenting Parties oversubscribe any available amount, then any oversubscribed amount shall be reduced
such that the oversubscriptions are provided on a pro rata basis in accordance with the holdings of the oversubscribing Initial Eligible Consenting Parties of the Specified Debt (reflecting any Open Trade as of the relevant time); and (iii) to
the extent that such Initial Eligible Consenting Parties do not fully subscribe for the Superpriority Commitments allocated to the Ad Hoc Group, then the Company shall be free to solicit commitments from any Person. 

(b) (i) Each Consenting Party that did not execute (and with respect to which no affiliate or associate thereof executed) a
confidentiality agreement with the Company prior to the public announcement of this Agreement and that becomes party to this Agreement by the date that is five (5) Business Days after the public announcement of this Agreement or such later date
acceptable to the Company and the Majority Consenting Parties (the “Record Date”), and each other Consenting Party designated by the Majority Consenting Parties in their sole discretion (together, the “Other Eligible
Consenting Parties”) and (ii) each Initial Eligible Consenting Party that purchased Specified Debt after the public announcement of this Agreement but before the Record Date (including any purchase that remains an Open Trade as of the
Record Date) shall have the right to elect, on the Record Date, by way of written notice (email being sufficient) to Houlihan Lokey Capital, Inc., PJT Partners Inc. and Evercore Group LLC, to (or cause to) provide (or for any of its Affiliates to
(or cause to) provide) a percentage (or, in the case of an Initial Eligible Consenting Party described in clause (ii) of this paragraph, an additional percentage) of the aggregate principal amount of the Superpriority Loans on the Closing Date;
provided that such 

  
 -16- 

 
percentage shall not exceed (x) in the case of an Other Eligible Consenting Party, such Other Eligible Consenting Party’s pro rata share of the Specified Debt of all outstanding
Specified Debt (reflecting any Open Trade as of the Record Date) calculated based on the Specified Debt held by such Other Eligible Consenting Party as set forth on its executed Joinder and (y) in the case of an Initial Eligible Consenting
Party described in clause (ii) of this paragraph, the pro rata share of the Specified Debt based on the amount of Specified Debt purchased as described in clause (ii) of this paragraph that was not held by a Person (or affiliate or
associate thereof) that was party to a confidentiality agreement with the Company prior to the public announcement of this Agreement; provided, further, that with respect to an Initial Eligible Consenting Party described in clause
(ii) of this paragraph making an election pursuant to this paragraph, such Initial Eligible Consenting Party shall provide supporting documentation reasonably acceptable to the Advisors evidencing that the Specified Debt purchased as described
in clause (ii) of this paragraph was not held by a Person (or affiliate or associate thereof) that was party to a confidentiality agreement with the Company prior to the public announcement of this Agreement. In order to reflect the additional
Superpriority Commitments of Other Eligible Consenting Parties or Initial Eligible Consenting Parties who have elected to fund or cause to be funded the Superpriority Facility and the Superpriority Loans in accordance with this paragraph, the
Superpriority Commitments representing oversubscribed amounts of the Initial Eligible Consenting Parties as determined under Section 6(a) shall be reduced such that such oversubscriptions by Initial Eligible Consenting Parties are provided on a
pro rata basis, in accordance with their portion of the oversubscribed amounts allocated to them as determined under Section 6(a). 

(c) One (1) Business Day following the Record Date, the Company shall deliver to each of the Initial Eligible Consenting
Parties and Other Eligible Consenting Parties that have elected to fund or cause to be funded the Superpriority Facility in accordance with this Section 6 and the Advisors a notice (the “Commitment Notice”) including a schedule
in the form of Exhibit B hereto setting forth the amount of the Superpriority Loans that the applicable Initial Eligible Consenting Parties and Other Eligible Consenting Parties have elected to commit to fund or cause to be funded;
provided that the Commitment Notice shall be (x) in form and substance reasonably acceptable to the Advisors, (y) redacted such that it shall not disclose to a Consenting Party the holdings of Existing Debt or the commitments of any
other Consenting Party, and (z) deemed to update and replace Exhibit B hereto. 
 (d) On the terms, subject to the
conditions and limitations, and in reliance on the representations and warranties set forth in this Agreement, each of the Initial Eligible Consenting Parties hereby (and each of the Other Eligible Consenting Parties by electing to (or cause to)
provide a portion of the aggregate principal amount of the Superpriority Loans on the Closing Date pursuant to Section 6(b)), severally and not jointly, grants the Company the right to require such Initial Eligible Consenting Party or Other
Eligible Consenting Party, as applicable, and, upon exercise of such right by the Company, each such Initial Eligible Consenting Party or Other Eligible Consenting Party, as applicable, has agreed, to fund or cause to be funded in cash an amount
equal to its Superpriority Commitment in accordance with Sections 6(a) and 6(b) on the Closing Date as set out in the Commitment Notice. The commitments of the Commitment Parties hereunder are several, not joint, obligations of such Commitment
Parties, such that no 

  
 -17- 

 
Commitment Party shall be liable or otherwise responsible for the commitments of any other Commitment Party. 

(e) On the Closing Date, provided that the Company has timely delivered the Commitment Notice to such Commitment Party, each
Commitment Party (or any of its Affiliates) shall, severally and not jointly, fund or cause to be funded the Superpriority Loans in an amount equal to the total amount of such Commitment Party’s Superpriority Commitment. 

(f) The Consenting Parties reserve the right to employ the services of their Affiliates (including, without limitation, funds,
vehicles, entities, accounts and clients managed or advised by or under common management with such Consenting Party, or whose investment manager shares a common investment team with the investment manager or investment advisor through secondment,
outsourcing or other similar contractual arrangements with such Consenting Party) in providing or causing to be provided all or a portion of their Superpriority Commitment, including by way of transfer, assignment or reallocation of such
Superpriority Commitment. 
 (g) Subject to the terms and conditions of this Agreement, as consideration for the agreements
of the Structuring Parties to structure the Superpriority Facility and the Transactions, the Company shall pay a structuring premium (the “Structuring Premium”) to the Structuring Parties. The Structuring Premium shall be
(i) payable in cash (or, if applicable, as provided in Section 7(g)(ii)) in an aggregate amount equal to $8,981,261.10 (the “Structuring Premium Amount”), (ii) fully earned on the Agreement Effective Date and due and
payable by the Company to the Structuring Parties on the Closing Date (or, if applicable, as provided in Section 7(g)(ii)), and (iii) allocated to the Structuring Parties pro rata in accordance with their holdings of Specified Debt held by
all Structuring Parties on the Agreement Effective Date (reflecting any Open Trade as of such time, but excluding any Exempt Notes), as set forth opposite such Structuring Party’s name on Exhibit C, as applicable hereto. The Structuring
Parties shall use the proceeds from the Structuring Premium in full (except as otherwise and to the extent permitted under subclause (x) of the proviso to this Section 6(g) and provided that the Structuring Parties shall not be required to
use any amounts in excess of the proceeds from the Structuring Premium, after accounting for the top-up amount described under subclause (y) of the proviso to this Section 6(g)) to purchase from the
Company, and the Company shall use commercially reasonable efforts to issue, up to 4.00% in the aggregate of the shares of common stock of the Company pursuant to an equity purchase agreement entered into by such Structuring Parties and the Company
on the Closing Date, which purchase of shares of common stock shall close no later than three (3) Business Days thereafter; provided that (x) if the Structuring Premium Amount exceeds 4.00% of the Company’s Market
Capitalization, then the Structuring Parties shall not be required to purchase any shares of common stock of the Company in excess of 4.00% and shall be permitted to retain any excess Structuring Premium Amount, (y) if the Structuring Premium
Amount is less than 4.00% of the Company’s Market Capitalization, then the Company shall pay to the Structuring Parties in cash an aggregate top-up amount that is the lesser of (1) the amount equal
to 4.00% of the Company’s Market Capitalization minus the Structuring Premium Amount and (2) $3,018,738.90, and (z) to the extent that the Company is not able to issue shares of common stock up to 4.00% in the aggregate of the
shares of common stock of the Company after the use of commercially reasonably efforts to do so, the Structuring Parties shall be permitted to retain any excess Structuring Premium Amount and 

  
 -18- 

 
any excess top-up amount described under subclause (y). The Structuring Parties shall be permitted to allocate all or a portion of the Structuring Premium
Amount or the Structuring Premium to their Affiliates and to employ the services of their Affiliates in fulfilling their obligations under this paragraph to purchase shares of common stock from the Company. Notwithstanding anything herein to the
contrary, solely to the extent that and so long as applicable fund policies of a Consenting Party prohibit such Consenting Party from accepting the Structuring Premium through the receipt or purchase of stock or equity interests, and such Consenting
Parties provide notice of such prohibition within two (2) Business Days of the Agreement Effective Date, such Consenting Party shall receive payment of its pro rata share of the Structuring Premium in cash. 

7. Termination. 

(a) Termination by the Ad Hoc Group. This Agreement may be terminated by the Majority Ad Hoc Parties as to the Ad Hoc
Group, in their sole and absolute discretion, upon three (3) days’ prior written notice thereof to all of the Parties, upon the occurrence of any of the following events (each, an “Ad Hoc Group Termination Event”):

 (i) a breach, in any material respect, by any Company Party of any of its material representations, warranties, covenants,
or obligations set forth in this Agreement or any other agreement to be entered into in connection with the Transactions that (if susceptible to cure) remains uncured for a period of five (5) Business Days after the receipt by the Company of
written notice of such breach; provided that nothing in this Section 7(a)(i) shall impair the Consenting Parties’ ability to terminate this Agreement pursuant to the remaining provisions in this Section 7(a); provided,
further, that the notice and cure period contained in this Section 7(a)(i) shall run concurrently with the notice period contained in Section 7(a) hereof; 

(ii) any Definitive Document does not comply with Section 2 of this Agreement; 

(iii) any Company Party (x) (1) publicly announces its intention to pursue, (2) delivers a term sheet or proposal in
respect of, or (3) consummates, or enters into a binding agreement to consummate, in each case, an Alternative Transaction (other than a Strategic Transaction) or (y) publicly announces its intention to not pursue the Transactions; 

  
 -19- 

 (iv) any Company Party has breached, in any material respect, any of its
obligations under the Existing Documents or any related guarantees, security documents, agreements, amendments, instruments or other relevant documents; provided that such breach has not been waived or cured pursuant to the relevant
documents; 
 (v) the occurrence of an event of default set forth in any of the Existing Documents; provided that
such event of default has not been waived or cured pursuant to the relevant documents; 
 (vi) the failure of the Company
Parties to pay the documented and invoiced fees, costs, and out-of-pocket expenses of the Ad Hoc Group Advisors in accordance with Section 4(j) of this Agreement;
provided that there shall be no notice requirement or cure right to terminate this Agreement in the event of a failure to timely satisfy Section 4(j)(i); 

(vii) there shall have occurred any event or condition that has had or would be reasonably expected to have, either
individually or in the aggregate, a Material Adverse Effect as compared to the date hereof; 
 (viii) the issuance by any
governmental authority, including any regulatory authority or court of competent jurisdiction of, or the initiation or threatened initiation of any legal action by any governmental authority seeking, any ruling or order making illegal or otherwise
enjoining, preventing, or prohibiting the consummation of a material portion of the Transactions, which legal action, threatened initiation of a legal action, ruling or order has not been withdrawn or discharged after thirty (30) days; or 

(ix) the termination of this Agreement in accordance with its terms by either the Term Loan Group or the Company. 

(b) Termination by the Term Loan Group. This Agreement may be terminated by the Majority Term Loan Parties as to the
Term Loan Group, in their sole and absolute discretion, upon three (3) days’ prior written notice thereof to all of the Parties, upon the occurrence of any of the following events (each, a “Term Loan Group Termination
Event”): 
 (i) a breach, in any material respect, by any Company Party of any of its material representations,
warranties, covenants, or obligations set forth in this Agreement or any other agreement to be entered into in connection with the Transactions that (if susceptible to cure) remains uncured for a period of five (5) Business Days after the
receipt by the Company of written notice of such breach; provided that nothing in this Section 7(b)(i) shall impair the Consenting Parties’ ability to terminate this Agreement pursuant to the remaining provisions in this
Section 7(b); provided, further, that the notice and cure period contained in this Section 7(b)(i) shall run concurrently with the notice period contained in Section 7(b) hereof;

  
 -20- 

 (ii) any Definitive Document does not comply with Section 2 of this
Agreement; 
 (iii) any Company Party (x) (1) publicly announces its intention to pursue, (2) delivers a term sheet
or proposal in respect of, or (3) consummates, or enters into a binding agreement to consummate, in each case, an Alternative Transaction (other than a Strategic Transaction) or (y) publicly announces its intention to not pursue the
Transactions; 
 (iv) any Company Party has breached, in any material respect, any of its obligations under the Existing
Documents or any related guarantees, security documents, agreements, amendments, instruments or other relevant documents; provided that such breach has not been waived or cured pursuant to the relevant documents; 

(v) the occurrence of an event of default set forth in any of the Existing Documents; provided that such event of
default has not been waived or cured pursuant to the relevant documents; 
 (vi) the failure of the Company Parties to pay
the documented and invoiced fees, costs, and out-of-pocket expenses of the Term Loan Advisors in accordance with Section 4(j) of this Agreement; provided
that there shall be no notice requirement or cure right to terminate this Agreement in the event of a failure to timely satisfy Section 4(j)(i); 

(vii) there shall have occurred any event or condition that has had or would be reasonably expected to have, either
individually or in the aggregate, a Material Adverse Effect as compared to the date hereof; 
 (viii) the issuance by any
governmental authority, including any regulatory authority or court of competent jurisdiction of, or the initiation or threatened initiation of any legal action by any governmental authority seeking, any ruling or order making illegal or otherwise
enjoining, preventing, or prohibiting the consummation of a material portion of the Transactions, which legal action, threatened initiation of a legal action, ruling or order has not been withdrawn or discharged after thirty (30) days; or 

(ix) the termination of this Agreement in accordance with its terms by either the Ad Hoc Group or the Company. 

  
 -21- 

 (c) Termination by the Company. The Company may terminate this
Agreement, on behalf of itself and the Company Parties, as to all Parties upon three (3) days’ prior written notice thereof to all of the Parties, upon the occurrence of any of the following events (each, a “Company Termination
Event”): 
 (i) the issuance by any governmental authority, including any regulatory authority or court of competent
jurisdiction of, or the initiation or threatened initiation of any legal action by any governmental authority seeking, any ruling or order making illegal or otherwise enjoining, preventing, or prohibiting the consummation of a material portion of
the Transactions, which legal action, threatened initiation of a legal action, ruling or order has not been withdrawn or discharged after thirty (30) days; 

(ii) with respect to any particular Consenting Party (but not as to all of the other Parties) upon three (3) days’
prior written notice thereof upon the occurrence of a breach, in any material respect, by such Consenting Party of any of the representations, warranties, covenants or obligations with respect to such Consenting Party set forth in this Agreement
that (if susceptible to cure) remains uncured for a period of five (5) Business Days after the receipt by all of the Consenting Parties of written notice of such breach (which notice periods shall run concurrently); provided that nothing
in this Section 7(c)(ii) shall impair the Company’s ability to terminate this Agreement pursuant to the remaining provisions of this Section 7(c); provided, further, that the notice and cure period contained in this
Section 7(c)(ii) shall run concurrently with the notice period contacted in Section 7(c) hereof; or 
 (iii) the
termination of this Agreement in accordance with its terms by either the Ad Hoc Group or the Term Loan Group. 
 (d)
Mutual Termination. This Agreement may be terminated as to all Parties at any time by mutual written consent of the Company Parties, the Majority Term Loan Parties, and the Majority Ad Hoc Parties (a “Mutual Termination
Event”). 
 (e) Automatic Termination. This Agreement will automatically terminate as to all Parties upon
(the occurrence of any such event, an “Automatic Termination Event”): 
 (i) 5:00 p.m., New York City time,
on December 31, 2022 if the Closing Date has not occurred before such date, as such date may be extended by mutual written consent of the Company and the Majority Consenting Parties; provided that in the event of an extension beyond
January 31, 2023, any Consenting Party that does not consent to such extension may terminate this Agreement solely with respect to itself upon notice to the Company and the other Consenting Parties; 

(ii) any Company Party or any of its respective material subsidiaries commencing insolvency proceedings, including
(A) voluntarily commencing any case or filing any petition seeking bankruptcy, winding up, dissolution, liquidation, administration, moratorium, reorganization or other relief under any federal, state or foreign bankruptcy, insolvency,
administrative receivership or similar law now or hereafter in effect, (B) consenting to the institution of, or failing to contest in a timely and appropriate manner, any involuntary proceeding or petition described above, (C) filing an
answer admitting the material allegations of a petition filed against it in any such proceeding, (D) applying for or consenting to the appointment of a receiver, administrator, administrative receiver, trustee, custodian, sequestrator,
conservator or 

  
 -22- 

 
similar official for a Company Party for a substantial part of its assets or (E) making a general assignment or arrangement for the benefit of creditors; provided in each case that
such insolvency proceeding is not dismissed, vacated or otherwise closed within five (5) Business Days following notice thereof to the Company Parties by an Advisor; 

(iii) the entry of an order, judgment or decree adjudicating the Company Parties or any of their respective material
subsidiaries bankrupt or insolvent, including the entry of any order for relief with respect to any of the Company Parties or any of their respective subsidiaries under the Bankruptcy Code; provided that such order, judgment or decree is not
overturned or vacated within five (5) Business Days following notice thereof to the Company Parties by an Advisor; 

(iv) the taking of any binding corporate action by any of the Company Parties or any of their respective material subsidiaries
in furtherance of any action described in the foregoing clauses (ii)—(iii); 
 (v) the funding of the Superpriority
Facility and Superpriority Loans in full and the consummation of the other Transactions on the Closing Date; or 
 (vi) the
board of directors of the Company, after consultation with outside legal counsel and in the good faith exercise of its fiduciary duties, (A) determines that continued performance under this Agreement (including taking any action or refraining
from taking any action) would be inconsistent with the exercise of its fiduciary duties or applicable law, or (B) enters into an Alternative Transaction (including for the avoidance of doubt any Strategic Transaction). 

(f) Termination Date and Survival. The date on which this Agreement is terminated in accordance with this
Section 7 with respect to a Party shall be referred to as the “Termination Date” with respect to such Party and the provisions of this Agreement shall terminate on the Termination Date; provided that Sections 1,
6(g), 7(f), 7(g), 10, 11, 12, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24 and 25 hereof shall survive the Termination Date. 

(g) Effect of Termination. 

(i) Upon the Termination Date, this Agreement shall forthwith become null and void and have no further force or effect, each
Party hereto shall be released from its commitments, undertakings and agreements under or related to this Agreement and there shall be no liability or obligation hereunder on the part of any Party hereto; provided that in no event shall any
such termination relieve a Party hereto from (i) liability for its breach or non-performance of its obligations hereunder prior to such Termination Date, notwithstanding any termination of this Agreement
by any other Party, and (ii) obligations under this Agreement which expressly survive any such termination pursuant to Section 7(f). For the avoidance of doubt, (a) if the Term Loan Group terminates this Agreement in accordance with
Section 7(b) hereto, the Ad Hoc Group does not terminate this Agreement in accordance with Section 7(a) hereto and the Company Parties do not terminate this Agreement in accordance with Section 7(c) hereto, then (x) the Term Loan
Group shall be released from its commitments, undertakings and agreements under or related to 

  
 -23- 

 
this Agreement and there shall be no liability or obligation hereunder on the part of the Term Loan Group and any Party hereto with respect to the Term Loan Group and (y) the Ad Hoc Group
shall not be released from its commitments, undertakings and agreements under or related to this Agreement; and (b) if the Ad Hoc Group terminates this Agreement in accordance with Section 7(a) hereto, the Term Loan Group does not
terminate this Agreement in accordance with Section 7(b) hereto and the Company Parties do not terminate this Agreement in accordance with Section 7(c) hereto, then (x) the Ad Hoc Group shall be released from its commitments,
undertakings and agreements under or related to this Agreement and there shall be no liability or obligation hereunder on the part of the Ad Hoc Group and any Party hereto with respect to the Ad Hoc Group and (y) the Term Loan Group shall not
be released from its commitments, undertakings and agreements under or related to this Agreement. Upon any Termination Event, unless the Closing Date has occurred, any and all consents, tenders, waivers, forbearances and votes delivered by a
Consenting Party in connection with the Transactions automatically shall be deemed, for all purposes, to be null and void ab initio. Notwithstanding the foregoing or anything herein to the contrary, no Party may exercise
any of its respective termination rights as set forth in clauses (a), (b) or (c) of this this Section 7 if such Party has failed to perform or comply in all material respects with the terms and conditions of this Agreement unless such
failure to perform or comply arises as a result of another Party’s actions or inactions or would not otherwise give rise to a Termination Event in favor of the other Party. 

(ii) Notwithstanding anything in this Agreement to the contrary: (a) in the event of a termination of this Agreement under
Section 7(e)(vi), 7(a)(iii) or 7(b)(iii), the applicable portion of the Structuring Premium shall become due and payable and be paid in full by the Company Parties to the applicable Structuring Parties within one (1) Business Day of the
occurrence of such termination, provided that in such case the applicable portion of the Structuring Premium shall be paid as 4.00% in the aggregate of the shares of common stock of the Company, rather than in cash, and (b) in the event
of a termination of this Agreement under Section 7(a)(i) or Section 7(b)(i), each of the applicable portion of (u) the Structuring Premium, (v) the Participation Premium (as defined in the Term Sheet), (w) the Term Loan
Transaction Premium (as defined in the Term Sheet), (x) the 2025 Transaction Premium (as defined in the Term Sheet), (y) the 2024 Transaction Premium (as defined in the Term Sheet) and (z) the Ticking Fee (as defined in the Term Sheet) shall
become due and payable and be paid in full by the Company Parties to the applicable Consenting Parties within one (1) Business Day of the expiration of the cure period set forth in Section 7(a)(i) or Section 7(b)(i), as applicable;
provided that in the case of the Structuring Premium, such amount shall be paid as 4.00% in the aggregate of the shares of common stock of the Company, rather than in cash and in the case of the Term Loan Transaction Premium, the 2025
Transaction Premium and the 2024 Transaction Premium, such amounts shall be paid in cash, and not in the form of New Term Loans, 2025 Notes or New 2L Notes. The payment by the Company Parties of the premiums set out in this Section 7(g)(ii)
shall be the sole and exclusive remedy of the Consenting Parties for any loss suffered by any Consenting Party as a result of the failure of the Transactions to be consummated, and upon such payment thereof in accordance with this
Section 7(g)(ii), the Company Parties shall not have any further liability or obligation relating to or arising out of this Agreement. The Parties acknowledge that the agreements contained in this Section 7(g)(ii) are an integral part of
the Transactions, and that 

  
 -24- 

 
without these agreements, the Parties would not enter into this Agreement, and that any amounts payable pursuant to this Section 7(g)(ii) do not constitute a penalty. 

8. Transfer of Claims and Interests. 

(a) Subject to the terms and conditions of this Agreement, each Consenting Party agrees, solely with respect to itself, as
expressly identified and limited on its signature page, and not in any other manner with respect to any Affiliates, not to (i) sell, transfer, assign, hypothecate, pledge, grant a participation interest in, or otherwise dispose of, directly or
indirectly, its right, title, or interest with respect to any of such Consenting Party’s Existing Debt, in whole or in part, or (ii) deposit any of such Consenting Party’s Existing Debt into a voting trust, or grant any proxies, or
enter into a voting agreement with respect to any such Existing Debt (any of the actions described in clauses (i) and (ii) of this Section 8(a) is referred to herein as a “Transfer”; “Transferred” shall
have a meaning correlative thereto; and the Consenting Party making such Transfer is referred to herein as the “Transferor”), unless the Transfer is to another Consenting Party, an Affiliate of the Transferor, an Affiliate of
another Consenting Party or any other entity; provided that, such entity, unless it is already a Consenting Party, shall first agree in writing to be bound by the terms of this Agreement by executing and delivering to Sullivan &
Cromwell, Davis Polk and Gibson Dunn a joinder agreement in the form attached hereto as Exhibit E; provided, further, the Transferor shall provide prompt notice of any such Transfer to the Company, Sullivan & Cromwell,
Davis Polk and Gibson Dunn, which such notice shall be no later than the date of such Transfer (any such transferee, a “Permitted Transferee”). Any Transfer in violation of this Section 8 shall be void ab initio.
Notwithstanding anything to the contrary in this Section 8(a), the restrictions set forth on Transfers set forth in this Section 8(a) shall not apply to the grant of any liens or encumbrances on Existing Debt in favor of a bank or
broker-dealer holding custody of such Existing Debt in the ordinary course of business and which lien or encumbrance is released upon the Transfer of such Existing Debt. 

(b) Upon the consummation of a Transfer in accordance herewith, such Permitted Transferee shall be deemed to make all of the
representations, warranties and covenants of a Consenting Party, as applicable, as set forth in this Agreement, and shall be deemed to be a Party and a Consenting Party for all purposes under this Agreement. 

(c) A Consenting Party that Transfers Existing Debt to a Permitted Transferee in accordance with the terms of this
Section 8 shall (i) be deemed to relinquish its rights and be released from its obligations under this Agreement solely to the extent of such Transferred Existing Debt, (ii) not be liable to any Party to this Agreement for the failure
of the Permitted Transferee to comply with the terms and conditions of this Agreement, provided that in no event shall any such Transfer relieve (x) a Consenting Party hereto from liability for its breach or non-performance of its obligations hereunder prior to the date of such Transfer or (y) an Initial Eligible Consenting Party or an Other Eligible Consenting Party from its obligations pursuant to Sections 6(d)
and 6(e), and (iii) within five (5) Business Days of the Transfer, deliver written notice of the Transfer to the Company, Sullivan & Cromwell, Davis Polk and Gibson Dunn, which notice may be provided through counsel and shall
include the amount and type of Existing Debt that was Transferred. 

  
 -25- 

 (d) This Agreement shall not limit, restrict, or otherwise affect in any way
any right, authority, or power of any Consenting Party to acquire additional Existing Debt after the Agreement Effective Date. Any such acquired Existing Debt (including pursuant to an Open Trade) shall automatically and immediately upon acquisition
by the Consenting Party be deemed to be subject to the terms of this Agreement. Within five (5) Business Days of any acquisition (calculated based on the settled trade debt) of Existing Debt by a Consenting Party from a person that, to the
acquiring party’s actual knowledge, is not a Consenting Party, such Consenting Party shall deliver written notice of the acquisition to the Company, Sullivan & Cromwell, Davis Polk and Gibson Dunn, which notice may be provided through
counsel and shall include the amount and type of Existing Debt that was acquired. 
 (e) Notwithstanding anything to the
contrary herein, Existing Debt that is Transferred to or by a Consenting Party pursuant to an Open Trade shall not be subject to, or bound by, the terms and conditions of this Agreement (it being understood that such Existing Debt so Transferred to
and held by a Consenting Party for its own account (i.e., not as part of a short transaction, or to be Transferred by the Consenting Party under an Open Trade or any other transaction entered into by such Consenting Party prior to, and
pending as of the date of, such Consenting Party’s entry into this Agreement) shall be subject to the terms of this Agreement, as provided in Section 8(d)). 

(f) The Parties understand that the Consenting Parties may be engaged in a wide range of financial services and businesses,
and, in furtherance of the foregoing, the Parties acknowledge and agree that, to the extent a Consenting Party expressly indicates on its respective signature page hereto that it is executing this Agreement solely on behalf of a specific trading
desk(s) and/or business group(s) of the Consenting Party, the obligations set forth in this Agreement shall apply only to such trading desk(s) and/or business group(s) and shall not apply to any other trading desk, business group or Affiliate of the
Consenting Party unless they separately become a party hereto. 
 (g) Notwithstanding anything to the contrary herein, a
(i) a Qualified Marketmaker4 that acquires any Existing Debt subject to this Agreement held by a Consenting Party with the purpose and intent of acting as a Qualified Marketmaker for such
Existing Debt, shall not be required to become a party to this Agreement as a Consenting Party, if such Qualified Marketmaker transfers such Existing Debt (by purchase, sale, assignment, or other similar means) to a Permitted Transferee within the
earlier of ten (10) Business Days after the Qualified Marketmaker acquires such Existing Debt and three (3) Business Days prior to the Closing Date; provided that a Qualified Marketmaker’s failure to comply with this
Section 8(g) shall result in the Transfer of such Existing Debt to such Qualified Marketmaker being deemed void ab initio, and (ii) to the extent any person is acting solely in its capacity as a Qualified Marketmaker, it may
transfer any ownership interests in the Existing Debt that it acquires from a holder of Existing Debt that is not a Consenting Party 

	

	 	 

 

	4 	 “Qualified Marketmaker” means an entity that (a) holds itself out to the
public, the syndicated loan market, or the applicable private markets as standing ready in the ordinary course of business to purchase from customers and sell to customers claims against the Company Parties (including Existing Debt), or enter with
customers into long and short positions in claims against the Company Parties, in its capacity as a dealer or market maker in such claims and (b) is, in fact, regularly in the business of making a market in claims against issuers or borrowers
(including term, loans, or debt or equity securities). 

  
 -26- 

 
to a transferee that is not a Consenting Party at the time of such transfer without the requirement that the transferee be a Permitted Transferee. 

9. Representations and Warranties. 

(a) Each Party (severally and not jointly), other than, with respect to Section 9(a)(i), Section 9(a)(ii),
Section 9(a)(iii) and Section 9(b)(iv), any Party that is a managed account (or portion thereof), represents and warrants to each other Party that: 

(i) such Party is duly organized, validly existing, and in good standing (where such concept is recognized) under the laws of
the jurisdiction of its organization, and has all requisite corporate, partnership, limited liability company or other organizational power and authority to enter into this Agreement and to carry out the Transactions contemplated herein, and to
perform its respective obligations under this Agreement and the Definitive Documents; 
 (ii) the execution, delivery, and
performance of this Agreement by such Party does not and shall not (A) violate any provision of law, rule, or regulation applicable to it or any of its subsidiaries or its organizational documents or those of any of its subsidiaries, or
(B) conflict with, result in a breach of, or constitute (with due notice or lapse of time or both) a default under its organizational documents or any material contractual obligations to which it or any of its subsidiaries is a party; 

(iii) as of the Agreement Effective Date (or such later date that it delivers its signature page hereto to the other Parties),
such Party has no actual knowledge of any event that, due to any fiduciary or similar duty to any other Person or entity, would prevent it from taking any action required of it under this Agreement; and 

(iv) this Agreement is a legally valid and binding obligation of such Party, enforceable against it in accordance with its
terms. 
 (b) Each Consenting Party (severally and not jointly) represents and warrants to the Company that, as of the
Agreement Effective Date: 
 (i) it is not a “Defaulting Lender” (under and as defined in the Existing Credit
Agreement); 
 (ii) it either (A) is the beneficial or record owner of the principal amount of the Existing Debt
indicated on its respective signature page hereto (other than with respect to Existing Debt that is subject to an Open Trade) or (B) has sole investment or voting discretion with respect to the principal amount of the Existing Debt indicated on
its respective signature page hereto and has the power and authority to bind the beneficial owner of such Existing Debt to the terms of this Agreement (other than with respect to Existing Debt that is subject to an Open Trade); 

(iii) other than pursuant to this Agreement, the Existing Debt held by it indicated on its respective signature page hereto is
free and clear of any equity, option, proxy, voting restriction, right of first refusal, or other limitation on disposition of any kind that could reasonably 

  
 -27- 

 
be expected to adversely affect in any way such Consenting Party’s performance of its obligations contained in this Agreement at the time such obligations are required to be performed; 

(iv) other than the Existing Debt indicated on its respective signature page hereto, such Consenting Party does not own any
other Existing Debt as of the Agreement Effective Date (other than with respect to Existing Debt that is subject to an Open Trade); and 

(c) Each Consenting Party represents to each other Party that it is (i) a “qualified institutional buyer”
within the meaning of Rule 144A of the Securities Act, (ii) an institutional “accredited investor” within the meaning of Rule 501(a)(1), (a)(2), (a)(3) or (a)(7) of Regulation D under the Securities Act, or (iii) not a “U.S.
person” as defined in Rule 902 under the Securities Act. 
 (d) Each Party that is a managed account (or portion
thereof) (severally and not jointly) represents and warrants that the manager or investment adviser executing this Agreement on behalf of such Party has the authority to execute, on behalf of such Party, this Agreement and any transactions that this
Agreement requires such Party to execute. 
 (e) The Company represents and warrants that, as of the Agreement Effective
Date, neither the Superpriority Borrower, nor any of the German Guarantors is over-indebted (“überschuldet”) within the meaning of section 19 of the German Insolvency Code (“Insolvenzordnung”) (as applicable
from time to time) or unable to pay its debts as they fall due (“zahlungsunfähig”) within the meaning of section 17 of the German Insolvency Code, or intend to suspend making payments on all or a material part of its debts or
to announce an intention to do so. 
 10. Releases. 

(a) Subject to the occurrence of, and effective from and after, the Closing Date, in exchange for the cooperation with,
participation in, and entering into the Transactions by the Consenting Parties and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Company Parties (on behalf of themselves and each of their
respective predecessors, successors, assigns, agents, subsidiaries, Affiliates, representatives and any other person or entity who has rights through them) hereby finally and forever release and discharge the Other Released Parties and their
respective property, to the fullest extent permitted under applicable law, from any and all causes of action and any other claims, debts, obligations, duties, rights, suits, damages, actions, derivative claims, remedies, and liabilities whatsoever,
whether known or unknown, foreseen or unforeseen, in law, at equity, or otherwise, sounding in tort, contract, or based on any other legal or equitable principle, including, without limitation, violation of any securities law (federal, state or
foreign), misrepresentation (whether intended or negligent), breach of duty (including any duty of candor), or any domestic or foreign law similar to the foregoing, based in whole or in part upon any act or omission, transaction, or other occurrence
or circumstance existing immediately prior to the occurrence of or before the Closing Date arising from, relating to, or in connection with the Existing Debt, the Existing Documents, the Transactions, the negotiation, formulation, or preparation of
this Agreement, the Definitive Documents or any related guarantees, security documents, agreements, amendments, instruments, 

  
 -28- 

 
or other documents, including those that the Company Parties and their respective subsidiaries or any holder of a claim against or interest in the Company Parties or any other entity could have
been legally entitled to assert derivatively or on behalf of any other entity (collectively, the “Company Released Claims”). Further, subject to the occurrence of, and effective from and after, the Closing Date, the Company Parties
(on behalf of themselves and each of their subsidiaries) hereby covenant and agree not to, directly or indirectly, bring, maintain, or encourage any cause of action or other claim or proceeding against an Other Released Party relating to or arising
out of any Company Released Claim. The Company Parties (on behalf of themselves and each of their subsidiaries) further stipulate and agree with respect to all Claims, that, subject to the occurrence of, and effective from and after, the Closing
Date, they hereby waive to the fullest extent permitted by applicable law, any and all provisions, rights, and benefits conferred by any applicable U.S. federal or state law, any foreign law, or any principle of common law, that would otherwise
limit a release or discharge of any unknown Claims pursuant to this Section 10(a). 
 (b) Subject to the occurrence of,
and effective from and after, the Closing Date, in exchange for the cooperation with, participation in, and entering into the Transactions by the Company Parties and other good and valuable consideration, the receipt and sufficiency of which are
hereby acknowledged, the Consenting Parties hereby finally and forever release and discharge the Company Released Parties and their respective property, to the fullest extent permitted under applicable law, from any and all causes of action and any
other claims, debts, obligations, duties, rights, suits, damages, actions, derivative claims, remedies, and liabilities whatsoever, whether known or unknown, foreseen or unforeseen, in law, at equity, or otherwise, sounding in tort, contract, or
based on any other legal or equitable principle, including, without limitation, violation of any securities law (federal, state or foreign), misrepresentation (whether intended or negligent), breach of duty (including any duty of candor), or any
domestic or foreign law similar to the foregoing, based in whole or in part upon any act or omission, transaction, or other occurrence or circumstance existing immediately prior to the occurrence of or before the Closing Date arising from, relating
to, or in connection with the Existing Debt, the Existing Documents, the Transactions, the negotiation, formulation, or preparation of this Agreement, the Definitive Documents or any related guarantees, security documents, agreements, amendments,
instruments, or other documents, including those that a Consenting Party or any holder of a claim against or interest in the Consenting Party or any other entity could have been legally entitled to assert derivatively or on behalf of any other
entity (collectively, the “Consenting Party Released Claims”). Further, subject to the occurrence of, and effective from and after, the Closing Date, each Consenting Party hereby covenants and agrees not to, directly or indirectly,
bring, maintain, or encourage any cause of action or other claim or proceeding against any Company Released Party relating to or arising out of any Consenting Party Released Claim. Each Consenting Party further stipulates and agrees with respect to
all Claims, that subject to the occurrence of, and effective from and after, the Closing Date, it hereby waives, to the fullest extent permitted by applicable law, any and all provisions, rights, and benefits conferred by any applicable U.S. federal
or state law, any foreign law, or any principle of common law, that would otherwise limit a release or discharge of any unknown Claims pursuant to this Section 10(b). 

(c) Each Consenting Party and each Company Party acknowledges that it is aware that it or its attorneys may hereafter discover
claims or facts in addition to or different from those which 

  
 -29- 

 
they now know or believe to exist with respect to either the subject matter of this Agreement or any party hereto, but hereto further acknowledges that it is the intention of the Company Parities
and each Consenting Party to hereby fully, finally, and forever settle and release all claims among them to the extent provided in this Agreement, whether known or unknown, suspected or unsuspected, which now exist, may exist, or heretofore have
existed. 
 (d) Notwithstanding the foregoing Sections 10(a), 10(b) and 10(c), nothing in this Agreement is intended to, and
shall not, (i) release any Party’s rights and obligations under this Agreement or any of the Definitive Documents (including, but not limited to, the indemnification contained in Section 11), (ii) bar any Party from seeking to enforce
or effectuate this Agreement or any of the Definitive Documents, (iii) release any obligation of any Company Party (or its subsidiaries) under the Existing Documents to the extent that any such obligation survives the closing of the
Transactions or (iv) release any causes of action and any other claims, debts, obligations, duties, rights, suits, damages, actions, derivative claims, remedies, or liabilities arising out of or resulting from any act or omission of a Party
that constitutes fraud, willful misconduct or gross negligence, each solely to the extent as determined by a final order of a court of competent jurisdiction. 

11. Indemnification. 

(a) Without limiting any Company Party’s obligations under the Existing Documents, the Definitive Documents or any
related guarantees, security documents, agreements, amendments, instruments or other relevant documents, each Company Party hereby agrees to indemnify, pay and hold harmless each Consenting Party and each of its Affiliates and all of their
respective officers, directors, members, managers, partners, employees, shareholders, advisors, agents, and other representatives of each of the foregoing and their respective successors and permitted assigns (each, an “Indemnified
Party”) from and against any and all losses, claims, damages, actions, obligations, penalties, judgments, suits, costs, expenses, disbursements and liabilities, joint or several, of any kind or nature whatsoever (including the reasonable
and documented out-of-pocket fees and disbursements of counsel for any Indemnified Party, and including any out-of-pocket costs associated with any discovery or other information requests), whether direct, indirect, special or consequential and whether based on any federal, state or foreign laws, statutes, rules or
regulations (including securities and commercial laws, statutes, rules or regulations) on common law or equitable cause or on contract or otherwise, that may be imposed on, incurred by, or asserted against any Indemnified Party, in any manner
relating to or arising out of, in connection with, or as a result of (i) this Agreement, the Transactions, the Definitive Documents or any related guarantees, security documents, agreements, instruments or other documents, (ii) the
negotiation, formulation, preparation, execution, delivery or performance of the foregoing, or (iii) any actual claim, litigation, investigation or proceeding relating to the foregoing, regardless of whether any Indemnified Party is a party
thereto and whether or not the transactions contemplated hereby are consummated (such foregoing amounts, “Losses” and such Company Party obligation, the “Indemnification Obligations”). The Company Parties shall
reimburse each Indemnified Party reasonably promptly upon written demand therefor (together with reasonable backup documentation supporting such reimbursement request). No Indemnified Party shall be entitled to indemnity hereunder in respect of any
Losses to the extent that it is found 

  
 -30- 

 
by a final, non-appealable judgment of a court of competent jurisdiction that such Losses arise from (i) the bad faith, gross negligence or willful
misconduct by such Indemnified Party, (ii) the willful and material breach of this Agreement by such Indemnified Party or (iii) any disputes solely among Indemnified Parties and not arising out of or related to any act or omission of any
of the Company Parties. 
 (b) Notwithstanding anything to the contrary contained in this Agreement, the Indemnification
Obligations set forth herein (i) shall survive the expiration or termination of this Agreement, (ii) shall remain operative and in full force and effect regardless of any investigation made by or on behalf of the Consenting Parties or any
other Indemnified Party and (iii) shall be binding on any successor or assign of the Company Parties and the successors or assigns to any substantial portion of its business and assets. 

12. Entire Agreement; Prior Negotiations. This Agreement, including all of the exhibits attached hereto, constitutes
the entire agreement of the Parties with respect to the subject matter of this Agreement, and supersedes all other prior negotiations, agreements and understandings, whether written, oral, or implied, among the Parties with respect to the subject
matter of this Agreement; provided, however, that any confidentiality agreement or non-disclosure agreement executed by any Party shall survive this Agreement and shall continue in full force and
effect, subject to the terms thereof, irrespective of the terms hereof. 
 13. Reservation of Rights. If the
Transactions contemplated herein are not consummated, or if this Agreement is terminated in accordance with its terms (except as a result of the occurrence of the Closing Date), nothing shall be construed herein as a waiver by any Party of any or
all of such Party’s rights, remedies or defenses and the Parties expressly reserve any and all of their respective rights, remedies or defenses. 

14. FRE 408. To the extent provided in Federal Rule of Evidence 408 and any other applicable rules of evidence in any
applicable jurisdiction, this Agreement and all negotiations relating hereto shall not be admissible into evidence in any proceeding other than a proceeding to enforce its terms. 

15. Counterparts; Execution. This Agreement may be executed in one or more counterparts, each of which, when so
executed, shall constitute one and the same instrument, and the counterparts may be delivered by facsimile transmission or by electronic mail in portable document format (PDF) or by DocuSign. This Agreement may be executed on behalf of one or more
Consenting Parties by such Consenting Party’s investment manager or advisor, which is a signatory hereto solely in its capacity as the investment manager or advisor of such Consenting Party. 

16. Amendments and Waivers. 

(a) Except as otherwise provided herein, this Agreement may not be modified, amended, or supplemented, and no provision of
this Agreement may be waived, without the prior written consent of the Company Parties and the Majority Consenting Parties; provided that any modification or amendment to the definition of “Majority Consenting Parties” shall require
the 

  
 -31- 

 
consent of the Company Parties and each Structuring Party; provided, further that any modification or amendment to the Structuring Premium, including Section 6(g) and related
definitions, and any modification or amendment to the definition of “Structuring Parties” or Exhibit C hereto shall require the consent of each Structuring Party; provided, further that any modification or amendment to
the definition of “Majority Ad Hoc Parties,” “Ad Hoc Steering Committee” or Exhibit D hereto shall require the consent of each member of the Ad Hoc Steering Committee; provided, further that any modification
or amendment to the definition of “Majority Term Loan Parties” shall require the consent of each member of the Term Loan Group; provided, further, that any modification or amendment to this Section 16(a) or
Section 7(e)(i) shall require the consent of the Company Parties and all Consenting Parties; provided, further, that (i) to the extent such modification, amendment or supplement has a material, disproportionate and adverse
effect, taken as a whole, on the Consenting Parties who hold a tranche of Existing Debt (i.e., the Existing Revolver Exposure, the Existing Term Loans, the 2025 Notes or the 2024 Notes), in their capacity as holders of such tranche of
Existing Debt, then the consent of Consenting Parties holding a majority of such tranche of Existing Debt held by all Consenting Parties shall also be required, (ii) to the extent such modification, amendment or supplement has a material,
disproportionate and adverse effect, taken as a whole, on the Consenting Parties that are not Structuring Parties, then the consent of Consenting Parties that are not Structuring Parties holding a majority of Existing Debt held by all Consenting
Parties that are not Structuring Parties shall also be required and (iii) to the extent such modification, amendment or supplement has a material, disproportionate and adverse effect, taken as a whole, on the Consenting Parties that were not
Consenting Parties as of the Execution Date, the consent of such Consenting Parties holding a majority of Existing Debt held by all such Consenting Parties shall also be required. For the avoidance of doubt, Exhibit B shall be updated,
replaced, amended and restated in accordance with Section 6(c) hereof. Prior to any funding of the Superpriority Loans, (a) except as otherwise set forth in Section 6(c) hereto, any change, modification, or amendment to Exhibit B hereto that
affects the Commitment Amount of any Commitment Party shall require the consent of such Commitment Party and (b) any change, modification, or amendment of the maturity, interest rate, call protection or fees set forth in the Term Sheet with respect
to the Superpriority Facility shall require the consent of each Commitment Party and, if such consent is withheld, the commitment of any Commitment Party to provide its portion of the Superpriority Loans may be terminated by such Commitment Party;
provided that to the extent such Commitment Party terminates its commitment to provide its portion of the Superpriority Loans, the Company shall be free to solicit commitments to provide such Superpriority Loans from any Person. 

(b) No waiver of any of the provisions of this Agreement shall be deemed to constitute a waiver of any other provision of this
Agreement, whether or not such provisions are similar, nor shall any waiver of a provision of this Agreement be deemed a continuing waiver of such provision. 

17. Headings. The headings of the sections, paragraphs, and subsections of this Agreement are included for convenience
only and shall not affect the interpretation of the provisions contained herein. 
 18. Acknowledgments; Obligations
Several. Notwithstanding that this Agreement is being executed by multiple Consenting Parties, the obligations of the Consenting Parties under this Agreement are several and neither joint nor joint and several. No Consenting Party shall be
responsible in any way for the performance of the obligations or any breach of any other Consenting Party under this Agreement, and nothing contained herein, and no action taken by any Consenting Party pursuant hereto shall be deemed to constitute
the Consenting Party as a partnership, an association or joint venture of any kind, or create a presumption that the Consenting Parties are in any way acting other than in their individual capacities. None of the Consenting Parties shall have any
fiduciary duty or other duties or responsibilities in any kind or form to each other, the Company Parties or any of the Company’s other lenders, noteholders or stakeholders as a result of this Agreement or the transactions contemplated hereby.
Each Consenting Party 

  
 -32- 

 
acknowledges that no other Consenting Party will be acting as agent of such Consenting Party in connection with monitoring such Consenting Party’s investment or enforcing its rights under
this Agreement, the Definitive Documents, or any other documents to be entered into in connection with the consummation of the Transactions. Each Consenting Party acknowledges, and acknowledges its Affiliates’ understanding, to each other
Consenting Party, that: (a) the Transactions described herein are arm’s-length commercial transactions between the Company and the Company’s Affiliates and each Consenting Party, (b) it has
consulted its own legal, accounting, regulatory and tax advisors to the extent it has deemed appropriate, (c) it is capable of evaluating, and understands and accepts, the terms, risks and conditions of the Transactions contemplated hereby, and
(d) the Consenting Parties and their respective Affiliates may be engaged in a broad range of transactions that involve interests that differ from the other Consenting Parties, the Company’s and those of the Company’s Affiliates or
the Affiliates of other Consenting Parties, and the Consenting Parties have no obligation to disclose any of such interests to any other Consenting Party, the Company, the Company’s Affiliates of the Affiliates of other Consenting Parties. Each
Consenting Party acknowledges that it has, independently and without reliance upon any other Consenting Party and based on such documents and information as it has deemed appropriate, made its own credit analysis and decision to enter into this
Agreement and that it has not relied on the credit analysis and decision or due diligence investigation of any other Consenting Party. No securities of the Company are being offered or sold hereby and this Agreement neither constitutes an offer to
sell nor a solicitation of an offer to buy any securities of the Company. The Consenting Parties are not intended to be, and shall not be deemed to be, a “Group” for purposes of Section 13(d) of the Exchange Act. 

19. Consenting Party Enforcement. A Consenting Party may only enforce this Agreement against the Company Parties and
not against another Consenting Party. 
 20. Specific Performance; Damages. It is understood and agreed by the
Parties that money damages may be an insufficient remedy for any breach of this Agreement by any Party and each non-breaching Party shall be entitled to seek specific performance and injunctive or other
equitable relief as a remedy for any such breach of this Agreement, including, without limitation, a court of competent jurisdiction requiring any Party to comply promptly with any of its obligations in this Agreement. Notwithstanding anything to
the contrary in this Agreement, in no event shall any Party or their representatives be liable to any other Party hereunder for any punitive, incidental, consequential, special or indirect damages, including the loss of future revenue or income or
opportunity, relating to the breach or alleged breach of this Agreement. 
 21. Governing Law. This Agreement shall
be governed by, and construed in accordance with, the laws of the State of New York without regard to any choice of law provision that would require the application of the laws of another jurisdiction. By the execution and delivery of this
Agreement, each of the Parties hereto hereby irrevocably and unconditionally agrees for itself that any action, suit, or proceeding against it with respect to any matter arising under or out of or in connection with this Agreement or for recognition
or enforcement of any judgment rendered in any such action, suit, or proceeding may be brought in either a state or federal court of competent jurisdiction in the State and County of New York, Borough of Manhattan. By the execution and delivery of
this Agreement, each of the Parties hereto hereby irrevocably accepts 

  
 -33- 

 
and submits itself to the exclusive jurisdiction of each such court, generally and unconditionally, with respect to any such action, suit, or proceeding. By executing and delivering this
Agreement, each of the Parties hereto irrevocably and unconditionally submits to the personal jurisdiction of each such court described in this Section 21, solely for purposes of any action, suit, or proceeding arising out of or relating to
this Agreement or for the recognition or enforcement of any judgment rendered or order entered in any such action, suit, or proceeding. EACH PARTY HERETO UNCONDITIONALLY WAIVES TRIAL BY JURY IN ANY ACTION, SUIT, OR PROCEEDING REFERRED TO ABOVE. Each
Party (a) certifies that no representative, agent, or attorney of any other Party has represented, expressly or otherwise, that such other Party would not, in the event of litigation, seek to enforce the foregoing waiver and
(b) acknowledges that it and the other Parties have been induced to enter into this Agreement by, among other things, the mutual waivers and certifications in this Section 21. 

22. Notices. All notices (including, without limitation, any notice of termination as provided for herein) and other
communications from any Party given or made pursuant to this Agreement shall be in writing and shall be deemed to have been duly given upon the earliest of the following: (a) upon personal delivery to the Party to be notified; (b) when
sent by confirmed electronic mail if sent during the normal business hours of the recipient, and if not so confirmed, on the next Business Day; (c) three (3) Business Days after having been sent by registered or certified mail, return receipt
requested, postage prepaid; and (d) one (1) Business Day after deposit with a nationally recognized overnight courier, specifying next-day delivery (with an email upon sending to the Party to be
notified), with written verification of receipt. All communications shall be sent: 
  

	 	(a)	 If to the Company: 

Diebold Nixdorf, Incorporated 

5995 Mayfair Road 

North Canton, Ohio 44720 

Attn: Jonathan Leiken 

Email: jonathan.leiken@dieboldnixdorf.com 

With copies to: 

Sullivan & Cromwell LLP 

125 Broad Street 

New York, New York 10006 

Attn: Ari Blaut 

Email: blauta@sullcrom.com 

and 

Evercore Group LLC 

55 East 52nd Street 

New York, NY 10055 

  
 -34- 

 Attn: Gregory Berube 

Email: gregory.berube@Evercore.com 
  

	 	(b)	 If to the Ad Hoc Group: 

Davis Polk & Wardwell LLP 

450 Lexington Avenue 

New York, New York 10017 

Attn:    Damian S. Schaible 

Adam L. Shpeen 

Dylan Consla 

Email:  damian.schaible@davispolk.com 

adam.shpeen@davispolk.com 

dylan.consla@davispolk.com 
  

	 	(c)	 If to the Term Loan Group: 

Gibson, Dunn & Crutcher LLP 

200 Park Avenue 

New York, New York 10166 

Attn:    Scott J. Greenberg 

Steven Domanowski 

Email: sgreenberg@gibsondunn.com 

sdomanowski@gibsondunn.com 

JPMorgan Chase Bank (N.A.), as administrative agent under the Existing Credit Agreement, shall receive copies of all notices given or made
pursuant to this Agreement. Such copies shall be sent to:  
 JPMorgan
Chase Bank (N.A.) 
 383 Madison Avenue 

New York, New York 10179 

Attn:    Spencer Liu 

Charles Dieckhaus 

Email: spencer.liu@jpmorgan.com 

charles.p.dieckhaus@jpmorgan.com 

With copies to: 

Simpson Thacher & Bartlett LLP 

425 Lexington Avenue 

New York, New York 10017 

Attn:    Patrick Ryan 

Art Robinson 

Daniel Kay 

  
 -35- 

 David Azarkh 

Stephanie Rotter 

Patrick Baron 

Email:  pryan@stblaw.com 

arobinson@stblaw.com 

dkay@stblaw.com 

dazarkh@stblaw.com 

srotter@stblaw.com 

pbaron@stblaw.com 

23. No Third-Party Beneficiaries. Unless expressly stated herein, this Agreement shall be solely for the benefit of the
Parties, and no other Person shall be a third-party beneficiary hereof; provided that it is acknowledged and agreed that (a) each Other Released Party is a third party beneficiary with respect to Section 10(a) hereof and shall be
permitted to enforce such provision in accordance with its terms and (b) each Company Released Party is a third-party beneficiary with respect to Section 10(b) hereof and shall be permitted to enforce such provision in accordance with its
terms. 
 24. Publicity; Non-Disclosure. 

(a) The Company will disclose this Agreement on the Agreement Effective Date at 5:00 p.m. (EST) or promptly thereafter (but,
in any event, no later than 11:59 p.m. (EST) on the Agreement Effective Date) by publicly filing a Form 8-K or any periodic report required or permitted to be filed by the Company under the Exchange Act with
the SEC or, if the SEC’s EDGAR filing system is not available, on a press release that results in prompt public dissemination of such information (the “Public Disclosure”). The Company will deliver drafts to the Advisors of
such Public Disclosure at least one (1) Business Day before making any such disclosure. Any Public Disclosure shall be reasonably acceptable to the Company Parties and reasonably acceptable to the Majority Consenting Parties. For the avoidance
of doubt, the Company Parties shall be permitted to make any Public Disclosure upon the failure of the Majority Consenting Parties (including by or through the Advisors) to respond within one (1) Business Day of receipt of such consent request.
Under no circumstances may any Party make any Public Disclosure of any kind that would disclose either: (a) the holdings of any Consenting Party (including on the signature pages of the Consenting Parties, which shall not be publicly disclosed
or filed) of any Existing Debt, or of any other debt obligations of the Company, whether prior to or after the consummation of the Transactions or (b) the identity of any Consenting Party, in each case without the prior written consent of such
Consenting Party or an order of a court with competent jurisdiction; provided, however, that, notwithstanding the foregoing, the Company Parties shall not be required to keep confidential the aggregate holdings of all Consenting
Parties, and each Consenting Party hereby consents to the disclosure of the execution of this Agreement by the Company Parties, and the terms and contents hereof, to the administrative agents, collateral agents, or trustees under the Existing
Documents, and in any filings required by applicable law or regulation or the rules of any applicable stock exchange or regulatory body. 

  
 -36- 

 (b) Other than as may be required by applicable law and regulation or by any
governmental or regulatory authority as determined by a Party based on reasonable advice of counsel, no Party shall issue any press release, make any filing with the SEC or make any other public announcement with respect to this Agreement or the
Transactions without the consent of the Company Parties and the Majority Consenting Parties, which consent shall not be unreasonably delayed, conditioned, or withheld. The Company Parties shall be permitted to make any filing or publish, issue or
file any public announcement or communication upon the failure of the Majority Consenting Parties (including by or through the Advisors) to respond within one (1) Business Day of receipt of such consent request. Each Supporting Party shall be
permitted to make any filing or publish, issue or file any public announcement or communication upon the failure of the Company Parties to respond within one (1) Business Day of receipt of such consent request by the Company Parties. For the
avoidance of doubt, each Party shall have the right, without any obligation to any other Party, to decline to comment to the press with respect to this Agreement. 

25. Successors and Assigns; Severability. This Agreement is intended to bind and inure to the benefit of the Parties
and their respective permitted successors, assigns, heirs, executors, estates, administrators, and representatives, provided that this Section 25 shall not be deemed to permit Transfers other than in accordance with the express terms of
this Agreement. The invalidity or unenforceability at any time of any provision hereof in any jurisdiction shall not affect or diminish in any way the continuing validity and enforceability of the remaining provisions hereof or the continuing
validity and enforceability of such provision in any other jurisdiction; provided that, after excluding the provision that is declared to be invalid or unenforceable, the remaining terms provide for the consummation of the Transactions
contemplated hereby in substantially the same manner as originally set forth at the later of the date hereof and the date this Agreement was last amended. 

26. Error; Ambiguity. Notwithstanding anything to the contrary herein, to the extent counsel to the Company Parties or
the Advisors identify, within four (4) Business Days following the Agreement Effective Date, any clear errors, material ambiguities or internally inconsistent provisions within or among this Agreement, each Party hereto covenants and agrees
that it will endeavor in good faith to enter into reasonable and mutually satisfactory modifications to this Agreement to remedy such errors, ambiguities, or inconsistent provisions. 

27. Joinder. Additional holders of Existing Debt and/or investment advisors,
sub-advisors, or managers of discretionary accounts (together with their respective successors and permitted assigns) that hold Existing Debt and that have authority to bind the beneficial owners of such
Existing Debt to the terms of this Agreement, as applicable, may become party to this Agreement from time to time (i) in accordance with Section 8 or (ii) on or before the Record Date (or thereafter solely with the consent of the
Majority Consenting Parties) by agreeing in writing to be bound by the terms of this Agreement (any such person, an “Additional Consenting Party”) by executing and delivering to the Company, Sullivan & Cromwell, Davis
Polk and Gibson Dunn a joinder agreement in the form attached hereto as Exhibit F. Upon the execution and delivery of such joinder agreement, such Additional Consenting Party shall be deemed to make all of the representations, warranties, and
covenants of a Consenting Party, as applicable, as set forth in this 

  
 -37- 

 
Agreement, and shall be deemed to be a Party and a Consenting Party for all purposes under this Agreement as if they were originally party hereto. 

[Signature Pages Follow] 

  
 -38- 

 IN WITNESS WHEREOF, the Parties hereto have caused this Agreement to be
executed and delivered by their duly authorized officers, all as of the day and year first written above. 
  

			
	DIEBOLD NIXDORF, INCORPORATED
		
	By	 	/s/ Jonathan Leiken
	 	 	Name: Jonathan Leiken
	 	 	Title: EVP, Chief Legal Officer and Secretary

  

			
	DIEBOLD GLOBAL FINANCE CORPORATION
		
	By	 	/s/ Jonathan Leiken
	 	 	Name: Jonathan Leiken
	 	 	Title: EVP, Chief Legal Officer and Secretary

  

			
	DIEBOLD HOLDING COMPANY, LLC
		
	By	 	/s/ Jonathan Leiken
	 	 	Name: Jonathan Leiken
	 	 	Title: EVP, Chief Legal Officer and Secretary

  

			
	DIEBOLD SST HOLDING COMPANY, LLC
		
	By	 	/s/ Jonathan Leiken
	 	 	Name: Jonathan Leiken
	 	 	Title: EVP, Chief Legal Officer and Secretary

  

			
	GRIFFIN TECHNOLOGY INCORPORATED
		
	By	 	/s/ Jonathan Leiken
	 	 	Name: Jonathan Leiken
	 	 	Title: EVP, Chief Legal Officer and Secretary

  

			
	DIEBOLD SELF-SERVICE SYSTEMS
		
	By	 	/s/ Jonathan Leiken
	 	 	Name: Jonathan Leiken
	 	 	Title: EVP, Chief Legal Officer and Secretary

  
 [Signature Page to
Transaction Support Agreement] 

 
			
	DIEBOLD NIXDORF DUTCH HOLDING B.V.
		
	By	 	/s/ Elizabeth Christine Radigan
	 	 	Name: Elizabeth Christine Radigan
	 	 	Title: Director A
		
	By	 	/s/ Hendrik Roelof Schouten
	 	 	Name: Hendrik Roelef Schouten
	 	 	Title: Director B

  
 [Signature Page to
Transaction Support Agreement] 

 [Consenting Parties’ signature pages on file with the Company.]

  
 [Signature Page to
Transaction Support Agreement] 

 Exhibit A 

Term Sheet 

 Diebold Nixdorf, Incorporated 

Summary of Terms and Conditions for 

Potential Financing Transaction 

Terms used but not defined herein shall have the meanings ascribed to them in the Transaction Support Agreement to which this term sheet is
attached. 
 Reference is made to (i) that certain Credit Agreement, dated as of November 23, 2015 (as amended, restated, amended
and restated, supplemented or otherwise modified prior to the Closing Date, the “Existing Credit Agreement,” and the revolving loans and revolving commitments issued thereunder the “Existing Revolver Exposure” and
the term loans issued thereunder the “Existing Term Loans”), by and among Diebold Nixdorf, Incorporated (the “Company”), JPMorgan Chase Bank (N.A.), as the administrative agent, the Company’s subsidiary
borrowers party thereto, the guarantors party thereto from time to time and the lenders party thereto, (ii) that certain Senior Notes Indenture, dated as of April 19, 2016 (as amended, restated, amended and restated, supplemented or
otherwise modified prior to the Closing Date, the “Existing 2024 Indenture,” and the notes issued thereunder, the “2024 Notes”), by and among the Company, U.S. Bank National Association, as the trustee, and the
Company’s subsidiary guarantors party thereto, (iii) that certain Senior Secured Notes Indenture, dated as of July 20, 2020 (as amended, restated, amended and restated, supplemented or otherwise modified from prior to the Closing
Date, the “Existing U.S. 2025 Indenture”), by and among the Company, U.S. Bank National Association, as the trustee, and the Company’s subsidiary guarantors party thereto and (iv) that certain Senior Secured Notes
Indenture, dated as of July 20, 2020 (as amended, restated, amended and restated, supplemented or otherwise modified prior to the Closing Date, the “Existing Euro 2025 Indenture,” together with the Existing U.S. 2025 Indenture,
the “Existing 2025 Indentures,” and the notes issued under the Existing 2025 Indentures, the “2025 Notes”), by and among Diebold Nixdorf Dutch Holding B.V., the Company, U.S. Bank National Association, as the
trustee, and the Company’s subsidiary guarantors party thereto. 
  

			
	 Superpriority Facility

		
	 Facility Amount & Type
	  	 A new money senior secured superpriority term loan facility in an aggregate principal amount of $400 million (the “Superpriority
Facility,” and the loans thereunder, the “Superpriority Loans”). Once repaid, the Superpriority Loans may not be reborrowed.
  

All of the Superpriority Loans shall be provided by a financial institution acting as a fronting lender that is mutually and reasonably acceptable to the
Company and the Majority Consenting Parties and subsequently assigned as a loan to the applicable Consenting Party. The Company will pay all reasonable documented fees, charges and disbursements of the fronting lender and outside counsel to the
fronting lender.

		
	 Borrower
	  	Diebold Nixdorf Holding Germany GmbH (the “Superpriority Borrower”)
		
	 Guarantors
	  	 (i) The borrower and all guarantors under the Existing Credit Agreement and Existing 2025 Indentures (the “Existing
Guarantors”) and (ii) subject to the Guaranty and Security Principles (as defined below), the subsidiaries of the Superpriority Borrower (other than Excluded Subsidiaries) that are domiciled in Germany and the other subsidiaries of the
Company (other than Excluded Subsidiaries) that are domiciled in the other Specified Jurisdictions (in each case, other than Existing Guarantors) (the “Foreign Guarantors” and, together with the Superpriority Borrower, the
“Foreign Obligors”).
  
 The provision of guarantees and the granting
of collateral by subsidiaries of the Company domiciled outside the United States will be effectuated to the maximum extent permitted by, but subject in all respects to applicable law (including capital maintenance, financial assistance, director and
officer fiduciary and other similar legal duties) and will be subject in all respects to customary enforcement limitation language, and materiality considerations, reasonably acceptable to the Company and the Majority Consenting Parties (the
“Guaranty and Security Principles”).1

 

	1 	 Providing liens in favor of the New Term Loans, the 2025 Notes and the New 2L Notes will be subject to
considerations under German insolvency law. Liens provided by German Guarantors other than pledges (“Pfandrechte”) or land charges (“Grundschulden”) (e.g. security on trade receivables or movable
assets) will be subject to the consent of the Majority Consenting Parties in consultation with the Company. 

			
		  	  
 The provision of such guarantees and the granting of such collateral
will be structured to the greatest extent reasonably practicable to minimize the risk of potential challenge in a manner reasonably acceptable to the Company and the Majority Consenting Parties, which may include (i) the provision of separate
guarantees and, to the extent possible, separate security interests and liens in collateral of different or equal rank for each facility, (ii) the provision of value by trustees, agents or other entities acting on behalf of holders of New Term
Loans, 2025 Notes and/or New 2L Notes in exchange for granting of guarantees and collateral for the benefit thereof by Foreign Obligors, which may include Diebold Nixdorf, Incorporated assigning to such entities a portion of intercompany claims owed
to Diebold Nixdorf, Incorporated by Diebold Nixdorf Holding Germany GmbH in an appropriate amount and, following such assignment, such entities forgiving such claims in exchange for the granting of guarantees and liens in favor of the New Term
Loans, 2025 Notes and New 2L Notes.
  
 Except as set forth above with respect to
guarantees provided by certain foreign subsidiaries, “Excluded Subsidiaries” under the loan documents for the Superpriority Facility (the “Superpriority Loan Documents”) shall be defined in a manner consistent with the
Existing Credit Agreement, as modified on Annex A hereto.2
  

“Specified Jurisdictions” means Germany, Canada, Belgium, France, the UK, Sweden, Spain, Poland, Italy and the Netherlands.

		
	 Lenders
	  	 The Initial Eligible Consenting Parties and Other Eligible Consenting Parties who properly elect to fund Superpriority Loans pursuant to the
Transaction Support Agreement (collectively, the “Superpriority Lenders”).
  

The Superpriority Lenders shall be paid a participation premium (the “Participation Premium”) on the Closing Date in cash in an amount equal
to 3% of the principal amount of the Superpriority Facility, which shall be allocated to the Superpriority Lenders pro rata based on the amount of Superpriority Loans funded.

		
	 Structuring Premium
	  	The Structuring Parties shall be paid, on the Closing Date, a structuring premium (the “Structuring Premium”) in cash equal to $8,981,261.10. The Structuring Premium will be used by the Structuring Parties to
purchase common stock from the Company as described in, and subject to the terms and conditions specified in, the Transaction Support Agreement. The Company shall use commercially reasonable efforts to issue such stock and to ensure such stock is
issued in a registered transaction. The Structuring Premium is subject to adjustment as described in the Transaction Support Agreement; provided that in no event shall the Structuring Premium exceed $12 million in the aggregate. To the
extent that the Company is not able to issue shares of common stock up to 4.00% in the aggregate of the shares of common stock of the Company after the use of commercially reasonably efforts to do so, the
Structuring

  

	2 	 For the avoidance of doubt, the existing pledges of less than 100% of the equity interest of an applicable
subsidiary shall be increased to 100% of such equity interests to the greatest extent practicable, subject to the Guaranty and Security Principles. 

  
 2 

					
		  	Parties shall be permitted to retain any excess Structuring Premium received. Notwithstanding anything herein to the contrary, solely to the extent that and so long as applicable fund policies of a Consenting Party
prohibit such Consenting Party from accepting the Structuring Premium through the receipt or purchase of stock or equity interests, and such Consenting Parties provide notice of such prohibition within two (2) Business Days of the Agreement
Effective Date, such Consenting Party shall receive payment of its pro rata share of the Structuring Premium in cash.
		
	Ticking Fee	  	To the extent the Closing Date has not occurred prior to the 61st day following the Execution Date, each Superpriority Lender shall be paid, on and subject to the
occurrence of the Closing Date, a ticking fee (the “Ticking Fee”) in an amount equal to the Applicable Ticking Fee Rate (as defined below) on such Superpriority Lender’s allocated commitments in respect of the Superpriority
Facility. “Applicable Ticking Fee Rate” means, with respect to each period set forth below:
			
		  	 Period
	  	Ticking Fee
			
		  	 Days 1-60
	  	0.00% per annum;
			
		  	 Days 61 and Thereafter
	  	A rate per annum equal to 100% of the interest rate margin applicable to SOFR loans (as determined according to such Superpriority Lender’s commitment) under the Superpriority Facility.
		
		  	 The Ticking Fee shall be paid in the form of additional Superpriority
Loans.

		
	Administrative and Collateral Agents	  	A financial institution reasonably acceptable to the Majority Consenting Holders and the Company.
		
	Interest Rate	  	 SOFR (with 10bps credit spread adjustment) + 640bps
  

SOFR provisions to be based on LSTA precedent with such changes to be mutually agreed; provided that there will be a 4.0% floor.

		
	Default Rate	  	2.0% plus the then-applicable rate in the case of overdue principal; 2.0% plus the rate then-applicable to ABR loans in the case of all other overdue amounts.
		
	Original Issue Discount	  	2.0%
		
	Amortization	  	None.
		
	Maturity Date	  	July 15, 2025
		
	Call Protection	  	Any payment of the Superpriority Loans prior to the maturity date (including any voluntary prepayment and payment as a result of or following the acceleration of the Superpriority Loans or otherwise, but excluding
certain mandatory prepayments as described below) will be accompanied by the following prepayment premium (the “Superpriority Prepayment Premium”) as set forth below opposite the relevant period from the Closing Date as indicated
below:
			
		  	 Period
	  	Superpriority Prepayment Premium
			
		  	 Months 1 – 24
	  	Make-Whole Amount (to be defined in a manner acceptable to the Company and the Majority Consenting Parties with customary T+50bps present value discounting)
			
		  	 Thereafter
	  	5% of principal amount being repaid;

  
 3 

			
		  	 provided that (i) the Superpriority Prepayment Premium shall be 1% of the principal amount being repaid for prepayments made as a
result of asset sales (other than a transformative disposition or other transaction involving all or substantially all of the assets of the Company) and (ii) the Superpriority Prepayment Premium shall be 5% of the principal amount being repaid,
including during months 1 – 24, for mandatory prepayments made as a result of any change of control, transformative acquisition or disposition or similar transaction, in each case, involving all or substantially all of the assets of the
Company.
  
 In addition, for the avoidance of doubt, the Superpriority Prepayment
Premium will be payable in the event of a bankruptcy filing or other insolvency event by the Company or any of the Guarantors, any foreclosure, exercise of remedies and/or sale of Collateral (as defined below) following an event of default, the sale
of Collateral in an insolvency proceeding, any restructuring, reorganization or compromise of the obligations under the Superpriority Facility, or the termination of the Superpriority Loan documentation as a result of such events.

		
	 Collateral
	  	 Foreign Collateral:
  

With respect to the Foreign Collateral (defined below), the ranking of the liens securing the Superpriority Facility, the ABL Facility, the New Term Loans, the
2025 Notes and the New 2L Notes shall be as follows:
  
 Subject to the Guaranty and
Security Principles, the ABL Facility (as defined below) shall have a first priority perfected security interest in and lien on certain current assets, including cash (other than cash constituting proceeds of
Non-ABL Priority Collateral), inventory and receivables (the “ABL Priority Collateral”) of the Foreign Obligors, and the Superpriority Facility shall have a first priority perfected security
interest in and lien on substantially all other assets (subject to exclusions for “Excluded Property” as defined consistent with the Existing Credit Agreement, as modified on Annex A hereto) other than the ABL Priority Collateral
(the “Non-ABL Priority Collateral”) of the Foreign Obligors (the “Foreign Collateral”).3 The ABL Facility shall have a
fourth priority perfected security interest in and lien on the Non-ABL Priority Collateral of the Foreign Obligors, and the Superpriority Facility shall have a second priority perfected security interest in
and lien on the ABL Priority Collateral of the Foreign Obligors.
  
 Subject to the
Guaranty and Security Principles, the New Term Loans and the 2025 Notes shall have a third priority perfected security interest in and lien on the ABL Priority Collateral of the Foreign Obligors and a second priority perfected security interest in
and lien on the Non-ABL Priority Collateral of the Foreign Obligors.
  

Subject to the Guaranty and Security Principles, the New 2L Notes shall have a fourth priority perfected security interest in and lien on the ABL Priority
Collateral of the Foreign Obligors and a third priority perfected security interest in and lien on the Non-ABL Priority Collateral of the Foreign Obligors.

 
 To the extent that applicable law does not provide that collateral can be secured by
both first priority and junior priority perfected security interests, the priorities set forth in this section entitled Collateral shall be established through contractual arrangements reasonably acceptable to the Majority Consenting Parties and the
Company.4

  

	3 	 Solely for purposes of the intercreditor relationship between the Superpriority Facility, the New Term
Loans, the 2025 Notes and the New 2L Notes, all property and assets of Foreign Obligors and proceeds thereof will be deemed to constitute Foreign Collateral, regardless of whether a perfected security interest in and lien on such property or
proceeds has been created. 

	4 	 For the avoidance of doubt, such collateral shall fall within the scope of footnote 4 above.

  
 4 

			
		  	  
 Domestic Collateral:

 
 With respect to the Domestic Collateral (defined below), the ranking of the liens
securing the Superpriority Facility, the ABL Facility, the New Term Loans, the 2025 Notes, the New 2L Notes, and the Existing Term Loans shall be as follows; provided that, from and after the date on which the Existing Term Loans are no
longer outstanding, the ranking of the liens with respect to the Domestic Collateral that is Non-ABL Priority Collateral shall be changed to be the same as the ranking of the liens with respect to the Foreign
Collateral that is Non-ABL Priority Collateral:
  

The Superpriority Facility shall have a first priority perfected security interest in and lien on substantially all assets of the Company and each Existing
Guarantor (subject to exclusions for “Excluded Property as defined consistent with the Existing Credit Agreement, as modified by Annex A hereto), including on certain assets (other than assets constituting the Foreign Collateral)
currently not encumbered by the liens securing the Existing Term Loans and the 2025 Notes to be agreed by the Company and the Majority Consenting Parties (the “Domestic Collateral,” and together with the Foreign Collateral, the
“Collateral”); provided, that the ABL Facility shall have a first priority security interest in and lien on Domestic Collateral constituting ABL Priority Collateral and the Superpriority Facility will have a second priority
perfected security interest in and lien on the Domestic Collateral constituting ABL Priority Collateral.
  

The New Term Loans and the 2025 Notes will have a pari passu first priority perfected security interest in and lien on Domestic Collateral that is Non-ABL Priority Collateral and a third priority perfected security interest in and lien on Domestic Collateral that is ABL Priority Collateral.

 
 The Existing Term Loans will have a pari passu first priority perfected security
interest in and lien on Domestic Collateral that is Non-ABL Priority Collateral.5 The liens of the Existing Term Loans on the ABL Priority Collateral and on
Foreign Collateral shall be released pursuant to the Amended Existing Credit Agreement.
  

The New 2L Notes will have a second priority perfected security interest in and lien on Domestic Collateral that is
Non-ABL Priority Collateral and a fourth priority perfected security interest in and lien on Domestic Collateral that is ABL Priority Collateral.

 
 The ABL Facility will have a third priority perfected security interest in and lien on
Domestic Collateral that is Non-ABL Priority Collateral.
  

“Excluded Property” shall be defined in a manner consistent with the Existing Credit Agreement, as modified on Annex A hereto.

 
 The Loan Parties will be required to, within 90 days of the Closing Date (which may be
extended by the administrative agent for the Superpriority Facility acting at the direction of the Required Superpriority Lenders (as defined below)), (i) deliver control agreements with respect to each of their U.S. deposit accounts and securities
accounts and (ii) in the case of non-U.S. Guarantors, subject to the Guaranty and

 

	5 	 Liens of the Existing Term Loans shall be released on certain Non-ABL Priority Collateral mutually
acceptable to the Company and the Majority Consenting Parties, and the lien priorities on such Non-ABL Priority Collateral shall be the same as the priorities on the Foreign Collateral that is Non-ABL Priority Collateral. 

  
 5 

			
		  	Security Principles, enter into customary foreign law governed security documentation under the law of the jurisdictions of such non-U.S. Guarantors (in each case under clauses (i) and
(ii), subject to additional exclusions to be agreed). In no event shall foreign law security documentation be required in jurisdictions other than the Specified Jurisdictions.
		
	 Mandatory Prepayments
	  	 Consistent with the Existing Credit Agreement, with appropriate modifications to reflect the terms of this term sheet (including all annexes
hereto) and the priority status of the Superpriority Facility. For the avoidance of doubt, there shall be no excess cash flow mandatory prepayments.
  

Any Superpriority Lender may elect not to accept any mandatory prepayment (other than in connection with a refinancing event in respect of the Superpriority
Loans). Any such rejected amount shall be re-offered to non-declining Superpriority Lenders and, if any amount is rejected after such
re-offering (any such amount, the “Declined Proceeds”), may be retained by the Company and used in a manner not otherwise prohibited.

		
	 Voluntary Prepayments
	  	The Company will be permitted to prepay the Superpriority Loans at any time, in minimum principal amounts to be agreed upon, without premium or penalty other than payment of the Superpriority Prepayment Premium as described herein
and subject to reimbursement of the Superpriority Lenders’ redeployment costs in the case of SOFR Loans (other than on the last date of the relevant interest period).
		
	 Documentation Principles
	  	Definitive documentation will be in form and substance satisfactory to the Company and the Majority Consenting Parties giving due regard to the Existing Credit Agreement and the security and other ancillary documents entered in
connection with the Existing Credit Agreement, with revisions to reflect the terms of this term sheet (including Annex A and all other annexes hereto) and additional revisions to reflect the priority status of the Superpriority Facility and
materiality thresholds, exceptions, grace periods and other revisions reasonably acceptable to the Company and the Majority Consenting Parties (collectively, the “Documentation Principles”).
		
	 Representations and Warranties
	  	To give due regard to the representations and warranties set forth in the Existing Credit Agreement in a manner consistent with the Documentation Principles, including, for avoidance of doubt, the revisions specified in Annex
A hereto.
		
	 Affirmative Covenants
	  	To give due regard to the affirmative covenants set forth in the Existing Credit Agreement in a manner consistent with the Documentation Principles, including, for avoidance of doubt, the revisions specified in Annex A
hereto. Notwithstanding the foregoing, the affirmative covenants will include a requirement to use commercially reasonable efforts to (a) obtain a facility rating from both S&P and Moody’s within 45 days of the Closing Date and
(b) maintain a corporate rating from both S&P and Moody’s (but will not include a requirement to maintain any specific rating).
		
	 Negative Covenants
	  	 To give due regard to the negative covenants set forth in the Existing Credit Agreement in a manner consistent with the Documentation
Principles, including, for avoidance of doubt, the revisions specified in Annex A hereto; provided that:
  

•  revisions shall reflect the corresponding provisions set forth in Annex
A;
  
 •  the
Company will not, nor will it permit any Subsidiary to, (other than at maturity and other than with respect to regular debt service) make or pay, directly or indirectly, any payment or other distribution (whether in cash, securities or other
property) of or in respect of any 2024 Notes, the New 2L Notes, or loans outstanding after the Closing Date under the Amended

  
 6 

			
		  	 Existing Credit Agreement (as defined below), including any payment or other distribution (whether in cash, securities or
other property), including any sinking fund or similar deposit, on account of the prepayment (whether optional or mandatory), satisfaction, purchase, exchange, redemption, retirement, acquisition, defeasance, cancellation or termination of any such
2024 Notes, the New 2L Notes, or loans outstanding after the Closing Date under the Amended Existing Credit Agreement; provided, that:
  

•  the Company may (i) use up to $100 million of proceeds from new equity
issuances consummated on or after the Closing Date to repay, repurchase or redeem the New 2L Notes, and (ii) redeem or refinance the New 2L Notes in connection with any change of control or sale of all or substantially all of the Company’s
assets solely to the extent the Superpriority Facility, the New Term Loans and the 2025 Notes have been paid in full in cash; and
  

•  the Company may make prepayments or repayments of the loans outstanding after the
Closing Date under the Amended Existing Credit Agreement or the 2024 Notes outstanding after the Closing Date, with the proceeds of (A) junior financing, that (x) is junior in security and priority to each of the Superpriority Facility,
the ABL Facility, the New Term Loans, the 2025 Notes and the New 2L Notes and (y) limits payment of interest on such financing to PIK interest or (B) newly issued equity of or capital contributions in the Company;

 
 •  except as
otherwise detailed on Annex A, the definitive documentation shall not allow for any non-ordinary course capacity with respect to negative covenants, including, without limitation, permitted
indebtedness, permitted liens, permitted investments, restricted payments, sale-leaseback transactions, asset sales and affiliate transactions; and
  

•  except as otherwise detailed on Annex A, the definitive documentation shall include,
without limitation, (i) waterfall protection, pro rata protection, and “Serta”, “J.Crew”, “Chewy” and “Incora” protection, in each case acceptable to the Majority Consenting Parties and the Company;
(ii) no day-one unrestricted subsidiaries and no ability to transfer assets to unrestricted subsidiaries, designate any new unrestricted subsidiaries, or hold assets at any unrestricted subsidiaries; and
(iii) standard yield protection provisions (including, without limitation, provisions relating to compliance with risk-based capital guidelines, increased costs and payments free and clear of withholding taxes (subject to customary
qualifications)).

		
	 Use of Proceeds
	  	Proceeds from the Superpriority Facility shall only be used by the Borrower for general corporate purposes and to make the New Term Loan Paydown, in each case pursuant to the terms hereof (and, for the avoidance of doubt, shall not
be used to make payments on any other funded indebtedness).
		
	 Events of Default
	  	To give due regard to the events of default in the Existing Credit Agreement in a manner consistent with the Documentation Principles, including, for avoidance of doubt, the revisions specified in Annex A
hereto.

  
 7 

			
	 Conditions Precedent to Closing
	  	 The closing of the Superpriority Facility will be subject to satisfaction or waiver by the Majority Consenting Parties of the following
conditions precedent:
  

(a)   execution of the Superpriority Facility and related loan documents; provided that if
any required collateral and guarantee items other than the filing of UCC financing statements and IP security agreements with the USPTO and USCO and the delivery of possessory collateral cannot be satisfied at closing, the Company and the Majority
Consenting Parties shall agree to reasonable extensions of time for such items to be completed on a post-closing basis;
  

(b)   delivery of the Intercreditor Agreements (as defined below);

 
 (c)   all of the
representations and warranties in the Superpriority Loan Documents shall be true and correct in all material respects (or if qualified by materiality or material adverse effect, in all respects) as of the Closing Date, or if such representation
speaks as of an earlier date, as of such earlier date;
  

(d)   no default or event of default under the Superpriority Facility shall have occurred or be
continuing;
  
 (e)   no
default or event of default under the Transaction Support Agreement shall have occurred or be continuing;
  

(f)   no event or circumstance that, individually or in the aggregate with other events or
circumstances, has had or would reasonably be expected to have a Material Adverse Effect, shall have occurred from the signing of the Transaction Support Agreement;
  

(g)   delivery of a customary borrowing notice and solvency certificate;

 
 (h)   delivery of a customary
expert opinion (“Sanierungsgutachten”) confirming that a sustainable restructuring of the German obligors is more likely than not;
  

(i) delivery of legal opinions (other than with respect to no conflicts) reasonably acceptable to the Majority
Consenting Parties, including from any local counsel to the loan parties;
  

(j) (1) receipt of executed copies of the Existing Credit Agreement Amendment, the 2025 Supplemental Indentures
and the 2024 Supplemental Indenture (collectively, the “Amendments”) and the substantially concurrent occurrence of the effective date of such Amendments, (2) receipt of an executed copy of the New 2L Indenture and
(3) receipt of an executed copy of the credit agreement for the ABL Facility (and, in the case of (2) and (3), customary evidence of the effectiveness of such agreements);

 
 (k)   the substantially
concurrent consummation of the Revolver Exchange, the Term Loan Exchange, the 2025 Consent Solicitation and the 2024 Consent Solicitation and Exchange Offer; provided that (x) in the case of the Term Loan Exchange, the aggregate
principal amount of Existing Term Loans exchanged pursuant to the Term Loan Exchange shall not be lower than 95% (or a different amount mutually agreed by the Company and the Majority Consenting Parties) of the aggregate principal amount of
outstanding Existing Term Loans and (y) in the case of the 2024 Consent Solicitation and Exchange Offer, the aggregate principal amount of 2024 Notes that provide consents and exchange pursuant to the 2024 Consent Solicitation and Exchange
Offer shall not be lower than 95% (or a different amount mutually agreed by the Company and the Majority Consenting Parties);

  
 8 

			
		  	 (l) delivery of a certificate by an officer or director of each loan party (i) attaching
copies of all constituent and governing documents of the loan party as in effect as of the Closing Date and at all times since a date prior to the date of the resolutions described in the following clause (ii), (ii) attaching resolutions adopted by
the applicable board of directors or equivalent governing body of the loan party authorizing the execution, delivery and performance of the Superpriority Loan Documents and (iii) certifying as to the good standing (to the extent such concept or
a similar concept exists under the laws of the applicable jurisdiction) of the loan party;
  

(m) delivery of (i) a perfection certificate and the results of a search of the UCC or PPSA (or
equivalent), tax and judgment, USPTO, USCO and CIPO filings made with respect to the loan parties and (ii) copies of the financing statements (or other documents) disclosed by the lien search and evidence reasonably satisfactory to the Majority
Consenting Parties that the liens indicated by such financing statements (or other documents) are permitted by the Superpriority Loan Documents or will be released in connection with closing;

 
 (n)   receipt of any applicable
KYC information requested by the administrative agent under the Superpriority Facility;
  

(o)   all fees or premiums required to be paid to the administrative agent under the Superpriority
Facility and the Superpriority Lenders on the Closing Date and reasonable and documented out-of-pocket expenses (including legal expenses) required to be paid to or for
the benefit of the administrative agent for the Superpriority Facility and the Superpriority Lenders on the Closing Date shall, upon the initial borrowing (or deemed borrowing) of the Superpriority Facility, have been paid;

 
 (p)   all fees and expenses
required to be paid to the Ad Hoc Group Advisors and the Term Loan Group Advisors under the terms of their respective fee and/or engagement letters or the Transaction Support Agreement shall have been paid;

 
 (q)   receipt of customary
evidence of: (1) the acceptance and cancellation of the 2024 Notes tendered in exchange for the New 2L Notes, (2) the issuance of the New 2L Notes, (3) the effectiveness of the Amendments and (4) the issuance of the New Term
Loans; and
  
 (r)   payment of
the amount of the New Term Loan Paydown due on the Closing Date.

		
	 Voting / Required Superpriority Lenders
	  	 To give due regard to the voting provisions in the Existing Credit Agreement in a manner consistent with the Documentation Principles,
including, for avoidance of doubt, the revisions specified in Annex A hereto.
  

Superpriority Lenders holding more than 50% of the outstanding principal amount of the Superpriority Loans are referred to herein as the “Required
Superpriority Lenders.”
  
 For the avoidance of doubt, voting thresholds
(including sacred rights) shall be consistent with Annex A hereto.

  
 9 

			
	 Assignments and Participations
	  	 Usual and customary for facilities of this type; provided that the Company may purchase with cash Superpriority Loans solely through
Dutch auction or similar procedures to be agreed that are offered to all Superpriority Lenders on a pro rata basis in accordance with customary procedures to be agreed and subject to customary restrictions to be agreed; provided, further,
that (i) any Superpriority Loans so repurchased will be immediately cancelled and (ii) no default or event of default is continuing or would result therefrom. The Company may not purchase the Superpriority Loans for any consideration other
than cash.
  
 The Company shall use commercially reasonable efforts to include in the
Superpriority Loan Documents that the administrative agent will (i) not charge any processing or recordation fee in respect of assignments of Superpriority Loans by Superpriority Lenders to any of their respective affiliates or managed funds
and (ii) charge only one processing or recordation fee in respect of related assignments of Superpriority Loans by affiliated Superpriority Lenders; provided that the Company shall not be required to pay such fees in lieu of
Superpriority Lenders.

		
	 Other Provisions
	  	 The Superpriority Loan Documents will include customary provisions regarding increased costs, illegality, tax indemnities, waiver of trial by
jury and other similar provisions consistent with the Documentation Principles.
  
 The
documentation for the Superpriority Facility shall provide that the “Secured Parties” under the Superpriority Facility shall exclude each lender that is subject to federally regulated lender flood laws (“Flood Laws”), solely with
respect to any mortgaged property that is subject to Flood Laws, unless such lender receives customary flood diligence information (including flood determinations, flood insurance certificates and related endorsements) that is acceptable to such
lender. The Company shall use commercially reasonable efforts to provide the Consenting Parties with such customary flood diligence information.

		
	 Governing Law
	  	The laws of the State of New York.
	
	New Term Loan Facility
		
	Facility Type	  	A secured term loan facility having the lien priority described under “Collateral” for the Superpriority Facility (the “New Term Loan Facility” and, the loans thereunder, the “New Term
Loans”). Once repaid, the New Term Loans may not be reborrowed.
		
	Borrower	  	Diebold Nixdorf, Incorporated.
		
	Guarantors	  	The Existing Guarantors and, subject to the Guaranty and Security Principles, the Foreign Obligors.
		
	Term Loan Exchange	  	 All holders of Existing Term Loans will have the opportunity to exchange 100% of the principal amount of their Existing Term Loans for New
Term Loans issued under a new credit agreement for the New Term Loan Facility in an aggregate principal amount equal to 100% of the principal amount of the Existing Term Loans so exchanged (such exchange, the “Term Loan
Exchange”).
  
 All accrued and unpaid interest on Existing Term Loans that are
exchanged shall be paid in full in cash.
  
 The holders of Existing Term Loans
participating in the Term Loan Exchange shall provide consents to amend the Existing Credit Agreement as set forth in this Term Sheet and other consents and waivers to be agreed by the Company and the Majority Consenting Parties in connection with
the Term Loan Exchange.

  
 10 

			
		  	  
 In addition to the foregoing, holders of Euro-denominated Existing
Term Loans that are Initial Eligible Consenting Parties shall have the option to exchange at par Euro-denominated Existing Term Loans into Dollar-denominated New Term Loans on the Closing Date. The Dollar-denominated tranche of New Term Loans will
be proportionately increased for any such exchanges, and the Euro-denominated tranche of New Term Loans will be proportionately decreased.

		
	Term Loan Transaction Premium	  	 Holders of Existing Term Loans that are Initial Eligible Consenting Parties and Other Eligible Consenting Parties shall, solely on account of
Existing Term Loans held as of the Record Date, be paid upon the Closing Date a transaction premium of 3.0% of the principal amount of New Term Loans received in exchange for such Existing Term Loans in the Term Loan Exchange, paid in the form of
additional New Term Loans (the “Term Loan Transaction Premium”).
  

For the avoidance of doubt, in the event that applicable Existing Term Loans are assigned or transferred in accordance with the terms of the Transaction
Support Agreement, the Term Loan Transaction Premium shall remain payable on account of such applicable Existing Term Loans and be paid to the holder thereof as of the Closing Date.

		
	Administrative Agent	  	J.P. Morgan Chase Bank N.A.
		
	Collateral Agent	  	A financial institution reasonably acceptable to the Majority Consenting Holders and the Company.
		
	Interest Rate	  	 SOFR (with 10bps credit spread adjustment) + 525bps / E+550bps
  

SOFR provisions to be same as the Superpriority Facility; provided the SOFR floor will be 1.5%.

 
 The EURIBOR floor will be 0.5%.

		
	Default Rate	  	2.0% plus the then-applicable rate in the case of overdue principal; 2.0% plus the rate then applicable to ABR loans in the case of all other overdue amounts.
		
	Amortization	  	0.25% per quarter, with the first such amortization payment payable on the final day of the quarter immediately following the quarter in which the Closing Date occurs; provided that such amortization payments in the applicable
calendar year shall be credited against any 5% New Term Loan Paydown contemplated hereunder on December 31, 2023 or 2024.
		
	Maturity Date	  	July 15, 2025
		
	Call Protection	  	None.
		
	Collateral	  	The Domestic Collateral and, subject to the Guaranty and Security Principles, the Foreign Collateral, as described under “Collateral” for the Superpriority Facility.
		
	Excess Cash Flow Sweep	  	None.
		
	Mandatory Prepayments	  	Same as the Superpriority Facility, subject to customary and appropriate changes to account for the lien priority status of the New Term Loan Facility reasonably acceptable to the Company and the Majority Consenting Parties
(including that no such prepayment may occur unless the obligations under the Superpriority Facility are discharged in full in cash unless such prepayment is made with Declined Proceeds).

  
 11 

			
	 Voluntary Prepayments
	  	Subject to the terms of the Superpriority Facility and the Amended 2025 Indentures, the Company shall be permitted to prepay the New Term Loans at any time, in minimum principal amounts to be agreed upon, without premium or
penalty.
		
	 Documentation Principles
	  	Substantially consistent with the corresponding provisions set forth in the Superpriority Facility with appropriate modifications to reflect the lien priority status of the New Term Loan Facility (the “New Term Loan Facility
Documentation Principles”).
		
	 Representations and Warranties
	  	To give due regard to the representations and warranties set forth in the Existing Credit Agreement in a manner consistent with the New Term Loan Facility Documentation Principles, including, for avoidance of doubt, the revisions
specified in Annex A hereto.
		
	 Affirmative Covenants
	  	To give due regard to the affirmative covenants set forth in the Existing Credit Agreement in a manner consistent with the New Term Loan Facility Documentation Principles, including, for avoidance of doubt, the revisions specified
in Annex A hereto.
		
	 Negative Covenants
	  	 To give due regard to the negative covenants set forth in the Existing Credit Agreement in a manner consistent with the New Term Loan
Facility Documentation Principles, including, for avoidance of doubt, the revisions specified in Annex A hereto; provided, that:
  

•  revisions shall reflect the corresponding provisions set forth in Annex
A;
  
 •  the
Company will not, nor will it permit any Subsidiary to, (other than at maturity and other than with respect to regular debt service) make or pay, directly or indirectly, any payment or other distribution (whether in cash, securities or other
property) of or in respect of any 2024 Notes, the New 2L Notes, or loans outstanding after the Closing Date under the Amended Existing Credit Agreement (as defined below), including any payment or other distribution (whether in cash, securities or
other property), including any sinking fund or similar deposit, on account of the prepayment (whether optional or mandatory), satisfaction, purchase, exchange, redemption, retirement, acquisition, defeasance, cancellation or termination of any such
2024 Notes, the New 2L Notes, or loans outstanding after the Closing Date under the Amended Existing Credit Agreement; provided, that:
  

•  the Company may (i) use up to $100 million of proceeds from new equity issuances
consummated on or after the Closing Date to repay, repurchase or redeem the New 2L Notes, and (ii) redeem or refinance the New 2L Notes in connection with any change of control or sale of all or substantially all of the Company’s assets
solely to the extent the Superpriority Facility, the New Term Loans and the 2025 Notes have been paid in full in cash; and
  

•  the Company may make prepayments or repayments of the loans outstanding after the Closing Date
under the Amended Existing Credit Agreement or the 2024 Notes outstanding after the Closing Date, with the proceeds of (A) junior financing, that (x) is junior in security and priority to each of the Superpriority Facility, the ABL
Facility, the New Term Loans, the 2025 Notes and the New 2L Notes and (y) limits payment of interest on such financing to PIK interest or (B) newly issued equity of or capital contributions in the
Company.

  
 12 

			
	Financial Covenant	  	None.
		
	Events of Default	  	To give due regard to the events of default set forth in the Existing Credit Agreement in a manner consistent with the New Term Loan Facility Documentation Principles, including, for avoidance of doubt, the revisions specified in
Annex A hereto.
		
	Conditions Precedent to Closing	  	Substantially consistent with the corresponding provisions set forth in the Superpriority Facility section above (as if the Superpriority Facility were structured as a term loan facility regardless of whether it is structured in
such manner or as a notes issuance).
		
	Voting/Required Lenders	  	To give due regard to the voting provisions set forth in the Existing Credit Agreement in a manner consistent with the New Term Loan Facility Documentation Principles, including, for avoidance of doubt, the revisions specified in
Annex A hereto.
		
	Assignments and Participations	  	To give due regard to the assignment and participation provisions set forth in the Existing Credit Agreement in a manner consistent with the New Term Loan Facility Documentation Principles, including, for avoidance of doubt, the
revisions specified in Annex A hereto. The Company may not purchase the New Term Loans for any consideration other than cash.
		
	Governing Law	  	The laws of the State of New York.
	
	Amendments to Existing 2025 Indentures
		
	Amendment and 2025 Consent Solicitation	  	 The Company shall solicit consents from holders of 2025 Notes to amend the Existing 2025 Indentures (and other consents and waivers to be
agreed by the Company and the Majority Consenting Parties) (the “2025 Consent Solicitation”).
  

Holders participating in the 2025 Consent Solicitation shall provide consents to amend the Existing 2025 Indentures through supplemental indentures (the
“2025 Supplemental Indentures,” and, the Existing 2025 Indentures as amended thereby, the “Amended 2025 Indentures,”) in a manner consistent with the terms of this term sheet (including the annexes hereto),
including, for the avoidance of doubt, Annex A, and to provide that the negative covenants thereunder shall be the same as under the New Term Loan Facility except as otherwise specifically provided on Annex A, with appropriate
modifications to reflect the lien priority status of the 2025 Notes after giving effect to the Transactions.
  

Holders participating in the 2025 Consent Solicitation shall also provide the other consents and waivers agreed by the Company and the Majority Consenting
Parties in connection with the 2025 Consent Solicitation.

		
	2025 Notes Transaction Premium	  	 Holders of 2025 Notes that are Initial Eligible Consenting Parties and Other Eligible Consenting Parties shall, solely on account of 2025
Notes held as of the Record Date, be paid upon the Closing Date a transaction premium of 3.0% of the principal amount such 2025 Notes, paid in the form of additional 2025 Notes (the “2025 Transaction Premium”).

 
 For the avoidance of doubt, in the event that applicable 2025 Notes are assigned or
transferred in accordance with the terms of the Transaction Support Agreement, the 2025 Transaction Premium shall remain payable on account of such applicable 2025 Notes and be paid to the holder thereof as of the Closing
Date.

  
 13 

			
	Guarantors	  	The Existing Guarantors and, subject to the Guaranty and Security Principles, the Foreign Obligors.
		
	Collateral	  	The Domestic Collateral and, subject to the Guaranty and Security Principles, the Foreign Collateral, as described under “Collateral” for the Superpriority Facility.
		
	Conditions Precedent to Closing	  	Substantially consistent with the corresponding provisions set forth in the Superpriority Facility (as if the Superpriority Facility were structured as a notes issuance).
		
	Governing Law	  	The laws of the State of New York.
	
	New 2L Indenture
		
	Issuance	  	A new secured indenture having the lien priority described under “Collateral” for the Superpriority Facility (the “New 2L Indenture,” and the notes issued thereunder, the “New 2L
Notes”).
		
	Issuer	  	Diebold Nixdorf, Incorporated
		
	Guarantors	  	The Existing Guarantors and, subject to the Guaranty and Security Principles, the Foreign Obligors.
		
	2024 Consent Solicitation and Exchange Offer	  	 The Company shall solicit consents from holders of 2024 Notes to amend the Existing 2024 Indenture. Each consenting holder of 2024 Notes will
have the opportunity to exchange 100% of the principal amount of their 2024 Notes for New 2L Notes issued under the New 2L Indenture in an aggregate principal amount equal to 95% of the principal amount of the 2024 Notes so exchanged (such consent
solicitation and exchange offer, the “2024 Consent Solicitation and Exchange Offer”).
  

Holders of 2024 Notes participating in the 2024 Consent Solicitation and Exchange Offer shall provide consents to amend the Existing 2024 Indenture through a
supplemental indenture (the “2024 Supplemental Indenture,” and the Existing 2024 Indenture as amended thereby, the “Amended 2024 Indenture”) in a manner consistent with the terms of this term sheet (including the
annexes hereto), with appropriate modifications to reflect the priority status of the 2024 Notes after giving effect to the Transactions.
  

Holders of 2024 Notes participating in the 2024 Consent Solicitation and Exchange Offer shall also provide the other consents and waivers agreed by the Company
and the Majority Consenting Parties in connection with the 2024 Consent Solicitation and Exchange Offer. The 2024 Consent Solicitation and Exchange Offer shall also provide for additional terms, including early tender premiums, reasonably acceptable
to the Company and the Majority Consenting Parties.

		
	2024 Notes Transaction Premium	  	 Holders of 2024 Notes that are Initial Eligible Consenting Parties and Other Eligible Consenting Parties shall, solely
on account of 2024 Notes held as of the Record Date, be paid upon the Closing Date a transaction premium of 5.0% of the principal amount of such 2024 Notes (excluding any Exempt Notes), paid in the form of New 2L Notes (the “2024 Transaction
Premium”).

  
 14 

			
		  	For the avoidance of doubt, in the event that applicable 2024 Notes are assigned or transferred in accordance with the terms of the Transaction Support Agreement, the 2024 Transaction Premium shall remain payable on account of such
applicable 2024 Notes and be paid to the holder thereof as of the Closing Date.
		
	 Interest Rate
	  	8.5%, with interest to be paid-in-kind (“PIK”) through July 15, 2025, and with the Company having the option thereafter to pay
interest at 8.5% in cash or 12.5% PIK; provided that the interest rate shall be subject to increase as provided in the section titled “Governance” below.
		
	 Default Rate
	  	Same as 2024 Notes.
		
	 Maturity Date
	  	October 15, 2026
		
	 Call Protection
	  	The New 2L Notes will be callable at par; provided that a Make-Whole Amount (to be defined in a manner acceptable to the Majority Consenting Parties and the Company with customary T+50bps present value discounting) will be
payable in the event of a bankruptcy filing or other insolvency event by the Company or any of the Guarantors of the New 2L Notes, any foreclosure, exercise of remedies and/or sale of Collateral securing the New 2L Notes following an event of
default or the sale of Collateral securing the New 2L Notes in an insolvency proceeding, any restructuring, reorganization or compromise of the obligations under the New 2L Indenture or any other termination of the New 2L Indenture or New 2L Notes
as a result of any such events.
		
	 Stapled Warrants
	  	 Warrants (the “Warrants”) shall be issued and granted on the Closing Date in connection with the issuance of the New 2L
Notes. The Warrants in the aggregate shall, upon their full exercise, represent 19.99% of the outstanding common stock of the Company.
  

The Warrants shall be allocated on a pro rata basis based on holdings of New 2L Notes. Prior to April 1, 2024, the Warrants may not be sold, transferred
or assigned to any person by the holder of the Warrants separate from, and independent of, the corresponding New 2L Notes (and the Warrants and the New 2L Notes, including any and all accrued PIK interest, shall trade as a single unit under a single
CUSIP until April 1, 2024, at which time the underlying Notes and Warrants will trade separately under separate CUSIPs, and upon and after which time the Warrants may be exercised (the “Unit Split Date”)). Any Equity Issuance
Prepayment of New 2L Notes (including any and all accrued PIK interest thereon) prior to April 1, 2024 shall result in the immediate cancellation of the Warrants attached thereto. In addition, any refinancing or redemption of New 2L Notes
(including any and all accrued PIK interest thereon) in connection with a change of control or sale of all or substantially all of the Company’s assets prior to April 1, 2024 shall result in the immediate cancellation of the Warrants
attached thereto. In the event of any other repayment, repurchase, redemption or other retirement of the New 2L Notes, the Warrants shall not be cancelled and shall immediately detach and be freely transferrable. On and after April 1, 2024, the
Warrants shall be detachable from the New 2L Notes and shall be freely transferable as of April 1, 2024 (subject to applicable securities laws).
  

The exercise price for the Warrants shall be equal to $0.01. The Warrants may be exercised at any time on and after April 1, 2024 and prior to their
expiration date. The Company shall use commercially reasonable efforts to provide that stock received upon exercise shall be issued in a registered transaction. The Warrants will expire on the date that is 5 years after the Closing
Date.

  
 15 

			
		  	  
 Additional terms and conditions with respect to the Warrants shall be
documented in a Warrant Agreement that shall set forth the rights described herein and other customary terms and conditions as may be reasonably agreed by the Majority Consenting Parties and the Company (the “Warrant Agreement”).
The Warrant Agreement will provide that (i) the Warrants shall not vote with shareholders on an as-converted basis until exercised and (ii) holders of Warrants shall exercise such Warrants in
accordance with Ohio law.

		
	 Collateral
	  	The Domestic Collateral and, subject to the Guaranty and Security Principles, the Foreign Collateral, as described under “Collateral” for the Superpriority Facility.
		
	 Mandatory Prepayments
	  	Limited to change of control and asset sale offers, provided that no such offers may be made unless the obligations under the Superpriority Facility, the New Term Loans and the 2025 Notes are discharged in full in cash unless such
offer is made with Declined Proceeds with respect to the Superpriority Facility, the New Term Loan Facility and the Amended 2025 Indentures.
		
	 Voluntary Prepayments
	  	 Subject to the terms of the Superpriority Facility, the New Term Loan Facility and the Amended 2025 Indentures, the Company shall be
permitted to prepay the New 2L Notes at any time, in minimum principal amounts to be agreed upon, without premium or penalty.
  

The Superpriority Facility, the New Term Loan Facility and the Amended 2025 Indentures shall provide that the Company will be permitted to use up to
$100 million of proceeds from new equity issuances consummated on or after the Closing Date to repay, repurchase or redeem the New 2L Notes (an “Equity Issuance Prepayment”). An Equity Issuance Prepayment and/or a refinancing
or redemption in connection with a change of control or sale of all or substantially all of the assets of the Company prior to April 1, 2024 shall result in the automatic cancellation of the Warrants (with no further preypayment premium or
other fee) attached to the New 2L Notes being prepaid or refinanced.
  
 For the
avoidance of doubt, no other prepayment or refinancing of the New 2L Notes shall result in the cancellation of any Warrants, and in the event such prepayment or refinancing is permitted to occur, the Unit Split Date shall be deemed to have occurred
on such date, and the Warrants shall continue to exist as a separate security, and the Company shall use commercially reasonable efforts to ensure that the Warrants trade under a standalone CUSIP.

 

		
	 Documentation
	  	Consistent with the Existing 2025 Indentures, with appropriate modifications to reflect the terms of this term sheet (including the annexes hereto) and the priority status of the New 2L Notes.
		
	 Affirmative Covenants
	  	Consistent with the Existing 2025 Indentures, with appropriate modifications to reflect the terms of this term sheet (including the annexes hereto) and the priority status of the New 2L Notes.
		
	 Negative Covenants
	  	Consistent with the Existing 2025 Indentures, with appropriate modifications to reflect the terms of this term sheet (including the annexes hereto) and the priority status of the New 2L Notes.
		
	 Events of Default
	  	Consistent with the Existing 2025 Indentures, with appropriate modifications to reflect the terms of this term sheet (including the annexes hereto) and the priority status of the New 2L
Notes.

  
 16 

			
	Conditions Precedent to Closing	  	 Substantially consistent with the corresponding provisions set forth in the Superpriority Facility (as if the
Superpriority Facility were structured as a notes issuance).

		
	Voting/Required Holders	  	 Consistent with the Existing 2025 Indentures, with appropriate modifications to reflect the terms of this term sheet
(including the annexes hereto) and the priority status of the New 2L Notes.

		
	Governing Law	  	 The laws of the State of New York.

	
	ABL Facility and Existing Revolver
		
	Facility	  	 A new senior secured asset-based loan facility (the “ABL Facility”) in an aggregate principal amount of
$250 million syndicated by JP Morgan.

		
	Interest Rate	  	 SOFR+250-300bps

		
	Maturity	  	 July 20, 2026 (with 91 day springing maturity inside the Superpriority Facility, the New Term Loan Facility and the
Amended 2025 Indentures based on thresholds of outstanding debt to be agreed)

		
	Collateral	  	 As described under “Collateral” for the Superpriority Facility.

		
	Other Provisions	  	 The terms of the ABL Facility shall be reasonably acceptable to the Majority Consenting Parties.

		
	Existing Revolver Treatment	  	 All holders of the Existing Revolver Exposure will have the opportunity to exchange their Existing Revolver Exposure at
par into the ABL Facility (such exchange, the “Revolver Exchange”).
  

Holders of Existing Revolver Exposure that do not participate in the Revolver Exchange will have such Existing Revolver Exposure left
outstanding with documentation and collateral changes as specified under “Certain Amendments” below.
  

The Company shall terminate any undrawn revolving commitments remaining under the Existing Credit Agreement on the Closing Date.

	
	 Existing Credit Agreement Amendment and 2024 Supplemental
Indenture

		
	 Certain Amendments
	  	 The holders participating in the Term Loan Exchange and the Revolver Exchange will execute an amendment to the Existing Credit Agreement (the
“Existing Credit Agreement Amendment,” and the Existing Credit Agreement as so amended, the “Amended Existing Credit Agreement”). Pursuant to the 2024 Consent Solicitation and Exchange Offer, holders of 2024 Notes
will provide consents to amend the Existing 2024 Indenture through the 2024 Supplemental Indenture.
  

The Existing Credit Agreement Amendment and the 2024 Supplemental Indenture shall be in form and substance reasonably satisfactory to the Majority Consenting
Parties and shall, among other things, (i) allow the Transactions (as defined below) to be consummated, (ii) remove substantially all negative covenants, mandatory prepayments with respect to the term loans or notes thereunder and certain
other

  
 17 

			
		  	provisions to be reasonably agreed that may be removed with the consent of the requisite lenders or holders under the applicable debt document (and under applicable law, including the Trust Indenture Act of 1939), (iii) direct the
administrative agent, collateral agent or trustee, as applicable, to enter into one or more intercreditor agreements in form and substance reasonably satisfactory to the Majority Consenting Parties (the “Intercreditor
Agreements”) establishing the priorities described under “Collateral” for the Superpriority Facility, (iv) direct the administrative agent, collateral agent or trustee, as applicable, to release the liens securing the
obligations under the Existing Credit Agreement on the ABL Priority Collateral, the Foreign Collateral and certain other assets to be agreed between the Majority Consenting Parties and the Company, (v) with respect to the 2024 Supplemental
Indenture, extend the grace period under the Existing 2024 Indenture applicable to the defaults in payment of interest to run through the maturity date thereof and (vi) provide for other terms or consents mutually and reasonably acceptable to
the Company and the Majority Consenting Parties.
	
	 Additional Terms

		
	 Implementation
	  	 The transactions set forth herein (collectively, the “Transactions”) will be implemented as follows:

 

(a)   Immediately prior to the closing of the Transactions, the Company shall have
completed the 2025 Consent Solicitation and the 2024 Consent Solicitation and Exchange Offer;
  

(b)   Immediately prior to the closing of the Transactions, the applicable
Consenting Parties, the Company and the agents and/or trustees under the Existing Credit Agreement, Existing 2025 Indentures and Existing 2024 Indenture will enter into the Amendments, 2L Indenture, and issue New 2L Notes;

 

(c)   Following the effectiveness of the Existing Credit Agreement Amendment, the
Company will offer holders of Existing Revolver Exposure and Existing Term Loans who are Consenting Parties the opportunity to participate in the Revolver Exchange and/or the Term Loan Exchange, as applicable, on the terms set forth herein.
Concurrently with the closing of the Exchanges, the agents or trustees for the Superpriority Facility, the ABL Facility, the New Term Loan Facility, the Amended 2025 Indentures, the New 2L Indenture and the Existing Credit Agreement will enter into
the Intercreditor Agreements; and
  

(d)   Concurrently with the closing of the Revolver Exchange, Term Loan Exchange,
2025 Consent Solicitation and 2024 Consent Solicitation and Exchange Offer (collectively, the “Exchanges”), the Superpriority Lenders will fund the new-money Superpriority Facility on the
terms and conditions set forth herein and in the Superpriority Loan Documents.

		
	Paydown	  	The Company shall repay (with no premium or penalty) the New Term Loans on a pro rata basis (i) on the Closing Date, at par in an amount equal to 15% of the principal amount of Existing Term Loans that participate in the Term
Loan Exchange, (ii) on December 31, 2023, at par in an amount equal to 5% of the principal amount (at the time of the Term Loan Exchange) of Existing Term Loans that participated in the Term Loan Exchange, subject in the case of clause
(ii) to pro forma liquidity (tested on a trailing 10-day average and based on global cash or cash

  
 18 

			
		  	equivalents, and unused availability under the ABL Facility) on December 31, 2023 in excess of $250 million (the “Liquidity Condition”) and (iii) solely in the event the repayment in clause (ii) is not
made as a result of the Liquidity Condition not being satisfied, on December 31, 2024, at par in an amount equal to 5% of the principal amount (at the time of the Term Loan Exchange) of Existing Term Loans that participated in the Term Loan
Exchange, subject to the Liquidity Condition (tested on a trailing 10-day average and based on global cash or cash equivalents, and unused availability under the ABL Facility) measured on a pro forma basis on
December 31, 2024 (together, the “New Term Loan Paydown”).
		
	Governance	  	Prior to the Closing Date, the Company shall identify two individuals acceptable to the Ad Hoc Group with significant financial expertise who shall be nominated by the Company as candidates to the existing board of directors of the
Company (i.e., to succeed two existing directors) at the next board of directors election. In the event that such individuals are either not so nominated or fail to be elected by the Company’s shareholders, the interest rate then applicable
(and any interest rate that may be applicable thereafter) on the New 2L Notes shall increase by 250bps (in the form of PIK).
		
	Fees and Expenses & Indemnification	  	 The Company and the Guarantors under the Superpriority Facility will indemnify the Ad Hoc Group and the Term Loan Group and its
representatives (including its counsel and financial advisor) for all claims related to or arising from the Transactions on terms reasonably acceptable to the Ad Hoc Group, the Term Loan Group and the Company, other than such claims arising from
gross negligence, bad faith or willful misconduct.
  
 The fees and expenses incurred by
the Ad Hoc Group (including the fees and expenses of Davis Polk & Wardwell LLP and Houlihan Lokey Capital, Inc.) and the Term Loan Group (including the fees and expenses of PJT Partners, Inc. and Gibson, Dunn & Crutcher LLP) in
connection with the Transactions will be paid by the Company, whether incurred prior to, on, or following the Closing Date.

		
	Tax Treatment	  	Notwithstanding anything to the contrary herein, Majority Consenting Parties and the Company will structure the Transactions in a mutually acceptable tax efficient manner, including with respect to income tax and withholding
tax consequences of the Transactions to holders and the Company, and support mutually acceptable tax positions, provided such positions are reasonable. The Company will provide a gross up, subject to customary exceptions, in respect of any
applicable non-US withholding tax.

  
 19 

 Annex A 

Other Terms 
 [attached]

 Diebold 2023 Credit Agreement and 2025 Indentures1 
 Baskets and Other Terms 

 

							
	 Provision/Basket/Ratio
	  	 2023 Credit Agreement
	  	 2025 Indentures
	  	 Agreed
Terms2

	 Financial Covenants

				
	 Total Net Leverage Ratio
	  	 6.5x, with quarterly step downs to 5.25x.

 
 (§ 6.22)

 
 Ratio decreases to 3.75x in the event of a Covenant Reset
Trigger.
	  	 N/A
	  	 Eliminate.

				
	 Interest Coverage Ratio
	  	 1.62x, with increase to 1.75x in December 2022.

 
 (§ 6.23)

 
 Ratio increases to 3x in the event of a Covenant Reset
Trigger.
	  	 N/A
	  	 Eliminate.

	
	General
				
	 Covenant Reset Trigger
	  	 Provides that financial covenants revert to the stricter levels noted above if the company fails to comply with limits on
certain baskets and certain other terms specified in Annex I.
  

(Annex I)
	  	 N/A
	  	 Eliminate Covenant Reset Triggers; certain restrictions previously structured as Covenant Reset Triggers to be incorporated
into covenants/other provisions as set forth herein.

				
	 Covenant Reset Triggers (the Breach of Which Would Cause Financial Covenants to
	  	 •   Covenant Reset Trigger (xxiv) prohibits pledges of
equity interests of Excluded
	  	 N/A
	  	 Eliminate Covenant Reset Triggers; certain restrictions previously structured as Covenant Reset Triggers to be incorporated
into

  

	1 	 Reference is made to (i) that certain Credit Agreement (the “2023 Credit
Agreement”), dated as of November 23, 2015 (as amended, restated, amended and restated, supplemented or otherwise modified from time to time), by and among Diebold Nixdorf, Incorporated (the “Company”), JPMorgan Chase
Bank N.A., the Company’s subsidiary borrowers party thereto, the guarantors party thereto from time to time and the lenders party thereto, (ii) that certain Senior Secured Notes Indenture, dated as of July 20, 2020, by and among the
Company, U.S. Bank National Association, and the Company’s subsidiary guarantors party thereto and (iii) that certain Senior Secured Notes Indenture, dated as of July 20, 2020, by and among Diebold Nixdorf Dutch Holding B.V., the
Company, U.S. Bank National Association and the Company’s subsidiary guarantors party thereto (clauses (ii) and (iii) collectively, the “2025 Indentures”). Capitalized terms used herein and not defined have the meanings
ascribed to such terms in the 2023 Credit Agreement or 2025 Indentures. 

	2 	 Unless otherwise specified, proposed amendments shall apply to both the extended 2023 Credit Agreement (as
amended by the proposed amendments, the “Extended Credit Agreement”) and the 2025 Indentures. Section references are included for reference purposes only and shall not be construed to limit in any way the provisions required
to be amended to effectuate to the fullest extent the proposed amendments. 

							
	 Provision/Basket/Ratio
	  	 2023 Credit Agreement
	  	 2025 Indentures
	  	 Agreed
Terms2

	 Reset to Pre-Amendment Covenant Ratios):

 
 General Covenants Not Related to Specific Baskets
	  	 Subsidiaries that do not also secure the Obligations, subject to a
carve-out that permits pledges to secure debt used to finance certain ordinary course working capital, cash management or tax/financing strategies.

 

•   Covenant Reset Trigger (xxv) requires the Company to take commercially
reasonable efforts to make future downstream investments from the guarantor group in Excluded Subsidiaries in the form of intercompany loans (or, as an alternative, in the form of non-voting preferred equity),
and obligates the company to use commercially reasonable efforts to pledge such investments to secure the Obligations.
  

•   Covenant Reset Trigger (xxvii) requires intercompany notes evidencing
Indebtedness of $10 million or more held by the guarantor group to be pledged.
  

•   Covenant Reset Trigger (xxix) requires the Loan Parties to use
commercially reasonable efforts to subject any domestic deposit or securities accounts to a control agreement.
  

•   Covenant Reset Trigger (xxxiii) requires the Company to use
commercially reasonable efforts to provide perfected security interests over substantially all material intellectual property owned by Loan Parties registered or licensed in foreign jurisdictions.
	  		  	 covenants/other provisions as set forth herein.

  
 -2- 

							
	 Provision/Basket/Ratio
	  	 2023 Credit Agreement
	  	 2025 Indentures
	  	 Agreed
Terms2

		  	 •   Covenant Reset Trigger (xxxv) requires the Company
to use commercially reasonable efforts to provide perfected pledges of equity interests in Material Subsidiaries.
	  		  	
				
	 Covenant Reset Triggers:

Ranking Protection
	  	 Covenant Reset Trigger (xxii) prohibits amendments without the consent of revolving lenders that adversely affect
ranking, release all or substantially all Collateral or release of guarantees.
	  	 N/A
	  	 Eliminate.

				
	 Designation of Unrestricted Subsidiaries
	  	 Designation of Unrestricted Subsidiaries subject to (i) no default, (ii) compliance with financial covenants,
(iii) designated Subsidiary no longer being a restricted subsidiary under other Material Indebtedness, (iv) subsidiaries of the designated Subsidiary also becoming Unrestricted Subsidiaries.

 
 (§ 6.30)

 
 Covenant Reset Trigger (xxi):

prohibits all Unrestricted Subsidiary designations.
	  	 Designation of Unrestricted Subsidiaries subject to (i) no default, (ii) Subsidiary does not own equity or debt of
restricted group, (iii) debt of Subsidiary is non-recourse, (iv) the restricted group has no obligations to purchase equity of designated Subsidiary or maintain Subsidiary’s financial condition,
(v) designation is permitted under Investments covenant.
  

(§ 4.13)
	  	 Prohibit Unrestricted Subsidiary designations.

				
	 Pro Rata Sharing
	  	 Payments by a Borrower are allocated pro rata to the Lenders.

 
 (§ 2.10(a))
	  	 Payments for consent required to be offered and paid to all consenting Holders.

 
 (§ 9.07)
	  	 Amendments to pro rata sharing provision to require all affected creditor consent.3
  
 Pro
rata sharing provision in Extended Credit Agreement to expressly cover payments for consent and other payments on account of Obligations.

 

	3 	 Pro Rata Sharing provision to be expanded to protect against changes to the Intercreditor Agreements or
division of assets acquired by means of credit bidding that could have the effect of avoiding such provisions. 

  
 -3- 

							
	 Provision/Basket/Ratio
	  	 2023 Credit Agreement
	  	 2025 Indentures
	  	 Agreed
Terms2

	 Domestic vs. Foreign Obligations
	  	 Bifurcates obligations between Domestic Loan Parties / Domestic Obligations and Foreign Loan Parties / Foreign
Obligations.
  
 (§ 1.1 definitions generally,
§ 2.10(b), § 17.4)
	  	 N/A
	  	 Will not be applicable in amended documents.

	
	Restricted Payments (i.e., dividends and distributions, Investments handled separately below)
				
	 General Restricted Payments
	  	 Up to the greater of $100 million and 2.5% of Total Tangible Assets.

 
 (§ 6.25(g))

 
 Covenant Reset Trigger (xiv):

Capped at $10 million and subject to Total Net Leverage Ratio not to exceed 3.0x.
	  	 Up to the greater of $100 million and 4% of Total Tangible Assets.

 
 (§ 4.08(b)(20))
	  	 Fixed dollar basket of $15 million.

 
 This basket cannot be used to make non-cash Restricted Payments consisting of Collateral.

				
	 Builder Basket
	  	 $30 million fixed starter amount for “Available Amount” basket which can be used for Investments and
Restricted Payments, subject to Total Net Leverage Ratio not to exceed 3.0x.
  

(§ 1.1 “Available Amount”, § 6.25(j)).

 
 Covenant Reset Trigger (xvi):

Basket cannot be used.4
	  	 No starter amount in builder basket.
  

(§ 4.08(a))
	  	 Eliminate.

				
	 Ratio Restricted Payments
	  	 Restricted Payments subject to a Total Net Leverage Ratio not to exceed 2.5x.

 
 (§ 6.25(i))

 
 Covenant Reset Trigger (xvi):

Basket cannot be used.
	  	 Restricted Payments subject to a Total Net Leverage Ratio not to exceed 2.75x.

 
 (§ 4.08(b)(13))
	  	 Eliminate.

				
	 Intercompany Restricted Payments
	  	 Uncapped for Restricted Payments by Restricted Subsidiaries to the Company or any Wholly Owned Restricted Subsidiary.

 
 (§ 6.25(a))
	  	 Uncapped for dividends and distributions by Restricted Subsidiaries.

 
 (§ 4.08(a)(1))
	  	 Uncapped for Restricted Payments within the restricted group (including by
non-wholly owned subsidiaries), provided that (i) Restricted Payments to Restricted Subsidiaries that are not ultimately 100% pledged must be ratable (or less than ratable), and (ii) Restricted
Payments to non-Guarantors must be ratable (or less than ratable).

 

	4 	 Available Amount basket can still be used for (1) Investments, but subject to Covenant Reset Trigger
(iv) (i.e., Company and US Guarantors can only use basket to make investments in Company, US Guarantors or non-US Guarantors), and (2) payments on Restricted Indebtedness, but subject to Covenant Reset
Trigger (xviii) (i.e., basket can only be used for payments in the form of common equity or certain preferred equity of the Company). 

  
 -4- 

							
	 Provision/Basket/Ratio
	  	 2023 Credit Agreement
	  	 2025 Indentures
	  	 Agreed
Terms2

	Quarterly Dividends	  	 Up to 12.5 cents per share on common stock for quarterly cash dividends.

 
 (§ 6.25(h))

 
 Covenant Reset Trigger (xv): capped at 10 cents per share and subject to Total Net
Leverage Ratio less than 3.0x.
	  	 Up to 12.5 cents per share on common stock for quarterly cash dividends.

 
 (§ 4.08(b)(11))
	  	Eliminate.
				
	Dividends for Employee Owned Equity	  	 Up to $5 million per fiscal year to repurchase employee stock. Unused amounts carry over to next two fiscal years.

 
 (§ 6.25(f))
	  	 Up to $10 million per fiscal year to repurchase employee stock. Unused amounts carry over to next two fiscal years.

 
 (§ 4.08(b)(7))
	  	$2.5 million per fiscal year, with one year carry over.
				
	Non-Qualified Stock Purchase Plan	  	 Restricted Payments made pursuant to the Diebold, Incorporated 2014 Non-Qualified Stock Purchase Plan
not to exceed $3 million in any fiscal year.
  
 (§ 6.25(k))
	  	 Restricted Payments made pursuant to the Diebold, Incorporated 2014 Non-Qualified Stock Purchase Plan
not to exceed $3 million in any fiscal year.
  
 (§ 4.08(b)(15))
	  	Fixed-dollar basket of $2 million.
				
	Acquisition of AEVI Equity interests	  	 Up to €100 million for Restricted Payments to acquire equity interests of AEVI International GmbH.

 
 (§ 6.25(l))

 
 Covenant Reset Trigger (xvii): Capped at €50 million, together with
investments made in AEVI permitted under the Investment covenant.
	  	N/A	  	Eliminate.

  
 -5- 

							
	 Provision/Basket/Ratio
	  	 2023 Credit Agreement
	  	 2025 Indentures
	  	 Agreed
Terms2

	 Payments on Restricted Indebtedness (i.e., junior lien, payment
subordinated, unsecured indebtedness)5

				
	Junior Debt Payment Basket6	  	 Up to the greater of $100 million and 2.5% of Total Tangible Assets for payments on Restricted Indebtedness.

 
 (§ 6.26(b))

 
 Covenant Reset Trigger (xviii): Basket can only be used for payments in the form of
common equity or certain preferred equity of the Company.
	  	N/A – no dedicated junior debt payment baskets.	  	Eliminate.
				
	Ratio Debt Payment Basket	  	 Permits payments on Restricted Indebtedness subject to Secured Net Leverage Ratio less than or equal to 2.5x.

 
 (§ 6.26(c))
	  	N/A – no dedicated junior debt payment baskets.	  	Eliminate.
				
	Existing Debt Payment Basket	  	 Permits payments on certain indebtedness existing on the Acquisition Closing Date.

 
 (§ 6.26(e))
	  	N/A – no dedicated junior debt payment baskets.	  	Company to provide schedule that discloses the indebtedness covered by this basket.
				
	Intercompany Debt Payment Basket	  	 Permits repayments of intercompany debt.
  

(§ 6.26(f))
	  	N/A – no dedicated junior debt payment baskets.	  	Uncapped for repayments of intercompany debt owed to Guarantors (or the Company). Repayments of debt owed to non-Guarantors permitted in connection with ordinary course cash management
activities, provided that any such repayments in excess of $10 million shall be reported to the full board in the immediately following regular quarterly reporting and that the full board shall receive regular updates regarding
intercompany payments generally.

  

	5 	 Applies to payments on New 2L Notes, provided that the Company may use up to $100 million of proceeds
from equity issuances to repay such notes, as further described in the Term Sheet. 

	6 	 Applies to debt subordinated in right of payment and unsecured debt under the 2023 Credit Agreement and debt
subordinated in right of payment under the 2025 Indentures. 

  
 -6- 

							
	 Provision/Basket/Ratio
	  	 2023 Credit Agreement
	  	 2025 Indentures
	  	 Agreed
Terms2

	
	Investments
				
	 General Investment Basket
	  	 Up to the greater of 10% of Total Tangible Assets for Investments made (net of any return in cash).

 
 (§ 6.15(viii))

 
 Covenant Reset Trigger (iv): Company and US Guarantors
can only use this basket to make investments in Company, US Guarantors or non-US Guarantors.
	  	 Up to the greater of $350 million and 14% of Total Tangible Assets.

 
 (§ 1.01 “Permitted Investments”
(21))
	  	 Fixed-dollar basket of $35 million (consistent with 2023 Credit Agreement, net of any returns in cash but not to exceed
amount initially invested).
  
 Can be used for cash
Investments and investments that do not consist of transfers of Collateral.

				
	 Ratio Investments
	  	 Investments subject to Total Net Leverage Ratio not to exceed the financial covenant ratio, minus 0.25x.

 
 (§ 6.15(x))

 
 Covenant Reset Trigger (iv): Company and US Guarantors
can only use this basket to make investments in Company, US Guarantors or non-US Guarantors.
	  	 N/A
	  	 Eliminate.

				
	 Foreign Subsidiary Investments
	  	 Investments by Foreign Subsidiaries that are not Foreign Subsidiary Borrowers in other Foreign Subsidiaries that are
Restricted Subsidiaries.
  
 (§ 6.15(iv))

 
 Covenant Reset Trigger (iii): Cannot use this basket for
investments in Unrestricted Subsidiaries.
	  	 N/A
	  	 Eliminate. Collapsed into more general Intercompany Investments provisions
below.

  
 -7- 

							
	 Provision/Basket/Ratio
	  	 2023 Credit Agreement
	  	 2025 Indentures
	  	 Agreed
Terms2

	 Intercompany Investments
	  	 •   Uncapped for investments in the Company and the
Guarantors.
  

•   N/A

 
 (§ 6.15(ii))
	  	 •   Uncapped for investments between restricted group
entities.
  

•   Uncapped for investments so long as the person becomes a Restricted
Subsidiary.
  
 (§ 1.01 “Permitted
Investments” (1), (2))
	  	 •   Investments made after execution of TSA7 (as reduced by returns solely on such investments, but not in excess of amount originally invested) by Guarantors in non-Guarantor Restricted Subsidiaries
limited up to a $10 million cap; provided that investments in connection with ordinary course cash management operations will be permitted, provided further that such investments in excess of $10 million shall be reported to the
full board in the immediately following regular quarterly reporting and that the full board shall receive regular updates regarding intercompany investments generally.

 

•   Cash investments by Guarantors in
non-Guarantor Restricted Subsidiaries made from cash proceeds received from non-Guarantors after TSA signing shall be excluded from such cap.

 

•   Investments in Guarantors and persons that become Guarantors uncapped.

 

•   Investments by non-Guarantor
Restricted Subsidiaries in non-Guarantor Restricted Subsidiaries or in persons that become non-Guarantor Restricted Subsidiaries uncapped.

				
	 Intercompany Loans
	  	 Up to $75 million for intercompany loans by Loan Parties to External Subsidiaries8 or by Domestic Loan Parties to Foreign Loan Parties.
  

(§ 6.15(v))
  

Covenant Reset Trigger (iv): Company and US Guarantors can only use this basket to make intercompany loans to Company, US Guarantors or non-US Guarantors.
	  	 N/A
	  	 Permitted intercompany loans to parallel permitted intercompany investments above.

  

	7 	 Applicable investments outstanding as of signing of TSA to be scheduled in Definitive Documentation. For the
avoidance of doubt, return of investments outstanding as of signing of TSA does not refresh basket. 

	8 	 “External Subsidiary” means a Subsidiary of the Company which is not a Loan Party.

  
 -8- 

							
	 Provision/Basket/Ratio
	  	 2023 Credit Agreement
	  	 2025 Indentures
	  	 Agreed
Terms2

	 Intellectual Property Basket
	  	 Investments consisting of the licensing, sublicensing or contribution of intellectual property pursuant to joint marketing
arrangements with other Persons.
  

(§ 6.15(xv))
	  	 Investments consisting of the licensing, sublicensing or contribution of intellectual property pursuant to joint marketing
arrangements with other Persons.
  
 (§ 1.01
“Permitted Investments” (16))
	  	 Add ordinary course of business limitation. To be limited to non-exclusive
licensing, sublicensing, etc. (provided that exclusive licensing will be permitted within the same territory). Cannot be used for Investments in Unrestricted Subsidiaries.

				
	 Future Acquisition Investments
	  	 Up to the greater of $100 million and 2.5% of Total Tangible Assets for Future Acquisitions.9
  

(§ 6.15(ix))
  

Covenant Reset Trigger (iv): Company and US Guarantors can only use this basket to make investments in Company, US Guarantors or non-US Guarantors.
  
 Covenant Reset Trigger
(vi): Use of basket subject to Total Net Leverage Ratio not to exceed 3.0x.
	  	 Uncapped for Investments with respect to permitted Future Acquisitions.

 
 (§ 1.01 “Permitted Investments”
(17))
	  	 Eliminate.

				
	 Employee Loans
	  	 N/A
	  	 Investments for loans to employees to fund purchases of equity permitted (i) in the ordinary course or (ii) in an
amount not to exceed $10 million.
  
 (§ 1.01
“Permitted Investments” (7))
	  	 Reduce fixed-dollar basket to $5 million. Cap applies to amounts outstanding on the closing date.

	
	
Debt10

  

	9 	
      “Future Acquisition means any transaction, or any series of related transactions, consummated on or after the date of [the Credit Agreement], other than the Acquisition, by which the Company or any of its Restricted Subsidiaries (i) acquires any going business or all or substantially all of the assets of any Person, business line or division thereof, whether through purchase of assets, merger or otherwise or (ii) directly or indirectly acquires (in one transaction or as the most recent transaction in a series of transactions) at least a majority (in number of votes) of the Voting Stock of any Person or, with respect to any non-wholly owned Subsidiary, additional Voting Stock thereof.” 

	10 	
      Proposed changes to debt baskets to also apply to existing corresponding lien baskets, if any. 

 

-9- 

							
	 Provision/Basket/Ratio
	  	 2023 Credit Agreement
	  	 2025 Indentures
	  	 Agreed
Terms2

	 General Debt Basket
	  	 Up to the greater of $100 million and 2.5% of Total Tangible Assets.

 
 (§ 6.18(xii))

 
 Covenant Reset Trigger (xii): subject to shared cap that
is limited to (1) up to $100 million of working capital loans and (2) up to $250 million for LC / bank guarantee facilities, where such debt can only be used for limited purposes.
	  	 Up to the greater of $200 million and 8% of Total Tangible Assets.

 
 (§ 4.09(b)(23))
	  	 Fixed-dollar basket of $50 million.

				
	 Ratio Debt Basket
	  	 Indebtedness subject to Total Net Leverage not to exceed the financial covenant ratio, minus 0.25x.

 
 (§ 6.18(xvii))

 
 Covenant Reset Trigger (xii): subject to shared cap that
is limited to (1) up to $100 million of working capital loans and (2) up to $250 million for LC / bank guarantee facilities, where such debt can only be used for limited purposes.
	  	 Indebtedness subject to Consolidated Coverage Ratio of at least 2.0x.

 
 (§ 4.09(a))
	  	 Eliminate.

				
	 Incremental Facilities / Refinancing Facilities
	  	 Permits incremental facilities subject to a Secured Net Leverage Ratio not to exceed 2.5x.

 
 (§ 1.1 “Incremental Amount”,
§ 2.19, § 2.21, § 8.2.4(a), § 8.2.4(b))
	  	 N/A
	  	 Eliminate.

				
	 2024 Unsecured Notes
	  	 Permits $500 million for the New Senior Unsecured Notes.

 
 (§ 6.18(i)(b))
	  	 N/A
	  	 Eliminate unused capacity; allow for notes previously issued thereunder.

				
	 Debt Facilities
	  	 N/A
	  	 Up to $2,475 million plus additional Indebtedness subject to a Secured Leverage Ratio not to exceed 3.0x.

 
 (§ 4.09(b)(1))
	  	 Eliminate.

				
	 Intercompany Indebtedness
	  	 Uncapped for Indebtedness between the Company and Subsidiaries; Indebtedness owing by
	  	 Uncapped for Indebtedness among the restricted group, provided that debt owed by
	  	 Parallel intercompany investments and intercompany loans provisions above. In addition, payment subordination
requirement

  
 -10- 

							
	 Provision/Basket/Ratio
	  	 2023 Credit Agreement
	  	 2025 Indentures
	  	 Agreed
Terms2

	  
	  	 any Loan Party to any non-Domestic Loan Party Subsidiary shall be unsecured.

 
 (§ 6.18(xvi))

 
 Covenant Reset Trigger (x): Cannot be used for loans to
Unrestricted Subsidiaries. Loans from Domestic Loan Party to Foreign Subsidiary Borrower or non-Loan Party Subsidiary must be permitted as an Investment, be pledged as Collateral, and must not be subject to
another Covenant Reset Trigger.
	  	 restricted group to non-guarantors must be payment subordinated.

 
 (§ 4.09(b)(5))
	  	 for debt owed by restricted group to non-guarantors same as 2025
Indentures.

	 Intercompany Guarantees
	  	 •   Permits Guarantees by the restricted group of permitted
Indebtedness.
  

•   N/A

 
 (§ 6.18(xiii))
	  	 •   Permits guarantees by guarantors of permitted
Indebtedness incurred by guarantors.
  

•   Permits guarantees by
non-guarantors of permitted Indebtedness incurred by non-guarantors.
  

(§ 4.09(b)(4))
	  	 •   Debt that can be guaranteed by guarantors to be limited
to (i) Indebtedness of guarantors existing on the closing date of the Extended Credit Agreement / amended 2025 Indentures (and refinancings thereof) or (ii) Indebtedness of non-guarantors, subject to
Investment basket limitations.
  

•   Non-guarantor guarantees of other non-guarantor debt permitted.

				
	 Foreign Subsidiaries Indebtedness
	  	 Up to the greater of $100 million and 2.5% of Total Tangible Assets for Indebtedness of Foreign Subsidiaries.

 
 (§ 6.18(xviii))

 
 Covenant Reset Trigger (xii): subject to shared cap that
is limited to (1) up to $100 million of working capital loans and (2) up to $250 million for LC / bank guarantee facilities, where such debt can only be used for limited purposes.
	  	 Up to the greater of $150 million and 6% of Total Tangible Assets for Indebtedness of Foreign Subsidiaries.

 
 (§ 4.09(b)(12))
	  	 Eliminate.

				
	 Receivables Facilities
	  	 Up to $100 million for Receivables Indebtedness.

 
 (§ 6.24)
	  	 Up to $200 million for Qualified Receivables Transactions and Permitted Factoring Transactions.
	  	 Eliminate.

  
 -11- 

							
	 Provision/Basket/Ratio
	  	 2023 Credit Agreement
	  	 2025 Indentures
	  	 Agreed
Terms2

	  
	  	Covenant Reset Trigger (xiii): capped at $50 million.	  	 (§ 4.09(b)(17))
	  	  

				
	 Working Capital Facilities
	  	 Up to $50 million for working capital facilities and other facilities.

 
 (§ 6.18(ii))

 
 Covenant Reset Trigger (xii): subject to shared cap that is limited to
(1) up to $100 million of working capital loans and (2) up to $250 million for LC / bank guarantee facilities, where such debt can only be used for limited purposes.
	  	 Up to $50 million for working capital facilities and other facilities.

 
 (§ 4.09(b)(14))
	  	 Eliminate.

				
	 Bi-lateral LC/WC Agreements
	  	 Up to $300 million for Bi-lateral LC/WC Agreements,11 with $50 million sub-cap for revolving credit facilities.
  

(§ 6.18(xxii))
  

Covenant Reset Trigger (xii): subject to shared cap that is limited to (1) up to $100 million of working capital loans and (2) up to
$250 million for LC / bank guarantee facilities, where such debt can only be used for limited purposes.
	  	 Up to $300 million for Bi-lateral LC/WC Agreements, with $50 million sub-cap for revolving credit facilities.
  

(§ 4.09(b)(22))
	  	 Reduce total basket to $55 million; eliminate capacity to use basket for revolving credit facilities.

				
	 Purchase Money / Capital Leases
  
	  	 Up to $20 million for purchase money debt / capital lease obligations.

 
 (§ 6.18(xix))
	  	 Up to the greater of $50 million and 2% of Total Tangible Assets for purchase money debt / capital lease
obligations.
  
 (§ 4.09(b)(9))
	  	 Fixed-dollar basket of $20 million.

				
	 Permitted Convertible Indebtedness
	  	 Up to $200 million for Permitted Convertible Indebtedness.
	  	 Up to $200 million for Permitted Convertible Indebtedness.
	  	 Eliminate.

 

	11 	 “Bi-lateral LC/WC Agreement” means an agreement between
the Company and/or any of its Restricted Subsidiaries and a financial institution providing for foreign and/or domestic revolving credit facilities, and/or the issuance of letters of credit, bank guarantees and/or similar obligations [subject to
designation requirements and limitations on lien baskets which can secure obligations thereunder]. 

  
 -12- 

							
	 Provision/Basket/Ratio
	  	 2023 Credit Agreement
	  	 2025 Indentures
	  	 Agreed
Terms2

		  	 (§ 6.18(xxiv))
	  	 (§ 4.09(b)(21))
	  	
				
	 Integrated Service Contract Debt
	  	 Up to $100 million for Integrated Service Contract Debt.

 
 (§ 6.18(ix))

 
 Covenant Reset Trigger (ix): capped at $50 million. Can only be
used to generate new business. Debt cannot have previously been incurred under the Bi-lateral LC/WC basket, Working Capital Facilities basket, General Debt basket, Ratio Debt basket. Debt must be incurred
after the Company uses commercially reasonable efforts to obtain acceptable external financing in lieu of such debt.
	  	 Up to $100 million for Integrated Service Contract Debt.

 
 (§ 4.09(b)(18))
	  	 Eliminate.

				
	 Acquired Debt
	  	 Up to $25 million for pre-existing Indebtedness of persons that become a
Restricted Subsidiary.
  
 (§ 6.18(iv))
	  	 Acquired Indebtedness permitted subject to compliance with Consolidated Coverage Ratio of at least 2.0x (or the ratio does
not decrease).
  
 (§ 4.09(b)(7))
	  	 Eliminate.

				
	 Definition of Refinancing Indebtedness
	  	 See 2023 Credit Agreement.
  

(§ 1.1 “Permitted Refinancing Indebtedness”, “Refinance”)
	  	 See 2025 Indentures.
  

(§ 1.01 “Refinancing Indebtedness”)
	  	 Clarify that Refinancing Indebtedness includes Indebtedness that is Incurred in connection with a repurchase, redemption or
similar transaction, whether through a privately negotiated transaction, open market transaction, tender offer or otherwise.
  

Limit liens in connection with Refinancing Indebtedness such that (i) any new liens securing Refinancing Indebtedness that is refinancing
secured Indebtedness cannot be more senior than the liens being refinanced and (ii) unsecured debt may not be refinanced with secured debt.
  

Refinancing Indebtedness cannot have any additional obligors or collateral relative to indebtedness being refinanced.

  
 -13- 

							
	 Provision/Basket/Ratio
	  	 2023 Credit Agreement
	  	 2025 Indentures
	  	 Agreed
Terms2

	 Additional Notes
	  	 N/A
	  	 Unlimited ability to issue Additional Notes (subject to debt capacity).

 
 (§ 2.01)
	  	 Eliminate.

	
	 Liens

				
	 Scope
	  	 See 2023 Credit Agreement.
  

(§ 6.16)
	  	 See 2025 Indentures.
  

(§ 4.10)
	  	 Lien covenant baskets shall not permit senior liens.

				
	 General Liens Basket
	  	 Up to the greater of $200 million and 5% of Total Tangible Assets.

 
 (§ 6.16(xviii))
	  	 Up to the greater of $200 million and 8% of Total Tangible Assets.

 
 (§ 1.01 “Permitted Liens” (35))
	  	 Fixed-dollar basket of $25 million; sub-basket for liens securing funded debt of
$10 million.
  
 Liens securing funded debt on
Collateral must be junior to the Super-Priority Term Loans, Extended Term Loans and 2025 Secured Notes.

				
	 Ratio Liens Basket
	  	 N/A
	  	 Liens subject to a Secured Leverage Ratio not to exceed 2.5x.

 
 (§ 1.01 “Permitted Liens” (36))
	  	 Eliminate.

				
	 Foreign Subsidiary Liens
	  	 Up to the greater of $100 million and 2.5% of Total Tangible Assets for liens on assets of Foreign Subsidiaries.

 
 (§ 6.16(x))
	  	 N/A
	  	 Fixed-dollar basket of $10 million.

				
	 2024 Unsecured Notes Refinancings
	  	 N/A
	  	 Permits up to $250 million of Indebtedness to be secured for refinancings of 2024 Unsecured Notes.

 
 (§ 4.10(c))
	  	 To amend as necessary to permit overall transaction.

	 Asset Dispositions

				
	 Asset Sale Sweep
	  	 Net Cash Proceeds from any Asset Sale Prepayment Event subject to sweep 5 business days after receipt (but for proceeds less
than $75 million, 5 business days after due date of next financial statement).
  

(§ 2.6.5)
	  	 Excess Proceeds (i.e., Net Available Cash after reinvestment right) in excess of $40 million to be offered to Holders
for prepayment.
  
 (§ 4.16(c))
	  	 Asset sale sweeps to apply to (i) Net Available Cash / Net Cash Proceeds (here, referred to as “Asset Sale
Proceeds”) from any single transaction or series of related transactions in excess of $25 million and (ii) Asset Sale Proceeds from any transactions (other than those referred to in (i)), to the extent aggregate Asset Sale
Proceeds from such asset sales on

  
 -14- 

							
	 Provision/Basket/Ratio
	  	 2023 Credit Agreement
	  	 2025 Indentures
	  	 Agreed
Terms2

		  		  		  	 a rolling 4-quarter basis exceed $25 million (to be calculated at the end of
each fiscal quarter, with respect to such quarter and the prior three fiscal quarters).
  

Amounts subject to these asset sale sweeps are required to be used to pay down, first, obligations under the new money (non ABL) facility and,
second, the 2025 Notes, extended Term Loans, and, if required, other pari secured debt, pro rata; provided that proceeds from ABL priority collateral will be used to first pay down the ABL facility.

 
 Timing of asset sale sweeps to be aligned at 5 business
days after the receipt of proceeds from the asset sale that triggers the asset sweep requirement set forth above in (i), and 5 business days after the delivery of the financial statements for the quarter in which the asset sweep requirement set
forth above in (ii) was triggered (eliminate dollar-threshold based bifurcation of payment timing in 2023 Credit Agreement).
  

The asset sale sweep requirement may be delayed for up to 90 days during which the Company may choose to reinvest the Asset Sale Proceeds (see
“Reinvestment Right” below).

				
	 Net Cash Proceeds Definition
	  	 Net Cash Proceeds are reduced by the amount required to repay Indebtedness that is secured by a Lien on an asset that is the
subject of an asset sale.
  
 (§ 1.1 “Net
Cash Proceeds”)
	  	 Net Available Cash is reduced by payments made on Indebtedness secured by assets subject to the asset sale.

 
 (§ 1.01 “Net Available Cash”)
	  	 Deduction may only be applied with respect to (i) non-Collateral assets held
by non-Guarantors and (ii) payments of Indebtedness made by Guarantors to the extent required by the terms of applicable priority lien
Indebtedness.

  
 -15- 

							
	 Provision/Basket/Ratio
	  	 2023 Credit Agreement
	  	 2025 Indentures
	  	 Agreed
Terms2

	 Reinvestment Right
	  	 Proceeds may be use to acquire, maintain, develop, construct, improve, upgrade or repair assets (other than current assets)
used in or useful in the Company’s or Restricted Subsidiary’s business or to make a Future Acquisition or other Investment to acquire assets.
	  		  	 Reinvestment period of 90 days.
  

Reinvestment right can be used for maintaining, developing, constructing, improving, upgrading, replacing disposed-of-assets or repairing assets (other than current assets) used or useful in such entity’s business or replacing assets sold in such Asset Sale, but subject to limitations on investments and
dispositions to non-loan parties / non-guarantors as set forth in the covenants.
  

No separate right to make Future Acquisitions or permitted investments otherwise.

				
	 Right to Reduce Certain Debt
	  	 N/A
	  	 Reinvestment right permits Net Available Cash to be applied, in the case of an Asset Disposition by a Non-Guarantor Subsidiary, to permanently reduce indebtedness of (A) a Non-Guarantor Subsidiary (other than Indebtedness owed to the Company or a Guarantor) or
(B) the Company or a Guarantor.
  
 (§
4.16(b))
	  	 Reinvestment right to reduce indebtedness available solely to the extent required by the terms of the priority lien
indebtedness or to the extent required by applicable local law or the terms of non-Guarantor debt.

				
	 FMV Asset Sale Requirement
	  	 N/A
	  	 Dispositions under the FMV asset sale basket must be for 75% cash consideration. Subject to sweep. Deemed cash includes:

 

•  Liabilities assumed by the transferee of the sold assets.

 

•  Designated Noncash Consideration basket of the greater of $75 million and 2%
of Total Tangible Assets.
  
 (§ 4.16(b))
	  	 FMV asset sale requirement to require 100% cash consideration requirement (with no designated non-cash consideration or deemed cash concept).

  
 -16- 

							
	 Provision/Basket/Ratio
	  	 2023 Credit Agreement
	  	 2025 Indentures
	  	 Agreed
Terms2

	 Substantial Portion Basket (cap on asset sales in rolling 12-month period)
	  	 Dispositions that are not a “Substantial Portion” of Property of the restricted group per 12-month period. Subject to sweep.
  

(§ 6.14(xvi))
  

Covenant Reset Trigger (i): dispositions in reliance of this basket subject to: (1) 100% cash consideration, (2) if Net Cash Proceeds exceeds
$50 million, no increase in Total Net Leverage Ratio, (3) at least 85% of Net Cash Proceeds used to prepay Term Loans with no reinvestment right (if Asset Sale Prepayment Event triggered), (4) if Net Cash Proceeds exceeds
$75 million, 100% used to prepay Term Loans, (5) any Net Cash Proceeds in excess of $25 million are subject to the sweep without giving effect to certain foreign jurisdiction related limitations.
	  	 N/A
	  	 Dispositions up to a fixed-dollar amount permitted, which such fixed-dollar amount will be based on the “Substantial
Portion” amount (i.e., the lower of clauses (a) through (d) in the definition thereof) on or around the closing date of the transactions. “Substantial Portion” defined as (a) 15% of assets as of 12-month lookback period, (b) 15% of net sales as of 12-month lookback period, (c) 25% of assets as of most recent financial statement date or (d) 25% of net
sales as of most recent financial statement date.
  

Dispositions in reliance of this basket subject to: (1) 100% cash consideration (with no designated
non-cash consideration or deemed cash concept), (2) if Net Cash Proceeds exceeds $50 million, no increase in Total Net Leverage Ratio, (3) at least 85% of Net Cash Proceeds used to prepay first,
debt under the new money (non ABL) facility (and debt under the ABL facility with respect to dispositions of ABL priority collateral) and, second, the 2025 Notes, extended Term Loans, and, if required, other pari debt, pro rata, with no reinvestment
right (if Asset Sale Prepayment Event triggered), (4) if Net Cash Proceeds exceeds $75 million, 100% used to make prepayments as set forth in clause (3).

				
	 Dispositions within Restricted Group
	  	 Unlimited for dispositions (i) to Domestic Loan Parties and (ii) between
non-Guarantor Restricted Subsidiaries. Not subject to sweep.
  

(§ 6.14(xii))
	  	 Unlimited for dispositions between the Company and Restricted Subsidiaries. Not subject to sweep.

 
 (§ 1.01 “Asset Disposition” (1))
	  	 Dispositions from Guarantors to non-Guarantor Restricted Subsidiaries subject to a
cap of $25 million. 100% cash consideration requirement.
  

The foregoing cap will not apply to Dispositions that are permitted Investments or permitted Restricted Payments. Affiliate Transactions
covenants to apply to such Dispositions.

  
 -17- 

							
	 Provision/Basket/Ratio
	  	 2023 Credit Agreement
	  	 2025 Indentures
	  	 Agreed
Terms2

	 Exchanges
	  	 N/A
	  	 Exchanges for assets useful in a Similar Business of equal or greater FMV carved out of Asset Disposition.

 
 (§ 1.01 “Asset Disposition” (18))
	  	 Exchanges where assets are not received by the entity transferring the exchanged assets subject to the same restrictions as
Dispositions within Restricted Group.

				
	 Sale/Leaseback Transactions
	  	 Sale leasebacks permitted to the extent permitted under Indebtedness covenants. Not subject to sweep.

 
 (§ 6.14(vii))
	  	 Dispositions of real property for sale leasebacks permitted. Not subject to sweep.

 
 (§ 1.01 “Asset Disposition”
(19))
	  	 Eliminate.

				
	 De Minimis Dispositions
	  	 Dispositions for proceeds less than or equal to $15 million, subject to a cap of $50 million per fiscal year, are
carved out of the definition of an “Asset Sale Prepayment Event,” which triggers the asset sale sweep.
  

(§ 1.1 “Asset Sale Prepayment Event”)

 
 Covenant Reset Trigger (ii): thresholds reduced to $10 million and
$30 million, respectively.
	  	 Single transaction or series of related transactions with an aggregate Fair Market Value of less than $30 million. Not
subject to sweep.
  
 (§ 1.01 “Asset
Disposition” (10))
	  	 Dispositions for proceeds less than or equal to $5 million, subject to a cap of $15 million per fiscal year, are
carved out of the definition of an “Asset Sale Prepayment Event,” which triggers the asset sale sweep.

				
	 Fundamental Changes
	  	 N/A
	  	 Fundamental changes covenant applies to a sale of all or substantially all assets.

 
 (§ 5.01(a))
	  	 Covenant to apply to a sale of all or substantially all assets.

 
 No merger, consolidation, amalgamation or otherwise of
Borrower or Guarantor if not the surviving entity.

	
	 ECF Sweep

				
	 ECF Percentage
	  	 50%, with step down to 25% if Total Net Leverage Ratio is less than 3.25x and step down to 0% if Total Net Leverage Ratio is
less than 2.75x.
  
 (§ 1.1 “ECF
Percentage”)
	  	 N/A
	  	 Eliminate.

  
 -18- 

							
	 Provision/Basket/Ratio
	  	 2023 Credit Agreement
	  	 2025 Indentures
	  	 Agreed
Terms2

	 Excess Cash Flow Definition
	  	 See 2023 Credit Agreement.
  

(§ 1.1 “Excess Cash Flow”)
	  	 N/A
	  	 N/A

	
	Affiliate Transactions
				
	 Arm’s-Length Transaction
Carve-out
	  	 Affiliate transactions covenant exception for fair and reasonable arm’s-length
transactions.
  
 (§ 6.17(d))
	  	 Affiliate transactions covenant exception for arm’s-length transactions, with
board approval requirement for transactions in excess of $30 million and fairness opinion for transactions in excess of $50 million.
  

(§ 4.14(a))
	  	 Conform Extended Credit Agreement with 2025 Indentures.

				
	 Non-Guarantor Subsidiaries
Carve-out
	  	 Affiliate transactions covenant exception for transactions among non-Borrower and non-Guarantor Subsidiaries.
  

(§ 6.17(c))
	  	 Affiliate transactions covenant exception for transactions among the restricted group.

 
 (§ 4.14(b)(1))
	  	 Affiliate transactions covenant exception for transactions among non-Borrower and non-Guarantor Subsidiaries.

				
	 Restricted Payment and Permitted Investments Carve-out
	  	 Affiliate transactions covenant does not prohibit permitted Restricted Payments and Permitted Investments.

 
 (§ 6.17(e))
	  	 Affiliate transactions covenant does not prohibit permitted Restricted Payments and Permitted Investments.

 
 (§ 4.14(b)(2))
	  	 Keep existing formulation. Investments made pursuant to any basket in non-Guarantor
Restricted Subsidiaries to be on commercially reasonable terms.

	
	Events of Default
				
	 Change of Control
	  	 Change of Control definition does not include sale of all or substantially all assets.
	  	 Change of Control triggers include the sale, assignment, conveyance, transfer, lease or other disposition of all or
substantially all assets of the Company.
  
 (§ 1.01
“Change of Control”)
	  	 Leave unchanged except that Change of Control triggered if a change of control occurs under other material debt
documents.

  
 -19- 

							
	 Provision/Basket/Ratio
	  	 2023 Credit Agreement
	  	 2025 Indentures
	  	 Agreed
Terms2

	 Insolvency
	  	 Carves out Immaterial Subsidiaries.
  

(§ 7.6)
	  	 Applies to Significant Subsidiary or group that would constitute Significant Subsidiary.

 
 (§ 6.01(8))
	  	 Carve-out for Immaterial Subsidiaries.

	
	Voting / Amendments
				
	 Sacred Rights
	  	 See 2023 Credit Agreement.
  

(§ 8.2.1(a))
	  	 See 2025 Indentures.
  

(§ 9.02(e))
	  	 Payment or lien subordination to require the consent of all affected Holders.

 
 Modifications to payment or application of proceeds
waterfalls (including waterfall priorities in intercreditor agreements) to require the consent of all affected Holders.

				
	 Amendments to Release Collateral / Guarantees
	  	 All affected Lender consent required to release all or substantially all of Collateral or Guarantees.

 
 (§ 8.2.1(c)(ii))
	  	 66.67% consent required for amendments to modify the Collateral Documents in a manner that is materially adverse to Holders
or to release all or substantially all of Collateral.
  

(§ 9.02(f))
	  	 67% consent required for release of more than $50 million of Collateral or Guarantees.

 
 All affected Lender consent required for release of all or
substantially all of Collateral or Guarantees, provided that, notwithstanding anything to the contrary herein, solely in immediate contemplation of or following commencement of insolvency proceedings with respect to Diebold Nixdorf, Incorporated and
its material US-domiciled subsidiaries, the Guarantees by German Obligors and liens on assets of such Obligors in each case with respect to the Superpriority Facility, the New Term Loans, the 2025 Notes and
the New 2L Notes may be released with the consent of (i) lenders holding in excess of 67% of the loans under the Superpriority Facility, (ii) lenders holding in excess of 67% of the New Term Loans, and (iii) holders holding in excess
of 67% of the 2025 Notes, solely in the event that such lenders and holders determine in good faith that the release of such Guarantees and liens is necessary to avoid material value deterioration of the German Obligors and, upon and simultaneously
with such release, the priority of liens on the pledged equity of 

  
 -20- 

							
	 Provision/Basket/Ratio
	  	 2023 Credit Agreement
	  	 2025 Indentures
	  	 Agreed
Terms2

		  		  		  	 Diebold Nixdorf Holding Germany GmbH shall automatically be changed such that the lien in favor of the Superpriority
Facility is senior to the lien in favor of the New Term Loans, the 2025 Notes and (for the avoidance of doubt) the New 2L Notes (it being understood that the lien on the pledged equity of Diebold Nixdorf Holding Germany GmbH securing the New 2L
Notes shall at all times be junior to the liens securing the Superpriority Facility, the New Term Loans and the 2025 Notes); provided that, no such release will be effective until the applicable insolvency proceeding is actually
commenced

				
	 Amendments to Lift Restrictions on Intercompany Restricted Payments, Investments and Loans
	  	 N/A
	  	 N/A
	  	 Majority consent required.

				
	 Amendments to Allow Designation of Unrestricted Subsidiaries
	  	 N/A
	  	 N/A
	  	 Consent of all affected Lenders required.

				
	 Amendments to Debt and Lien Baskets
	  	 N/A
	  	 N/A
	  	 Majority consent required, provided that:

 
 Any additional debt that is senior to the debt under the
New Term Loan Credit Agreement and provided by lenders under the New Term Loan Credit Agreement can be approved with 67% consent but must be offered to existing holders of debt under the New Term Loan Credit Agreement for participation pro rata to
their holdings thereof at such time and any such additional debt must, on the day of incurrence, be in all material respects substantially equivalent to the terms of such debt at the time it was offered to existing holders.

 
 All affected lender consent required to increase
incremental debt in order to influence voting thresholds.

  
 -21- 

							
	 Provision/Basket/Ratio
	  	 2023 Credit Agreement
	  	 2025 Indentures
	  	 Agreed
Terms2

	 Other Thresholds
	  	 N/A
	  	 N/A
	  	 Require 75% consent to allow for reintroduction of open market purchases of term loans with
non-cash assets and also to waive or modify Chewy protection.

	
	Leverage Calculations
				
	 EBITDA Definition
	  	 Cap of 10% in the aggregate for synergies and cost savings.

 
 (§ 1.1 “EBIT”)
	  	 Cap of 15% in the aggregate for synergies and cost savings.

 
 (§ 1.01 “Consolidated EBITDA”)
	  	
	
	Guarantee and Collateral Requirements
				
	 Collateral Definition
	  	 See 2023 Credit Agreement.
  

(§ 1.1 “Collateral”)
	  	 See 2025 Indentures.
  

(§ 1.01 “Excluded Property”)
	  	
				
	 Excluded Assets / Property
	  	 See 2023 Credit Agreement
  

(§ 1.1 “Excluded Assets”)
	  	 See 2025 Indentures.
  

(§ 1.01 “Excluded Property”)
	  	
				
	 Excluded Subsidiaries
	  	 •  Adverse Tax Consequences: Subsidiaries where the pledge
of 66.67% or more of equity, or the provision of a guarantee, could result in adverse tax consequences are Excluded Subsidiaries.
  

•  Immaterial Subsidiaries: defined as Restricted Subsidiaries that account
for not more than (i) 5% of the total assets of the restricted group or (ii) 5% of the total revenue of the restricted group. The aggregate total assets or revenues for all Immaterial Subsidiaries shall not exceed 10% of the total assets or revenues
of the restricted group.
	  	 •  Adverse Tax Consequences: Subsidiaries where the pledge
of 66.67% or more of equity, or the provision of a guarantee, could result in adverse tax consequences are Excluded Subsidiaries.
  

•  Immaterial Subsidiaries: defined as Restricted Subsidiaries that account
for not more than (i) 5% of the total assets of the restricted group or (ii) 5% of the total revenue of the restricted group. The aggregate total assets or revenues for all Immaterial Subsidiaries shall not exceed 10% of the total assets or revenues
of the restricted group.
	  	

  
 -22- 

							
	 Provision/Basket/Ratio
	  	 2023 Credit Agreement
	  	 2025 Indentures
	  	 Agreed
Terms2

		  	  

•  Wholly Owned Subsidiaries: defined as any person of which 100% of Capital
Stock is owned by another person.
  
 (§ 1.1
“Excluded Subsidiary”, “Immaterial Subsidiary”, “Wholly Owned Subsidiary”)
	  	  

•  Wholly Owned Subsidiaries: defined as Restricted Subsidiaries with respect
to which all Capital Stock is owned by the Company or another Wholly Owned Subsidiary.
  

(§ 1.01 “Excluded Subsidiary”, “Immaterial Subsidiary”, “Wholly Owned Subsidiary”)
	  	  

•  Covenant to be added to provide that company will not make any transfers or other
dispositions (for the avoidance of doubt, including de minimus transfers) of the shares/equity interests in any Guarantor to any party that would cause such Guarantor no longer to be able to provide a Guarantee due to local law or contractual
restrictions.

				
	 Future Guarantors Requirement
	  	 Requirement for Wholly Owned Domestic Restricted Subsidiaries to provide guarantees.

 
 (§ 6.12)
	  	 Requirement to add Guarantors applies to certain entities that, on the Issue Date or any time thereafter, guarantee any other
Indebtedness for borrowed money of the Company or any Guarantor.
  

(§ 4.11(a))
	  	 Broaden to apply to entities in existing collateral and guarantee jurisdictions as of the closing date that guaranty funded
debt of a non-guarantor in excess of $10 million.

				
	 Release of Guarantees under Senior Credit Facility
	  	 N/A
	  	 Provides for the release of Guarantees upon the release of Guarantees under the Senior Credit Facility.

 
 (§ 10.06(a)(B))
	  	 Remove provision from Notes (i.e., neither facility can drag).

				
	 Release of Collateral and Perfection under Senior Credit Facility
	  	 N/A
	  	 Provides for the release of Collateral upon release under the Senior Credit Facility, and Lien perfection requirements are
subject to the requirements in the Senior Credit Facility.
  

(§§ 11.07(a)(8), 11.07(b))
	  	 Remove provision from Notes (i.e., neither facility can drag)

				
	 Release of Collateral
	  	 N/A
	  	 Provides for the release of Collateral with 66.67% consent.

 
 (§ 11.07(a)(5))
	  	 To be governed by amendment thresholds in new § 9.02(f) of 2025 Indentures. Consistent with above.

  
 -23- 

							
	 Provision/Basket/Ratio
	  	 2023 Credit Agreement
	  	 2025 Indentures
	  	 Agreed
Terms2

	 Intercreditor Waterfall
	  	 N/A
	  	 N/A
	  	 Intercreditor agreements to provide that any dispositions of collateral pursuant to sections 363 or 1129 of the Bankruptcy
Code (or similar provisions under similar insolvency laws) shall be subject to intercreditor priorities. Rights to credit bid pursuant to section 363(k) of the Bankruptcy Code (or similar provisions under similar insolvency laws) shall be subject to
intercreditor priorities.

  
 -24- 

 Exhibit B 

Superpriority Commitments 
  

													
	 Commitment Party
	  	Allocated
Superpriority
Commitment
Amount (pro rata
share)	 	  	Allocated
Superpriority
Commitment
Amount
(oversubscription)	 	  	Total Allocated
Superpriority
Commitment
Amount	 
	 [Redacted]
	  	$	[Redacted	] 	  	$	[Redacted	] 	  	$	[Redacted	] 
		  	  
	  
	 	  	  
	  
	 	  	  
	  
	 
	 Total
	  	$	[Redacted	] 	  	$	[Redacted	] 	  	$	400,000,000.00	 
		  	  
	  
	 	  	  
	  
	 	  	  
	  
	 

 Exhibit C 

Structuring Parties 
  

					
	 Structuring Party
	  	Percentage of Structuring
Premium	 
	 [Redacted]
	  	 	[Redacted	]% 
		  	  
	  
	 
	 Total
	  	 	100.00	% 
		  	  
	  
	 

 Exhibit D 

Ad Hoc Group Steering Committee 
  

					
	 Member
	  	Percentage of Specified Debt held by all
Members of the Ad Hoc Group 
Steering
Committee	 
	 [Redacted]
	  	 	[Redacted	]% 
		  	  
	  
	 
	 Total
	  	 	100.00	% 
		  	  
	  
	 

 Exhibit E 

FORM OF PERMITTED TRANSFEREE JOINDER 

The undersigned (the “Transferee”) hereby (a) acknowledges that it has read and understands the
Transaction Support Agreement (together with the exhibits and attachments thereto (including the Term Sheet (as defined therein)), as each may be amended, restated, supplemented, or otherwise modified from time to time in accordance with the terms
thereof, the “Agreement”), dated as of October 20, 2022, entered into by and among (i) Diebold Nixdorf, Incorporated (the “Company”), (ii) certain affiliates of the Company and
(iii) [Transferor’s Name] (the “Transferor”), and (iv) other holders of the Existing Revolver Exposure, the Existing Term Loans, the 2025 Notes, and/or the 2024 Notes (as defined in the
Agreement); and (b) with respect to the Existing Revolver Exposure, the Existing Term Loans, the 2025 Notes, and/or the 2024 Notes to be acquired from the Transferor, agrees from and after such acquisition to be bound by the terms and
conditions of the Agreement, without modification, and shall be deemed a “Consenting Party” and a “Party” under the terms of the Agreement. The Transferee hereby makes as of the date hereof all representations and warranties made
in the Agreement by all other Consenting Parties. All Existing Revolver Exposure, the Existing Term Loans, the 2025 Notes, and/or the 2024 Notes held by the Transferee (now or hereafter) shall be subject in all respects to the Agreement. All notices
and other communications given or made pursuant to the Agreement shall be sent to the Transferee at the address set forth below in the Transferee’s signature below. Capitalized terms used but not defined herein shall have the meanings given to
such terms in the Agreement. 
 This Form of Permitted Transferee Joinder shall be governed by, and construed in accordance
with, the laws of the State of New York without regard to any choice of law provision that would require the application of the laws of another jurisdiction. 

Date Executed: _____________, 202[•] 
  

			
	[Name of Transferee]
		
	By:	 	  

		
	Name:	 	  

		
	Title:	 	  

	
	Notice Information:
	
	                                    
            
	
	                                    
            

 Holdings: 
  

													
	 	  	Beneficial/Record
Ownership	 	  	Open Trade
Acquisitions	 	  	Open Trade
Sales	 
	 Revolving Credit Loans (as defined under the Existing Credit Agreement)
	  	$	[___	] 	  	$	[___	] 	  	$	[___	] 
	 Revolving Credit Commitments (as defined under the Existing Credit Agreement), excluding any
Revolving Credit Loans
	  	$	[___	] 	  	$	[___	] 	  	$	[___	] 
	 Dollar-denominated Existing Term Loans
	  	$	[___	] 	  	$	[___	] 	  	$	[___	] 
	 Euro-denominated Existing Term Loans
	  	€	[___	] 	  	€	[___	] 	  	€	[___	] 
	 U.S. 2025 Notes
	  	$	[___	] 	  	$	[___	] 	  	$	[___	] 
	 Euro 2025 Notes
	  	€	[___	] 	  	€	[___	] 	  	€	[___	] 
	 2024 Notes
	  	$	[___	] 	  	$	[___	] 	  	$	[___	] 

 Exhibit F 

FORM OF ADDITIONAL CONSENTING PARTY JOINDER 

The undersigned (the “Additional Consenting Party”) hereby (a) acknowledges that it has read and
understands the Transaction Support Agreement (together with the exhibits and attachments thereto (including the Term Sheet (as defined therein)), as each may be amended, restated, supplemented, or otherwise modified from time to time in accordance
with the terms thereof, the “Agreement”), dated as of October 20, 2022, entered into by and among (i) Diebold Nixdorf, Incorporated (the “Company”), (ii) certain affiliates of the Company and (iii) other
holders of Existing Debt (as defined in the Agreement), (b) represents that it (x) either (A) is the beneficial or record owner of the principal amount of Existing Debt indicated on its respective signature page hereto or (B) has sole
investment or voting discretion with respect to the principal amount of Existing Debt indicated on its respective signature page hereto and has the power and authority to bind the beneficial owner of such Existing Debt to the terms of this Agreement
and (c) with respect to the Existing Debt held by such Additional Consenting Party, agrees from and after the date of this joinder to be bound by the terms and conditions of the Agreement, and shall be deemed a “Consenting Party” and
a “Party” under the terms of the Agreement. The Additional Consenting Party hereby makes as of the date hereof all representations and warranties made in the Agreement by all other Consenting Parties. All Existing Debt held by the
Additional Consenting Party (now or hereafter) shall be subject in all respects to the Agreement. All notices and other communications given or made pursuant to the Agreement shall be sent to the Additional Consenting Party at the address set forth
below in the Additional Consenting Party’s signature below. Capitalized terms used but not defined herein shall have the meanings given to such terms in the Agreement. 

This Form of Permitted Transferee Joinder shall be governed by, and construed in accordance with, the laws of the State of New
York without regard to any choice of law provision that would require the application of the laws of another jurisdiction. 
 Date Executed:
_____________, 202[•] 
  

			
	 [Name of Additional Consenting Party]

		
	By:	 	  

		
	Name:	 	  

		
	Title:	 	  

	
	Notice Information:
	
	                                    
            
	
	                                    
            

 Holdings: 
  

													
	 	  	Beneficial/Record
Ownership	 	  	Open Trade
Acquisitions	 	  	Open Trade
Sales	 
	 Revolving Credit Loans (as defined under the Existing Credit Agreement)
	  	$	[___	] 	  	$	[___	] 	  	$	[___	] 
	 Revolving Credit Commitments (as defined under the Existing Credit Agreement), excluding any
Revolving Credit Loans
	  	$	[___	] 	  	$	[___	] 	  	$	[___	] 
	 Dollar-denominated Existing Term Loans
	  	$	[___	] 	  	$	[___	] 	  	$	[___	] 
	 Euro-denominated Existing Term Loans
	  	€	[___	] 	  	€	[___	] 	  	€	[___	] 
	 U.S. 2025 Notes
	  	$	[___	] 	  	$	[___	] 	  	$	[___	] 
	 Euro 2025 Notes
	  	€	[___	] 	  	€	[___	] 	  	€	[___	] 
	 2024 Notes
	  	$	[___	] 	  	$	[___	] 	  	$	[___	]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00349-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00349-of-00352.parquet"}]]